Sentence,class,file
Carcinogenesis 2014; (Forthcoming);  PMID:24590894 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/03/55/onci-3-e29287.PMC4126836.pdf
Trends Immunol 2012; 33:119-26; PMID:22277903 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/03/55/onci-3-e29287.PMC4126836.pdf
Curr Opin Immunol 2012; 24:207-12; PMID:22236695 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/03/55/onci-3-e29287.PMC4126836.pdf
Blood 2014; 123:2625-35; PMID:24578504 ; http://dx.doi.org/10.1182/ blood-2013-11-492231 10.,Non-OADS,/arxiv_data1/oa_pdf/03/55/onci-3-e29287.PMC4126836.pdf
"OncoImmunology 2014; 3:e29259; http://dx.doi.org/10.4161/onci.29259STING-dependent cytosolic DNA sensor pathways  regulate NKG2D ligand expression Nina Le Bert1, Adeline r Lam1,2, sa mantha sw  ho1, Yu J sh en1, 2, Mo M Liu1, and st ephan Gasser1, 2,* 1im munology Programme; Centre of Life sc iences; Department of Microbiology; Yong Loo Lin sc hool of Medicine; National un iversity of si ngapore; si ngapore; 2Nu s  Graduate  sc hool for  in tegrative  sc iences and  en gineering; National  un iversity of  si ngapore;  si ngapore Keywords:  Natural killer cells, NKG2D, signal transduction, tumor immunology, DNA sensor th e DNA damage response (DD r) u pregulates the expression of NKG2D ligands (NKG2DLs).1,2 we h ave recently  reported that the DD r  also induces the presence of cytosolic DNA in B-cell lymphoma cells, which leads to the activation  of  stiN G-dependent cytosolic DNA sensor pathways and the expression of  rA e- 1 ligands for NKG2D.3 ©2014 Landes Bioscience.",Non-OADS,/arxiv_data1/oa_pdf/2c/71/onci-3-e29259.PMC4126837.pdf
Annu Rev Immunol 2013; 31:413- 41; PMID:23298206 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-095951 2.,Non-OADS,/arxiv_data1/oa_pdf/2c/71/onci-3-e29259.PMC4126837.pdf
Nature 2005; 436:1186-90;  PMID:15995699 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/71/onci-3-e29259.PMC4126837.pdf
Cancer Res 2014; 74:2193-203; PMID:24590060 ; http://dx.doi.org/10.1158/0008- 5472.CAN-13-1703 4.,Non-OADS,/arxiv_data1/oa_pdf/2c/71/onci-3-e29259.PMC4126837.pdf
Nature 2009; 461:1071-8; PMID:19847258 ; http://dx.doi.org/10.1038/ nature08467 5.,Non-OADS,/arxiv_data1/oa_pdf/2c/71/onci-3-e29259.PMC4126837.pdf
Blood 2013; 121:2512-21;  PMID:23349395 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/71/onci-3-e29259.PMC4126837.pdf
Nat Rev Mol Cell Biol 2010; 11:208-19;  PMID:20177396 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2c/71/onci-3-e29259.PMC4126837.pdf
Trends Immunol 2014; 35:1-2; PMID:24231656 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2c/71/onci-3-e29259.PMC4126837.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Food & Nutrition Research 2014, 58: 21796 - http://dx.doi.org/10.3402/fnr.v58.21796 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
"The United Kingdom NICE 2012 guidelines on fractures and osteoporosis, that are mainly focused onfracture risk and other related NICE guidelines, haveno special focus on calcium and vitamin D (http://www.nice.org.uk/nicemedia/ live/13857/60399/60399.pdf) (last assessed on April 24, 2013).",Non-OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
"The Australian guideline (http://www.osteoporosis.org.au/images/stories/updatedthinkgp.pdf)(last assessed on April 24th 2013) advises for women over50 years of age a calcium intake of 1,300 mg per dayand a vitamin D intake of 800 IE.",Non-OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
"2 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 21796 - http://dx.doi.org/10.3402/fnr.v58.21796",Non-OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
"Relationship between serum 25(OH)D level and fractional calcium absorption (20).Calcium and vitamin D supplementation Citation: Food & Nutrition Research 2014, 58: 21796 - http://dx.doi.org/10.3402/fnr.v58.21796 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
"4 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 21796 - http://dx.doi.org/10.3402/fnr.v58.21796",Non-OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
"/C30not significant, AUC /C30area under the curve, BSAP /C30bone-specific alkaline phosphatase.Calcium and vitamin D supplementation Citation: Food & Nutrition Research 2014, 58: 21796 - http://dx.doi.org/10.3402/fnr.v58.21796 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
"6 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 21796 - http://dx.doi.org/10.3402/fnr.v58.21796",Non-OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
"Calcium intake and serum 25(OH)D in 50 /C27patients with a recent fracture, according to gender, age, fracture location and BMD.Calcium and vitamin D supplementation Citation: Food & Nutrition Research 2014, 58: 21796 - http://dx.doi.org/10.3402/fnr.v58.21796 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
"8 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 21796 - http://dx.doi.org/10.3402/fnr.v58.21796",Non-OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
"Practical advice for calcium and vitamin D supplementation Based on guidelines, optimization of total calcium intake towards a total of 1,000 /C11,200 mg calcium per day is considered necessary and sufficient in the context of osteoporosis and fracture prevention strategies with drugCalcium and vitamin D supplementation Citation: Food & Nutrition Research 2014, 58: 21796 - http://dx.doi.org/10.3402/fnr.v58.21796 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
Available from: http://www.nvr.nl/uploads/lF/c0/lFc0oDLyo7H0 Nnn70mdQ9w/CBO-richtlijn- osteoporose-en-fractuurpreventie-2011.pdf [cited 20 February 2013].,OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
"10 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 21796 - http://dx.doi.org/10.3402/fnr.v58.21796",Non-OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
"Am J Epidemiol 1999; 149: 151 /C161.Calcium and vitamin D supplementation Citation: Food & Nutrition Research 2014, 58: 21796 - http://dx.doi.org/10.3402/fnr.v58.21796 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
"12 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 21796 - http://dx.doi.org/10.3402/fnr.v58.21796",Non-OADS,/arxiv_data1/oa_pdf/30/e4/FNR-58-21796.PMC4126954.pdf
2003 Available from:  http://www.who.int/chp/knowledge/publications /adherence_report/en/ [Accessed 15 May 2010]  3.,Non-OADS,/arxiv_data1/oa_pdf/46/9c/pharmpract-08-147.PMC4127049.pdf
2005  Available from: http://www.medslear ning.leeds.ac.uk/pages/documents/usef ul_docs/76-final-report%5B1%5D.pdf  [Accessed 10 July 2010]  6.,Non-OADS,/arxiv_data1/oa_pdf/46/9c/pharmpract-08-147.PMC4127049.pdf
2009 Available from:  http://retki.stakes.fi/EN/index.htm [Accessed 10 July 2010],Non-OADS,/arxiv_data1/oa_pdf/46/9c/pharmpract-08-147.PMC4127049.pdf
The Ministry of  Social Affairs and Health and its administrative sector 2010  Available from: http://www.stm.fi/en/ ministry [Accessed 10 August 2010]  27.,Non-OADS,/arxiv_data1/oa_pdf/46/9c/pharmpract-08-147.PMC4127049.pdf
2009 Available from: http://www.ak ava.fi/files/67/atm2009nettiin.pdf [Accessed 9 August 2010]  31.,Non-OADS,/arxiv_data1/oa_pdf/46/9c/pharmpract-08-147.PMC4127049.pdf
2006 Available from: http://www.stm.fi/c/doc ument_library/get_file?folderId=28707&name=DLFE- 4090.pdf&title=Turvallinen_laakehoito_fi.pdf [Accessed 15 May 2010]  73.,Non-OADS,/arxiv_data1/oa_pdf/46/9c/pharmpract-08-147.PMC4127049.pdf
Available from:  http://www2.fda.moph.go.th/consumer/drug/dcenter.asp.,Non-OADS,/arxiv_data1/oa_pdf/e8/66/pharmpract-08-167.PMC4127051.pdf
Available from: http://wwwapp1.fda.moph.go.th/drug/z one_law/law031.asp.,Non-OADS,/arxiv_data1/oa_pdf/e8/66/pharmpract-08-167.PMC4127051.pdf
http://www cdc  gov/PRAMS/UP htm 2009 February 4;Available at: URL: http://www.cdc.gov/PRAMS/UP.htm.,Non-OADS,/arxiv_data1/oa_pdf/da/f2/pharmpract-08-173.PMC4127052.pdf
Dalla s (TX): American Heart Association; [updated 2007; cited 2010  March 25].Available from: http://www.americ anheart.org/presenter.jhtml?identifier=3002530.,Non-OADS,/arxiv_data1/oa_pdf/4c/36/pharmpract-08-187.PMC4127054.pdf
Available from: http://pharmacyhealthliteracy.ahrq.gov/sites /PharmHealthLiteracy/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/4c/36/pharmpract-08-187.PMC4127054.pdf
"Available at:  http://www.chi.nhs.uk/Ratings/Trust/Indi cator/IndicatorDescriptionShort.asp?IndicatorId=4553, accessed on 21 February  2008.",Non-OADS,/arxiv_data1/oa_pdf/11/a8/pharmpract-08-193.PMC4127055.pdf
"Available at:  http://www.dh.gov.uk/en/Publicationsandstatisti cs/Pressreleases/DH_4095409, accessed on 10 January 2008.",Non-OADS,/arxiv_data1/oa_pdf/11/a8/pharmpract-08-193.PMC4127055.pdf
"Available at: http://www.ppa.org.uk,   accessed on: 10 November 2007  19.",Non-OADS,/arxiv_data1/oa_pdf/11/a8/pharmpract-08-193.PMC4127055.pdf
"Available at: http://www.primary-care-db.org.uk, accessed 1 February 2008.",Non-OADS,/arxiv_data1/oa_pdf/11/a8/pharmpract-08-193.PMC4127055.pdf
"Available at: http://www.ic.nhs.uk/statistics-and- data-collections/qof-information/qof- 2004-05, accessed 11 November 2007  34.",Non-OADS,/arxiv_data1/oa_pdf/11/a8/pharmpract-08-193.PMC4127055.pdf
"Ava ilable at: http://www.sepho.org.uk, accessed 20 January 2008  35.",Non-OADS,/arxiv_data1/oa_pdf/11/a8/pharmpract-08-193.PMC4127055.pdf
Available from the World Wide Web  http://www.searo.who.int/LinkFiles/Country_Health_System_Profile_8-Nepal.pdf  2.,OADS,/arxiv_data1/oa_pdf/9a/17/pharmpract-08-201.PMC4127056.pdf
2004/2005; 15 (2) Available at http://www.dinon.org/publications/dbn-vol16.pdf (Accessed on May  21st 2008)   8.,Non-OADS,/arxiv_data1/oa_pdf/9a/17/pharmpract-08-201.PMC4127056.pdf
"Kathmandu  Univ J Sci Eng Technol 2006; 2 http://www.ku.edu.np/ku set/second_issue/o2/Rajeev.pdf  (Accessed on 3rd January,  2010)   19.",Non-OADS,/arxiv_data1/oa_pdf/9a/17/pharmpract-08-201.PMC4127056.pdf
[Online] Available from:  http://jop.ascopubs.org/cgi/data/2/4/196/DC2/1 [accessed 12.4.08].,OADS,/arxiv_data1/oa_pdf/9e/27/pharmpract-08-213.PMC4127058.pdf
[Online] Available from:  http://www.londonpharmacy.nhs.uk/educationandtraining/pr ereg/pfizerProjectAwards2007/Bronagh%20McBrien%20Qu een%20Elizabeth%20Hospital.pdf [accessed 20.6.08].,Non-OADS,/arxiv_data1/oa_pdf/9e/27/pharmpract-08-213.PMC4127058.pdf
[Online] Available from:  http://www.ssipph.scot.nhs.uk/Pfizer_2006/AN%20AUDIT%20OF%20COMPLIANCE%20WITH%20NORTH%20GLASG OW%20G.doc [accessed 20.6.08].,Non-OADS,/arxiv_data1/oa_pdf/9e/27/pharmpract-08-213.PMC4127058.pdf
"[Online] Available from: http://www.cancer- therapy.org/CT1A/pdf/20%20%20Saab%20et%20al,%20191-196%20cop.pdf [accessed 23.06.08].",Non-OADS,/arxiv_data1/oa_pdf/9e/27/pharmpract-08-213.PMC4127058.pdf
[Online] Avail able from: http://info.cancerres earchuk.org/cancerstats/reports/  [accessed 10.7.08].,Non-OADS,/arxiv_data1/oa_pdf/9e/27/pharmpract-08-213.PMC4127058.pdf
Available from:  http://www.apha.org/advocacy/policy/policysearch/default.htm?id=1338  3.,Non-OADS,/arxiv_data1/oa_pdf/e9/77/pharmpract-08-220.PMC4127059.pdf
[Internet] Joint Commission on  Pharmacy Practice [created 10 Nov 2004; cited 15 Feb 2009] Available from: http://www.pharmacist.com/  9.,Non-OADS,/arxiv_data1/oa_pdf/e9/77/pharmpract-08-220.PMC4127059.pdf
[updated Jan 2008; cited 25 Nov 2008] Available from  http://www.atpm.org/resources/pdfs/Official_CPPH_Framework_2008.pdf   10.,OADS,/arxiv_data1/oa_pdf/e9/77/pharmpract-08-220.PMC4127059.pdf
[updated May 2004; cited 25 Nov 2008] Available from:  http://www.aacp.org/Docs/MainNavigation/Resources/6075_CAPE2004.pdf   11.,OADS,/arxiv_data1/oa_pdf/e9/77/pharmpract-08-220.PMC4127059.pdf
Available from: http://www.acpe- accredit.org/pdf/ACPE_Revised_PharmD_Standards_Adopted_Jan152006.pdf  12.,Non-OADS,/arxiv_data1/oa_pdf/e9/77/pharmpract-08-220.PMC4127059.pdf
Available from:  http://www.cdc.gov/ncbddd/bd/mp.htm  14.,OADS,/arxiv_data1/oa_pdf/e9/77/pharmpract-08-220.PMC4127059.pdf
Available from: http://www.marchofdimes.com/pnhec/173_769.asp\  26.,Non-OADS,/arxiv_data1/oa_pdf/e9/77/pharmpract-08-220.PMC4127059.pdf
Available from : http://www.cdc.gov/ncbddd/folicacid/about.html  27.,OADS,/arxiv_data1/oa_pdf/e9/77/pharmpract-08-220.PMC4127059.pdf
Inclusion criteria:  Two hundred and ten hospitalized patients  [according to calculated sample size using Raosoft  SampleSize Calculator  (http://www.raosoft.com/samplesize.html) at 5%,Non-OADS,/arxiv_data1/oa_pdf/c9/6a/pharmpract-08-233.PMC4127061.pdf
http://www.wsmi.org.,Non-OADS,/arxiv_data1/oa_pdf/c9/6a/pharmpract-08-233.PMC4127061.pdf
"Caution on self-medication In: Regulatory Action and News, WHO Drug Information 2005;  19(3), 201-242 (Press Release 17th June, 2005. http://www.hsa.gov.org)   13.",Non-OADS,/arxiv_data1/oa_pdf/c9/6a/pharmpract-08-233.PMC4127061.pdf
http://www.safekids.org.nz/Downloads/Safekids%20Facts heets/Safekids%20Poisoning% 20Injury%20Factsheet%20200 6.pdf.,Non-OADS,/arxiv_data1/oa_pdf/40/25/pharmpract-08-238.PMC4127062.pdf
"297 http://dx.doi.org/10.3345/kjp.2014.57.7.297 Comprehensive understanding of atrial septal  defects by imaging studies for successful  transcatheter closure Jinyoung Song, MD, PhD Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Transcatheter closure of atrial septal defects has become a popular procedure.",Non-OADS,/arxiv_data1/oa_pdf/35/76/kjped-57-297.PMC4127391.pdf
"Key words: Atrial heart septal defects, Vascular access device, Echocardiography, X-ray computed  tomography scannerCorresponding author:  Jinyoung Song, MD, PhD Department of Pediatrics, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81  Irwon-ro, Gangnam-gu, Seoul 135-710, Korea  Tel: +82-2-3410-3539 Fax: +82-2-3410-0043 E-mail: amyjys@naver.com Received: 2 May, 2014 Accepted: 31 May, 2014 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2014;57(7):297-303 http://dx.doi.org/10.3345/kjp.2014.57.7.297 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Atrial septal defect (ASD) is one of the most common congenital heart diseases  encountered in outpatient clinics.",Non-OADS,/arxiv_data1/oa_pdf/35/76/kjped-57-297.PMC4127391.pdf
http://dx.doi.org/10.3345/kjp.2014.57.7.297Song J  • Imaging studies for transcatheter closure of ASD 298The general indications for closure include evidence of right  cardiac volume overload even without symptoms.,Non-OADS,/arxiv_data1/oa_pdf/35/76/kjped-57-297.PMC4127391.pdf
"299 http://dx.doi.org/10.3345/kjp.2014.57.7.297Korean J Pediatr 2014;57(7):297-303 CT for ASD device closure and demonstrated superior resolution  and measurement of the surrounding rims using cardiac CT15,16)  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/35/76/kjped-57-297.PMC4127391.pdf
http://dx.doi.org/10.3345/kjp.2014.57.7.297Song J  • Imaging studies for transcatheter closure of ASD 30075% smaller than the long diameter could be closed safely with  an ASO smaller than that used for a circular defect.,Non-OADS,/arxiv_data1/oa_pdf/35/76/kjped-57-297.PMC4127391.pdf
301 http://dx.doi.org/10.3345/kjp.2014.57.7.297Korean J Pediatr 2014;57(7):297-303 been suspected to play an important role in cardiac erosion after  implantation and should be avoided during size selection.,Non-OADS,/arxiv_data1/oa_pdf/35/76/kjped-57-297.PMC4127391.pdf
http://dx.doi.org/10.3345/kjp.2014.57.7.297Song J  • Imaging studies for transcatheter closure of ASD 302good outcome even without the use of balloon sizing methods.,Non-OADS,/arxiv_data1/oa_pdf/35/76/kjped-57-297.PMC4127391.pdf
303 http://dx.doi.org/10.3345/kjp.2014.57.7.297Korean J Pediatr 2014;57(7):297-303 25.,Non-OADS,/arxiv_data1/oa_pdf/35/76/kjped-57-297.PMC4127391.pdf
"304 http://dx.doi.org/10.3345/kjp.2014.57.7.304 Benign convulsion with mild gastroenteritis Ben Kang, MD1, Young Se Kwon, MD, PhD2 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 2Department of Pediatrics, Inha University Hospital,  Incheon, Korea Benign convulsion with mild gastroenteritis (CwG) is a type of afebrile seizure that occurs in children.",Non-OADS,/arxiv_data1/oa_pdf/78/1c/kjped-57-304.PMC4127392.pdf
"Key words: Seizures, Gastroenteritis, Rotavirus, NorovirusCorresponding author:  Young Se Kwon, MD, PhD Department of Pediatrics, Inha University Hospital,  27 Inhang-ro, Jung-gu, Incheon 400-711, Korea Tel: +82-32-890-3579 Fax: +82-32-890-2844 E-mail: ysped@inha.ac.kr Received: 19 February, 2014 Accepted: 3 June, 2014 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2014;57(7):304-309 http://dx.doi.org/10.3345/kjp.2014.57.7.304 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction In 1982, Morooka1) first reported a clinical condition in which mild viral gastroenteritis  without severe dehydration, electrolyte imbalance, or hypoglycemia could trigger afebrile  convulsions.",Non-OADS,/arxiv_data1/oa_pdf/78/1c/kjped-57-304.PMC4127392.pdf
"305 http://dx.doi.org/10.3345/kjp.2014.57.7.304Korean J Pediatr 2014;57(7):304-309 Epidemiology  CwG is known to occur predominantly in winter and early  spring in temperate countries, corresponding to the outbreaks  of viral gastroenteritis—especially rotavirus gastroenteritis4,5,12).",Non-OADS,/arxiv_data1/oa_pdf/78/1c/kjped-57-304.PMC4127392.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.7.304Kang B and Kwon YS  • Benign convulsion with mild gastroenteritis 306virus may stimulate a strong immune response in the host24,32- 34).",Non-OADS,/arxiv_data1/oa_pdf/78/1c/kjped-57-304.PMC4127392.pdf
"307 http://dx.doi.org/10.3345/kjp.2014.57.7.304Korean J Pediatr 2014;57(7):304-309 acute necrotizing encephalitis, meningitis, Reye syndrome, and  flaccid paralysis have been associated with 2%–5% of rotavirus  infections, with a presentation that may mimic CwG in some  cases48,49).",Non-OADS,/arxiv_data1/oa_pdf/78/1c/kjped-57-304.PMC4127392.pdf
http://dx.doi.org/10.3345/kjp.2014.57.7.304Kang B and Kwon YS  • Benign convulsion with mild gastroenteritis 308viruses are required in the future.,Non-OADS,/arxiv_data1/oa_pdf/78/1c/kjped-57-304.PMC4127392.pdf
309 http://dx.doi.org/10.3345/kjp.2014.57.7.304Korean J Pediatr 2014;57(7):304-309 34.,Non-OADS,/arxiv_data1/oa_pdf/78/1c/kjped-57-304.PMC4127392.pdf
"310 http://dx.doi.org/10.3345/kjp.2014.57.7.310 Prader-Willi syndrome: a single center’s experi- ence in Korea Yea Ji Kim, MD1, Chong Kun Cheon, MD, PhD1,2,3 1Department of Pediatrics, Pusan National University School of Medicine, Yangsan, 2Department of Pediatrics, Pediatric Endocrinoloy and Metabolism, Pusan  National University Children’s Hospital, Yangsan, 3Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan  Hospital, Yangsan, Korea Purpose:  Prader-Willi syndrome (PWS) is a complex genetic disorder that results from the lack of  paternally expressed genes in the chromosome 15q11–q13 region.",Non-OADS,/arxiv_data1/oa_pdf/2a/b3/kjped-57-310.PMC4127393.pdf
"Key words:  Prader-Willi syndrome, Growth hormone, Clinical manifestations Corresponding author:  Chong Kun Cheon, MD,  PhD  Department of Pediatrics, Pusan National Univer - sity Children’s Hospital, Pusan National University  School of Medicine, 20 Geumo-ro, Mulgeum-eup,  Yangsan 626-700, Korea Tel: +82-55-360-2180 Fax: +82-55-360-2181 E-mail: chongkun@pusan.ac.kr Received: 22 October, 2013 Revised: 8 January, 2014 Accepted: 11 March, 2014 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2014;57(7):310-316 http://dx.doi.org/10.3345/kjp.2014.57.7.310 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Prader-Willi syndrome (PWS) is a complex genetic disorder that results from the lack  of paternally expressed genes in the chromosome 15q11–q13 region caused by a deletion  of the paternal copy (70%), maternal uniparental disomy (UPD) (25%), an imprinting  center defect, or balanced translocation1-3).",Non-OADS,/arxiv_data1/oa_pdf/2a/b3/kjped-57-310.PMC4127393.pdf
"311 http://dx.doi.org/10.3345/kjp.2014.57.7.310Korean J Pediatr 2014;57(7):310-316 with a decline in fat percentage and an increment in lean  body mass (LBM), resulting in increased muscle strength and  agility3,7,8).",Non-OADS,/arxiv_data1/oa_pdf/2a/b3/kjped-57-310.PMC4127393.pdf
http://dx.doi.org/10.3345/kjp.2014.57.7.310Kim YJ and Cheon CK  • Growth hormone therapy in Prader-Willi syndrome patients 312leukomalacia (3.3%).,OADS,/arxiv_data1/oa_pdf/2a/b3/kjped-57-310.PMC4127393.pdf
313 http://dx.doi.org/10.3345/kjp.2014.57.7.310Korean J Pediatr 2014;57(7):310-316 under two years of age compared with individuals older than two  years of age after GH treatment ( P=0.014) (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/2a/b3/kjped-57-310.PMC4127393.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.7.310Kim YJ and Cheon CK  • Growth hormone therapy in Prader-Willi syndrome patients 314Discussion This study was performed to delineate the phenotypic charac - terization of Korean PWS infants and toddlers and assess  their response to two years of GH treatment according to  gender and age at the start of treatment, which would allow  a comprehensive understanding of the natural course of PWS  and the effects of GH treatment.",Non-OADS,/arxiv_data1/oa_pdf/2a/b3/kjped-57-310.PMC4127393.pdf
315 http://dx.doi.org/10.3345/kjp.2014.57.7.310Korean J Pediatr 2014;57(7):310-316 should be conducted to gain more insight into the relationship  between GH treatment and muscle strength.,Non-OADS,/arxiv_data1/oa_pdf/2a/b3/kjped-57-310.PMC4127393.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.7.310Kim YJ and Cheon CK  • Growth hormone therapy in Prader-Willi syndrome patients 316We thank the patients and their families for participating in  this study, which was supported by a 2-Year Research Grant of  Pusan National University.",Non-OADS,/arxiv_data1/oa_pdf/2a/b3/kjped-57-310.PMC4127393.pdf
"317 http://dx.doi.org/10.3345/kjp.2014.57.7.317 Prevalence of restless legs syndrome and sleep  problems in Korean children and adolescents  with attention deficit hyperactivity disorder: a  single institution study Soonhak Kwon, MD1, Youngsoo Sohn, MD1, Seong-Hoon Jeong, MD, PhD2, Un-Sun Chung, MD, PhD2, Hyeeun Seo, MD, PhD3 Departments of 1Pediatrics and 2Psychiatry, Kyungpook National University School of Medicine, Daegu, 3Department of Pediatrics, Busan St. Mary’s Medical Center,  Busan, Korea Purpose:  Attention deficit hyperactivity disorder (ADHD) is a common disorder in school-aged children.",Non-OADS,/arxiv_data1/oa_pdf/76/29/kjped-57-317.PMC4127394.pdf
"Key words:  Attention deficit disorders with hyperactivity, Child, Adolescents, East Asian, Restless legs  syndromeCorresponding author:  Hyeeun Seo, MD, PhD Department of Pediatrics, Busan St. Mary’s Medical  Center, 23 Yongho-ro 252beon-gil, Nam-gu, Busan  608-838, Korea Tel: +82-51-933-7982 Fax: +82-51-932-8600 E-mail: she0922@hanmail.net Received: 9 August, 2013 Revised: 18 December, 2013 Accepted: 21 February, 2014 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2014;57(7):317-322 http://dx.doi.org/10.3345/kjp.2014.57.7.317 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Attention deficit hyperactivity disorder (ADHD) is a common neurobehavioral and  psychiatric disorder present in 4% to 12% of school-aged children1,2).",Non-OADS,/arxiv_data1/oa_pdf/76/29/kjped-57-317.PMC4127394.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.7.317Kwon S, et al.",OADS,/arxiv_data1/oa_pdf/76/29/kjped-57-317.PMC4127394.pdf
319 http://dx.doi.org/10.3345/kjp.2014.57.7.317Korean J Pediatr 2014;57(7):317-322 2.,Non-OADS,/arxiv_data1/oa_pdf/76/29/kjped-57-317.PMC4127394.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.7.317Kwon S, et al.",OADS,/arxiv_data1/oa_pdf/76/29/kjped-57-317.PMC4127394.pdf
"321 http://dx.doi.org/10.3345/kjp.2014.57.7.317Korean J Pediatr 2014;57(7):317-322 The subjects of this study also complained of various sleep  problems such as bedtime resistance, sleep onset difficulties,  difficulties with morning awakening, daytime sleepiness.",Non-OADS,/arxiv_data1/oa_pdf/76/29/kjped-57-317.PMC4127394.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.7.317Kwon S, et al.",OADS,/arxiv_data1/oa_pdf/76/29/kjped-57-317.PMC4127394.pdf
"323 http://dx.doi.org/10.3345/kjp.2014.57.7.323 Articulation error of children with adenoid  hypertrophy Tae-Hoon Eom, MD1, Eun-Sil Jang, MA2, Young-Hoon Kim, MD1, Seung-Yun Chung, MD1, In-Goo Lee, MD1 1Department of Pediatrics, The Catholic University of Korea College of Medicine, Seoul, 2Department of Speech-Language Therapy, Uijeongbu St. Mary’s Hospital, The  Catholic University of Korea College of Medicine, Uijeongbu, Korea Purpose: Adenoid hypertrophy is a physical alteration that may affect speech, and a speech disorder  can have other negative effects on a child’s life.",Non-OADS,/arxiv_data1/oa_pdf/28/ae/kjped-57-323.PMC4127395.pdf
"Key words: Adenoids, Hypertrophy, Mouth breathing, Articulation disorders, ChildCorresponding author:  Young-Hoon Kim Department of Pediatrics, Uijeongbu St. Mary’s  Hospital, 271 Cheonbo-ro, Uijeongbu 480-717,  Korea Tel: +82-31-820-3582 Fax: +82-31-821-3108 E-mail: pedkyh@catholic.ac.kr Received: 11 November, 2013 Revised: 14 December, 2013 Accepted: 22 January, 2014 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2014;57(7):323-328 http://dx.doi.org/10.3345/kjp.2014.57.7.323 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Adenoid hypertrophy is a common condition in children and can cause symptoms  such as mouth breathing, nasal discharge, snoring and sleep apnea1).",Non-OADS,/arxiv_data1/oa_pdf/28/ae/kjped-57-323.PMC4127395.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.7.323Eom T, et al.",OADS,/arxiv_data1/oa_pdf/28/ae/kjped-57-323.PMC4127395.pdf
325 http://dx.doi.org/10.3345/kjp.2014.57.7.323Korean J Pediatr 2014;57(7):323-328 Results 1.,Non-OADS,/arxiv_data1/oa_pdf/28/ae/kjped-57-323.PMC4127395.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.7.323Eom T, et al.",OADS,/arxiv_data1/oa_pdf/28/ae/kjped-57-323.PMC4127395.pdf
"327 http://dx.doi.org/10.3345/kjp.2014.57.7.323Korean J Pediatr 2014;57(7):323-328 Discussion In this study, some characteristics were found in articulation  error of children with adenoid hypertrophy.",Non-OADS,/arxiv_data1/oa_pdf/28/ae/kjped-57-323.PMC4127395.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.7.323Eom T, et al.",OADS,/arxiv_data1/oa_pdf/28/ae/kjped-57-323.PMC4127395.pdf
"329 http://dx.doi.org/10.3345/kjp.2014.57.7.329 Asymptomatic maternal 3-methylcrotonyl- glycinuria detected by her unaffected baby’s  neonatal screening test Sun Hee Lee, MD1, Yong Hee Hong, MD2 1Department of Pediatrics, Gachon University Gil Medical Center, Incheon, 2Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Bucheon, Korea 3-methylcrotonyl-coenzyme A carboxylase (3MCC) deficiency is an autosomal recessive  disorder in which leucine catabolism is hampered, leading to increased urinary excretion of  3-methylcrotonylglycine.",Non-OADS,/arxiv_data1/oa_pdf/d9/31/kjped-57-329.PMC4127396.pdf
"Key words:  Neonatal screening, 3-Methylcrotonyl CoA carboxylase, Asymptomatic disease, Mother,  Unaffected newbornCorresponding author:  Sun Hee Lee, MD Department of Pediatrics, Gachon University Gil  Medical Center, 1198, Guwol-dong, Namdong-gu,  Incheon 405-760, Korea Tel: +82-32-460-3596 Fax: +82-32-460-3596 E-mail: sun-9268@hanmail.net Received: 17 September, 2014 Revised: 7 February, 2014 Accepted: 5 March, 2014 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2014;57(7):329-332 http://dx.doi.org/10.3345/kjp.2014.57.7.329 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction 3-methylcrotonyl-coenzyme A carboxylase (3MCC) deficiency is a rare defect of  L-leucine metabolism1).",Non-OADS,/arxiv_data1/oa_pdf/d9/31/kjped-57-329.PMC4127396.pdf
http://dx.doi.org/10.3345/kjp.2014.57.7.329Lee SH and Hong YH  • Asymptomatic Maternal 3-methylcrotonylglycinuria 330Case report A 14-day-old boy was referred to our Endocrinology and  Metabolic Disease Clinic because of increased levels of 3-  hydroxyisovaleryl carnitine on a neonatal screening test  performed at one week of age.,Non-OADS,/arxiv_data1/oa_pdf/d9/31/kjped-57-329.PMC4127396.pdf
331 http://dx.doi.org/10.3345/kjp.2014.57.7.329Korean J Pediatr 2014;57(7):329-332 and normal concentrations of free and total carnitine.,Non-OADS,/arxiv_data1/oa_pdf/d9/31/kjped-57-329.PMC4127396.pdf
http://dx.doi.org/10.3345/kjp.2014.57.7.329Lee SH and Hong YH  • Asymptomatic Maternal 3-methylcrotonylglycinuria 332Conflict of interest  No potential conflict of interest relevant to this article was  reported.,Non-OADS,/arxiv_data1/oa_pdf/d9/31/kjped-57-329.PMC4127396.pdf
"333 http://dx.doi.org/10.3345/kjp.2014.57.7.333 Atypical teratoid rhabdoid brain tumor in an  infant with ring chromosome 22 Eun Hae Cho, MD1, Jae Bok Park, MD2, Jin Kyung Kim, MD, PhD3 1Green Cross Genome, Seoul, Departments of 2Pathology and 3Pediatrics, Catholic University of Daegu School of Medicine, Daegu, Korea Reports of constitutional ring chromosome 22, r(22) are rare.",Non-OADS,/arxiv_data1/oa_pdf/1f/31/kjped-57-333.PMC4127397.pdf
"Key words:  Ring chromosome, 22q13.3 Deletion syndrome, Rhabdoid tumorCorresponding author:  Jin Kyung Kim, MD, PhD Department of Pediatrics, Catholic University of  Daegu School of Medicine, 33 Duryugongwon-ro  17-gil, Nam-gu, Daegu 705-718, Korea Tel: +82-53-650-4240 Fax: +82-53-622-4240 E-mail: kimjk@cu.ac.kr Received: 16 November, 2013 Revised: 4 April, 2014 Accepted: 8 May, 2014 Copyright © 2014 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2014;57(7):333-336 http://dx.doi.org/10.3345/kjp.2014.57.7.333 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Reports of constitutional ring chromosome 22, r(22) are rare.",Non-OADS,/arxiv_data1/oa_pdf/1f/31/kjped-57-333.PMC4127397.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.7.333Cho EH, et al.",OADS,/arxiv_data1/oa_pdf/1f/31/kjped-57-333.PMC4127397.pdf
335 http://dx.doi.org/10.3345/kjp.2014.57.7.333Korean J Pediatr 2014;57(7):333-336 revealed nonspecific findings.,OADS,/arxiv_data1/oa_pdf/1f/31/kjped-57-333.PMC4127397.pdf
"http://dx.doi.org/10.3345/kjp.2014.57.7.333Cho EH, et al.",OADS,/arxiv_data1/oa_pdf/1f/31/kjped-57-333.PMC4127397.pdf
"In addition, the distribution of NTM variants is  not uniform, and there is marked geographic variability in the REVIEW http://dx.doi.org/10.4046/trd.2014.77.1.1 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:1-5 1Address for correspondence: Won-Jung Koh, M.D.",Non-OADS,/arxiv_data1/oa_pdf/a5/5e/trd-77-1.PMC4127406.pdf
"28, 2014 Revised:  May 8, 2014 Accepted:  May 15, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/a5/5e/trd-77-1.PMC4127406.pdf
Pulmonary TB and NTM lung disease http://dx.doi.org/10.4046/trd.2014.77.1.1  3 www.e-trd.orgcavitary forms of NTM lung disease have cavitary lesions that  mostly involve the upper lobes and are similar radiographic  features of pulmonary TB1.,Non-OADS,/arxiv_data1/oa_pdf/a5/5e/trd-77-1.PMC4127406.pdf
Available from: http://apps.who.int/iris/bitstre am/10665/79199/1/9789241505345_eng.pdf.,OADS,/arxiv_data1/oa_pdf/a5/5e/trd-77-1.PMC4127406.pdf
Pulmonary TB and NTM lung disease http://dx.doi.org/10.4046/trd.2014.77.1.1  5 www.e-trd.orgsequence-based typing and clinical significance of isolated  strains.,Non-OADS,/arxiv_data1/oa_pdf/a5/5e/trd-77-1.PMC4127406.pdf
"All rights reserved.Introduction Two thirds of lung cancers are diagnosed in late or ad -ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2014.77.1.13 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:13-17 13Address for correspondence: Jung Hyun Chang, M.D., Ph.D. Department of Internal Medicine, Respiratory Center, Ewha Womans  University School of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu,  Seoul 158-710, Korea Phone:  82-2-2650-5686, Fax: 82-2-2655-2076 E-mail: hs1017@ewha.ac.kr Received:  Mar.",Non-OADS,/arxiv_data1/oa_pdf/57/75/trd-77-13.PMC4127407.pdf
"31, 2014 Accepted:  May 21, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/57/75/trd-77-13.PMC4127407.pdf
"Second-line chemotherapy in lung cancer http://dx.doi.org/10.4046/trd.2014.77.1.13  15 www.e-trd.orgDiscussion Age over 65 years, T4 tumor stage, and poor response to  first-line chemotherapy were the most influential predic -tors of survival after second-line chemotherapy in this study.",Non-OADS,/arxiv_data1/oa_pdf/57/75/trd-77-13.PMC4127407.pdf
Second-line chemotherapy in lung cancer http://dx.doi.org/10.4046/trd.2014.77.1.13  17 www.e-trd.orggood therapeutic responsive to initial chemotherapy predict  favorable outcome of second-line chemotherapy.,Non-OADS,/arxiv_data1/oa_pdf/57/75/trd-77-13.PMC4127407.pdf
Keywords:  Pulmonary Emphysema; Pulmonary Fibrosis; Idiopathic Pulmonary Fibrosis; Respiratory Function TestsORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2014.77.1.18 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:18-23 18Copyright © 2014 The Korean Academy of Tuberculosis and Respiratory Diseases.,Non-OADS,/arxiv_data1/oa_pdf/0e/96/trd-77-18.PMC4127408.pdf
"24, 2014 Revised:  May 7, 2014 Accepted:  May 28, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/0e/96/trd-77-18.PMC4127408.pdf
Comparison between CPFE and IPF http://dx.doi.org/10.4046/trd.2014.77.1.18  19 www.e-trd.orgIntroduction Combined pulmonary fibrosis and emphysema (CPFE) is  defined as concurrent emphysema and pulmonary fibrosis in  a patient.,Non-OADS,/arxiv_data1/oa_pdf/0e/96/trd-77-18.PMC4127408.pdf
"Comparison between CPFE and IPF http://dx.doi.org/10.4046/trd.2014.77.1.18  21 www.e-trd.orgbetes, hypertension, heart disease, cerebral disease, and lung  cancer to survival rate, there were no significant differences in  any of the variables between the two groups.",Non-OADS,/arxiv_data1/oa_pdf/0e/96/trd-77-18.PMC4127408.pdf
"Comparison between CPFE and IPF http://dx.doi.org/10.4046/trd.2014.77.1.18  23 www.e-trd.orgMI, Brown KK.",OADS,/arxiv_data1/oa_pdf/0e/96/trd-77-18.PMC4127408.pdf
"In this case, we suggest that pulmonary tuberculosis CASE REPORThttp://dx.doi.org/10.4046/trd.2014.77.1.24 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:24-27 24Address for correspondence: Sang Haak Lee, M.D., Ph.D. Division of Pulmonology, Critical Care and Sleep Medicine, Department  of Internal Medicine, St. Paul’s Hospital, The Catholic University of Korea  College of Medicine, 180 Wangsan-ro, Dongdaemun-gu, Seoul 130-709,  Korea Phone:  82-2-958-4500, Fax: 82-2-968-7250 E-mail: mdlee@gmail.com Received:  Feb. 3, 2014 Revised:  Mar.",Non-OADS,/arxiv_data1/oa_pdf/8f/87/trd-77-24.PMC4127409.pdf
"14, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/8f/87/trd-77-24.PMC4127409.pdf
Takotsubo cardiomyopathy caused by tuberculosis http://dx.doi.org/10.4046/trd.2014.77.1.24  25 www.e-trd.orgFigure 1.,Non-OADS,/arxiv_data1/oa_pdf/8f/87/trd-77-24.PMC4127409.pdf
Takotsubo cardiomyopathy caused by tuberculosis http://dx.doi.org/10.4046/trd.2014.77.1.24  27 www.e-trd.orgdiomyopathy: the pathophysiology.,Non-OADS,/arxiv_data1/oa_pdf/8f/87/trd-77-24.PMC4127409.pdf
http://dx.doi.org/10.1007/s00059-013- 3956-2.,Non-OADS,/arxiv_data1/oa_pdf/8f/87/trd-77-24.PMC4127409.pdf
"All rights reserved.Introduction Although invasive pulmonary aspergillosis is not rare in  immunocompromised patients, it is very rare in immuno -CASE REPORThttp://dx.doi.org/10.4046/trd.2014.77.1.28 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:28-33 28Address for correspondence: Eun Kyung Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ec/ea/trd-77-28.PMC4127410.pdf
"9, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/ec/ea/trd-77-28.PMC4127410.pdf
Invasive pulmonary aspergillosis with mediastinal invasion http://dx.doi.org/10.4046/trd.2014.77.1.28  29 www.e-trd.orgwere diminished over the right lung.,Non-OADS,/arxiv_data1/oa_pdf/ec/ea/trd-77-28.PMC4127410.pdf
"Invasive pulmonary aspergillosis with mediastinal invasion http://dx.doi.org/10.4046/trd.2014.77.1.28  31 www.e-trd.orgcyte dominant exudate, a white blood cell count of 1,630/ mL  (lymphocyte 43%), albumin of 2.2 g/dL, lactate dehydroge - nase of 883 U/L, glucose of 210 mg/dL, and adenosine deami - nase of 15I U/L.",Non-OADS,/arxiv_data1/oa_pdf/ec/ea/trd-77-28.PMC4127410.pdf
Invasive pulmonary aspergillosis with mediastinal invasion http://dx.doi.org/10.4046/trd.2014.77.1.28  33 www.e-trd.orgthe endocardium in the left atrium was also directly invaded  by the Aspergillus .,Non-OADS,/arxiv_data1/oa_pdf/ec/ea/trd-77-28.PMC4127410.pdf
"Venous thromboembolism, such CASE REPORThttp://dx.doi.org/10.4046/trd.2014.77.1.34 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:34-37 34Address for correspondence: Jeong-Seon Ryu, M.D., Ph.D. Department of Internal Medicine, Center for Lung Cancer, Inha  University Hospital, 366 Seohae-daero, Jung-gu, Incheon 400-103, Korea  Phone:  82-32-890-3738, Fax: 82-32-882-6578 E-mail: jsryu@inha.ac.kr  Received:  Dec. 18, 2013 Revised:  Mar.",Non-OADS,/arxiv_data1/oa_pdf/71/4d/trd-77-34.PMC4127411.pdf
"18, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/71/4d/trd-77-34.PMC4127411.pdf
"Severe form of hypercoagulability disorders in lung cancer http://dx.doi.org/10.4046/trd.2014.77.1.34  35 www.e-trd.orgCase Report A 61-year-old Korean woman was admitted to the Depart - ment of Vascular Surgery, presenting with a tingling sensation  on both lower legs and vague chest discomfort for one month.",Non-OADS,/arxiv_data1/oa_pdf/71/4d/trd-77-34.PMC4127411.pdf
"Severe form of hypercoagulability disorders in lung cancer http://dx.doi.org/10.4046/trd.2014.77.1.34  37 www.e-trd.orgtion, and heart failure at the time of diagnosis of lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/71/4d/trd-77-34.PMC4127411.pdf
"The first case of a rhabdoid tumor in the lung was reported CASE REPORThttp://dx.doi.org/10.4046/trd.2014.77.1.38 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:38-41 38Address for correspondence: Chan Woo Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ea/6e/trd-77-38.PMC4127412.pdf
"28, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/ea/6e/trd-77-38.PMC4127412.pdf
Lung carcinoma with rhabdoid phenotype mimicking an aspergilloma http://dx.doi.org/10.4046/trd.2014.77.1.38  39 www.e-trd.organ anti-tuberculosis medication for 6 months.,Non-OADS,/arxiv_data1/oa_pdf/ea/6e/trd-77-38.PMC4127412.pdf
"Lung carcinoma with rhabdoid phenotype mimicking an aspergilloma http://dx.doi.org/10.4046/trd.2014.77.1.38  41 www.e-trd.orgAlso, we must consider the possibility of a malignancy  arising from a cavitary pulmonary tuberculosis scar because  the risk of lung cancer arising subsequent to a pulmonary  tuberculosis infection is significantlyhigh12.",Non-OADS,/arxiv_data1/oa_pdf/ea/6e/trd-77-38.PMC4127412.pdf
"Usually related with hypotension, it can be oc - curred in normal blood pressure state in the case of partial  hypoperfusion to a specific organ or toxin-induced encepha -REVIEW http://dx.doi.org/10.4046/trd.2014.77.1.6 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2014;77:6-12 6Address for correspondence: Heung Bum Lee, M.D., Ph.D. Department of Internal Medicine, Chonbuk National University Medical  School, 567 Baekje-daero, Deokjin-gu, Jeonju 561-756, Korea Phone:  82-63-250-1685, Fax: 82-63-250-1609 E-mail: lhbmd@jbnu.ac.kr Received:  May 26, 2014 Revised:  Jun.",Non-OADS,/arxiv_data1/oa_pdf/ff/ed/trd-77-6.PMC4127413.pdf
"11, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/ff/ed/trd-77-6.PMC4127413.pdf
"Critical care review, sepsis, pain, agitation, delirium, mechanical ventilation http://dx.doi.org/10.4046/trd.2014.77.1.6  7 www.e-trd.org(1C): MAP≥65 mm Hg, central venous pressure 8−12 mm Hg  (recommend 12−15 mm Hg, in the case of ventilator care or  decrease ventricular compliance), hourly urine output (U/ O)≥0.5 mL/kg/hr, central venous (superior vena cava) oxygen  saturation (ScvO2)≥70%, or mixed venous oxygen saturation  (SvO2)≥65%.",Non-OADS,/arxiv_data1/oa_pdf/ff/ed/trd-77-6.PMC4127413.pdf
"Critical care review, sepsis, pain, agitation, delirium, mechanical ventilation http://dx.doi.org/10.4046/trd.2014.77.1.6  9 www.e-trd.orgNarcotrend Index (NI), Patient State Index (PSI), and State  Entropy (SE) as an measures of neurologic evaluation, they  are not recommended as the primary evaluation method un - less patients has been administered nerve root blocker with  the exception of the case of coma, or if there is no paralysis.",Non-OADS,/arxiv_data1/oa_pdf/ff/ed/trd-77-6.PMC4127413.pdf
"Critical care review, sepsis, pain, agitation, delirium, mechanical ventilation http://dx.doi.org/10.4046/trd.2014.77.1.6  11 www.e-trd.orgB, et al.",Non-OADS,/arxiv_data1/oa_pdf/ff/ed/trd-77-6.PMC4127413.pdf
"http://dx.doi.org/10.1016/j.redox.2013.10.010Abbreviations: GSH, reduced glutathione; GSSG, glutathione disul ﬁde; Cys-SSG, L-cysteine –glutathione mixed disul ﬁde; Mn-TMPyP, Mn(III) tetrakis (1-methyl-4- pyridyl) porphyrin; tetratosylate, hydroxide; DT, sodium dithionite; SSM, heartsubsarcolemmal mitochondria; IFM, Heart inter ﬁbrillar mitochondria; t-Bid, caspase-8-cleaved human BID; Grx, glutaredoxin ☆This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided theoriginal author and source are credited.",OADS,/arxiv_data1/oa_pdf/cf/33/main.PMC4127417.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e6/41/srep06014.PMC4127495.pdf
All authors reviewed and discussed themanuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/27/39/srep06017.PMC4127496.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6020 | DOI: 10.1038/srep06020 5",Non-OADS,/arxiv_data1/oa_pdf/52/91/srep06020.PMC4127497.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e6/89/srep06021.PMC4127498.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6021 | DOI: 10.1038/srep06021 5",Non-OADS,/arxiv_data1/oa_pdf/e6/89/srep06021.PMC4127498.pdf
Thepeptide structures were visualized and investigated on Delano Scientific’s PyMOL http://pymol.sourceforge.net/22.,OADS,/arxiv_data1/oa_pdf/06/6c/srep06015.PMC4127500.pdf
The program PyMOL http://pymol.sourceforge.net/22 was used to characterize peptide-protein interactions.,OADS,/arxiv_data1/oa_pdf/06/6c/srep06015.PMC4127500.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/06/6c/srep06015.PMC4127500.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e5/e0/srep05901.PMC4127501.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5901 | DOI: 10.1038/srep05901 7",Non-OADS,/arxiv_data1/oa_pdf/e5/e0/srep05901.PMC4127501.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/96/79/srep06011.PMC4127502.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6011 | DOI: 10.1038/srep06011 9",Non-OADS,/arxiv_data1/oa_pdf/96/79/srep06011.PMC4127502.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/52/e0/srep05951.PMC4127518.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c2/05/srep05865.PMC4127519.pdf
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022249s002lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/3f/48/cro-0007-0465.PMC4127542.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/a9/main.PMC4127651.pdf
"Speci ﬁcations Organism/cell line/tissue Human normal oral keratinocytes Sex N/A Sequencer or array type Affymetrix Human Genome Plus 2.0Data format Raw and analyzedExperimental factors Normal oral keratinocytes treated with EtOH and/or nicotine Experimental features Time and dose dependency exposure experiment to compare molecular effects of EtOH and nicotinein normal human oral keratinocytes Consent N/A Sample source location N/ADirect link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57634 Experimental design, materials and methods Cell culture Primary normal human oral keratinocytes (NHOKs) were prepared from normal oral mucosal tissues according to methods described in elsewhere [1].",OADS,/arxiv_data1/oa_pdf/21/a9/main.PMC4127651.pdf
http://dx.doi.org/10.1016/j.gdata.2014.06.021 2213-5960/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/21/a9/main.PMC4127651.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/a9/main.PMC4127651.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/21/a9/main.PMC4127651.pdf
The complete tutorial including necessary codes to run the analysis is publically available from http://labs.genetics.ucla.edu/horv ath/CoexpressionNe twork/Rpackages/ WGCNA/Tutorials/ .,Non-OADS,/arxiv_data1/oa_pdf/21/a9/main.PMC4127651.pdf
Available from: http://www.mcshanesnursery.,Non-OADS,/arxiv_data1/oa_pdf/e8/2f/PRev-8-101.PMC4127818.pdf
Available from: http://www.clarence.nsw.gov.au/content/ uploads/Blackberry.pdf	[Last	accessed	on	2013	 Aug	26].,Non-OADS,/arxiv_data1/oa_pdf/e8/2f/PRev-8-101.PMC4127818.pdf
Available	 from:	 http://www.liveandfeel.com/vegetables/blackberry.htm	 [Last	accessed 	on	2013	 Aug	28].,Non-OADS,/arxiv_data1/oa_pdf/e8/2f/PRev-8-101.PMC4127818.pdf
Available from: http://herbsrainbear.com/ encylopedia/blackberry.htm	[Last	accessed	on	2013	Sep	04].,Non-OADS,/arxiv_data1/oa_pdf/e8/2f/PRev-8-101.PMC4127818.pdf
Available from: http://www.altnature.com/gallery/ Blackberry.htm	[Last	accessed 	on	2013	Sep	06].,Non-OADS,/arxiv_data1/oa_pdf/e8/2f/PRev-8-101.PMC4127818.pdf
Available from: http: http://www.cloverleaffarmherbs.,Non-OADS,/arxiv_data1/oa_pdf/e8/2f/PRev-8-101.PMC4127818.pdf
Available from:  http://www.biomedcentral.com/1472‑6882/13/71 [Last accessed  on 2013 Apr 16].,OADS,/arxiv_data1/oa_pdf/a5/8a/PRev-8-113.PMC4127820.pdf
Available from: http://onlinelibrary.wiley.com/doi/10.1111/and.,Non-OADS,/arxiv_data1/oa_pdf/a5/8a/PRev-8-113.PMC4127820.pdf
Available  from:  http://archive.ispub.com/journal/ the‑internet‑  journal‑of‑alternative‑medicine/volume‑8‑number‑2/ethanolic‑  extracts‑of‑vernonia‑amygdalina‑and‑ocimum‑gratissimum‑  enhance‑testicular‑improvement‑in‑diabetic‑wistar‑rats.html  [Last accessed on 2011 Mar 11].,Non-OADS,/arxiv_data1/oa_pdf/a5/8a/PRev-8-113.PMC4127820.pdf
"Available from:  http://www.thenutfactory.com/kitchen/edible.html, [last accessed  on 2014 May 23].",Non-OADS,/arxiv_data1/oa_pdf/3b/75/PRev-8-147.PMC4127822.pdf
"Available from: http://www.ars‑grin.gov/duke/, [last  accessed on 2013 Dec 18].",Non-OADS,/arxiv_data1/oa_pdf/3b/75/PRev-8-147.PMC4127822.pdf
"Available  from: http://homecooking.about.com/od/foodhistory/a/ sesamehistory.htm, [last accessed on 2014 May 23].",Non-OADS,/arxiv_data1/oa_pdf/3b/75/PRev-8-147.PMC4127822.pdf
Available from: http://www.indianmedicine.nic.in/ ayurveda.asp [Last cited on 2013 May 18].,Non-OADS,/arxiv_data1/oa_pdf/c2/71/PRev-8-156.PMC4127823.pdf
Available from: http://www.dictionary.reference.com/ browse/oleander [Last cited on 2013 Mar 11].,OADS,/arxiv_data1/oa_pdf/c2/71/PRev-8-156.PMC4127823.pdf
Ziya Ozel H. Available from: http://www.drozel.org/eng/ historical_background.htm [Last cited on 2013 May 05] 42.,Non-OADS,/arxiv_data1/oa_pdf/c2/71/PRev-8-156.PMC4127823.pdf
Available from: http://www.drozel.org/eng/27‑2.htm.,Non-OADS,/arxiv_data1/oa_pdf/c2/71/PRev-8-156.PMC4127823.pdf
Available from: http://www.google.com/patents/ CA2016948A1?cl=en [Last cited on 2013 Mar 19].,OADS,/arxiv_data1/oa_pdf/c2/71/PRev-8-156.PMC4127823.pdf
Available from: http://www.naturalnews.,Non-OADS,/arxiv_data1/oa_pdf/c2/71/PRev-8-156.PMC4127823.pdf
Available from: http://www.nccam.nih.gov/sites/nccam.,OADS,/arxiv_data1/oa_pdf/35/fa/PRev-8-73.PMC4127824.pdf
Available  from: http://www.longwoodherbal.org/ginger/ginger.pdf.,Non-OADS,/arxiv_data1/oa_pdf/35/fa/PRev-8-73.PMC4127824.pdf
Available from: http://www.holheal.com/index.html.,Non-OADS,/arxiv_data1/oa_pdf/35/fa/PRev-8-73.PMC4127824.pdf
Available  from:http://www.csuvets.colostate.edu/pain/Articlespdf/ BleedingRisksofHerbs.pdf.,Non-OADS,/arxiv_data1/oa_pdf/35/fa/PRev-8-73.PMC4127824.pdf
Available from: http://www.boloji.com/index.cf m?md=Content&sd=Articles&ArticleID=1103.,Non-OADS,/arxiv_data1/oa_pdf/35/fa/PRev-8-73.PMC4127824.pdf
: CAM in geriatric care86 Pharmacognosy Reviews |  July-December 2014 | Vol 8 | Issue 16Available from: http://www.medscape.com/viewarticle/542207  [Last date accessed on 2013 Dec 31].,Non-OADS,/arxiv_data1/oa_pdf/45/ba/PRev-8-81.PMC4127825.pdf
"66pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.2.66 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Rationale and surgical technique of laparoscopic left  lateral sectionectomy using endoscopic staples Beom Hui Lee, Sung-Su Yun, Man Ki Kim, Hwa-Kyung Jung, Dong-Shik Lee, Hong-Jin Kim Department of Surgery, Yeungnam University Medical Center, Daegu, Korea INTRODUCTION Laparoscopic left lateral sectionectomy (LLLS) has been  accepted with respect to its usefulness and benefits related to  minimally invasive surgery [1-3].",Non-OADS,/arxiv_data1/oa_pdf/e4/43/astr-87-66.PMC4127897.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose: Laparoscopic left lateral sectionectomy (LLLS) has been widely accepted due to benefits of minimally invasive  surgery.",Non-OADS,/arxiv_data1/oa_pdf/e4/43/astr-87-66.PMC4127897.pdf
"108pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.2.108 Annals of Surgical Treatment and ResearchTECHNICAL ADVANCE Salvage dual graft living donor liver transplantation after  major hepatectomy Joo Dong Kim, Dong Lak Choi, Young Seok Han Division of Hepatobiliary Pancreas Surgery and Abdominal Organ Transplantation, Department of Surgery, Catholic University of  Daegu School of Medicine, Daegu, Korea INTRODUCTION Salvage liver transplantation (LT) has been proposed for  patients who undergo primary liver resection for hepatocellular  carcinoma (HCC), due to recurrence of HCC, or deterioration in  liver function [1,2].",Non-OADS,/arxiv_data1/oa_pdf/fc/cb/astr-87-108.PMC4127898.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Salvage living donor liver transplantation (LDLT) after major hepatectomy has been considered a challenging procedure  due to operative complexity.",Non-OADS,/arxiv_data1/oa_pdf/fc/cb/astr-87-108.PMC4127898.pdf
"94pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.2.94 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Pancreaticoduodenectomy for secondary periampullary  cancer following extrahepatic bile duct cancer resection Dong Hun Kim, Dong Wook Choi1, Seong Ho Choi1, Jin Seok Heo1 Department of Surgery, Dankook University Hospital, Cheonan, 1Department of Surgery, Samsung Medical Center, Sungkyunkwan  University School of Medicine, Seoul, Korea INTRODUCTION Cholangiocarcinoma is a relatively rare tumor with a poor  prognosis and few long-term survivors [1].",Non-OADS,/arxiv_data1/oa_pdf/04/9b/astr-87-94.PMC4127899.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose: This study addressed the feasibility and effect of surgical treatment of metachronous periampullary carcinoma  after resection of the primary extrahepatic bile duct cancer.",Non-OADS,/arxiv_data1/oa_pdf/04/9b/astr-87-94.PMC4127899.pdf
"100pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.2.100 Annals of Surgical Treatment and ResearchCASE REPORT Extremely rare case of extrahepatic duct phytobezoar  treated with intraoperative transenteral endoscopy Jung Min Bae, Yong Kook Lee1 Department of Surgery,Yeungnam University College of Medicine, Daegu, 1Department of Internal Medicine, Dongguk University  Gyeongju Hospital, Gyeongju, Korea INTRODUCTION Bezoar stones are concrete masses of indigestible material.",Non-OADS,/arxiv_data1/oa_pdf/10/63/astr-87-100.PMC4127900.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Phytobezoar is a rare cause of gastro-intestinal tract obstruction.",Non-OADS,/arxiv_data1/oa_pdf/10/63/astr-87-100.PMC4127900.pdf
" Annals of Surgical Treatment and Research 81pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.2.81 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Four-channel single incision laparoscopic  cholecystectomy using a snake retractor: comparison  between 3- and 4-channel SILC 4-channel single incision  cholecystectomy Nak Song Sung, In Seok Choi, Ju Ik Moon, Yu Mi Ra, Sang Eok Lee, Won Jun Choi Department of Surgery, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea INTRODUCTION Since Phillipe Mouret of France performed the first laparo­ scopic cholecystectomy (LC) in 1987, multiport conventional  LC (CLC) has become the gold standard for the treatment of  gallbladder (GB) disease [1], with advantages of better cosmesis,  less scar, less pain, and shorter hospitalization [2].",Non-OADS,/arxiv_data1/oa_pdf/a6/21/astr-87-81.PMC4127901.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Single incision laparoscopic cholecystectomy (SILC) is a widely used method of performing cholecystectomy.",Non-OADS,/arxiv_data1/oa_pdf/a6/21/astr-87-81.PMC4127901.pdf
" Annals of Surgical Treatment and Research 61pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.2.61 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Long-term outcomes of intraoperative and perioperative  albendazole treatment in hepatic hydatidosis: single  center experience Kagan Karabulut, G. Selcuk Ozbalci, Tugrul Kesicioglu, Ismail Alper Tarim, Gokhan Lap, Ayfer Kamali Polat,  Ilhan Karabıcak, Kenan Erzurumlu Department of General Surgery, Ondokuz Mayis University Medical School, Samsun, Turkey INTRODUCTION Benzoimidazole derivatives have been the drugs of choice  for the medical treatment of echinococcosis since Bekhti’s  first report in 1977 [1].",Non-OADS,/arxiv_data1/oa_pdf/23/7e/astr-87-61.PMC4127902.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The aim of this study was to evaluate long-term outcome of the intraoperative and perioperative albendazole (ALB)  treatment on the recurrence and/or secondary hydatidosis.",Non-OADS,/arxiv_data1/oa_pdf/23/7e/astr-87-61.PMC4127902.pdf
" Annals of Surgical Treatment and Research 87pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.2.87 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Role of resection for Bismuth type IV hilar  cholangiocarcinoma and analysis of determining factors  for curative resection In Woong Han, Jin-Young Jang1, Mee Joo Kang1, Wooil Kwon1, Jae Woo Park1, Ye Rim Chang1, Sun-Whe Kim1 Department of Surgery, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, 1Department of  Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea INTRODUCTION   Hilar cholangiocarcinoma (HCCA), also known as Klatskin’s  tumor, is a relatively rare tumor typically affecting the hepatic  duct confluence.",Non-OADS,/arxiv_data1/oa_pdf/4a/45/astr-87-87.PMC4127903.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Extended liver resection may provide long-term survival in selected patients with Bismuth type IV hilar  cholangiocarcinoma (HCCA).",Non-OADS,/arxiv_data1/oa_pdf/4a/45/astr-87-87.PMC4127903.pdf
"104pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.2.104 Annals of Surgical Treatment and ResearchCASE REPORT Acute cholecystitis associated with Clonorchis sinensis   infection Jung Taek Oh, Dong Baek Kang, Hyang Jeong Jo1 Departments of Surgery and 1Pathology, Digestive Disease Research Institute and Institute of Medical Science, Wonkwang  University College of Medicine, Iksan, Korea INTRODUCTION Clonorchis sinensis causes an important foodborne parasitic  infection that predominantly occurs as a hepatobiliary disease  caused by the ingestion of a raw fish contaminated with  infective cysts [1].",Non-OADS,/arxiv_data1/oa_pdf/f4/ba/astr-87-104.PMC4127904.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Clonorchis sinensis  is one of the most common causes of trematodiasis that is caused by the ingestion of raw fish  contaminated with infective cysts.",Non-OADS,/arxiv_data1/oa_pdf/f4/ba/astr-87-104.PMC4127904.pdf
"72pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.2.72 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE A comparison between surgical resection and  radiofrequency ablation in the treatment of  hepatocellular carcinoma Eun Kyu Park, Hee Joon Kim, Choong Young Kim, Young Hoe Hur, Yang Seok Koh, Jung Chul Kim, Hyun Jong  Kim, Jin Woong Kim1, Chol Kyoon Cho Division of Hepatico-Biliary-Pancreatic Surgery, Department of Surgery, Chonnam National University Medical School, Gwangju,  1Department of Radiology, Chonnam National University Medical School, Gwangju, Korea INTRODUCTION It has been reported that liver cancer is the fifth most  common malignant tumor worldwide and the fourth most  common malignant cancer nationwide [1], and according to  domestic statistics of South Korea, five-year survival rates from  hepatocellular carcinoma (HCC) was 15.3% [2], a relatively low  survival rate compared to its high incidence.",OADS,/arxiv_data1/oa_pdf/76/3c/astr-87-72.PMC4127905.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The aim of this study was to compare the therapeutic effects of radiofrequency ablation (RFA) and hepatic  resection (HR) with regards to procedural morbidity, mortality, overall survival (OS) and disease-free survival (DFS) rates in  hepatocellular carcinoma (HCC) patients.",Non-OADS,/arxiv_data1/oa_pdf/76/3c/astr-87-72.PMC4127905.pdf
"112pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.2.112 Annals of Surgical Treatment and ResearchERRATUM ERRA TUM: Correction for affiliation of the 8th author—corresponding author Multicenter nonrandomized trial of ramosetron versus  palonosetron in controlling chemotherapy-induced  nausea and vomiting for colorectal cancer Jin Soo Kim, Ji Yeon Kim, Sang-Jeon Lee1, Dong Kook Park2, Hwan Namgung2, Chang Nam Kim3, Won Jun  Choi4, Moo Jun Baek5 Department of Surgery, Chungnam National University School of Medicine, Daejeon, 1Department of Surgery, Chungbuk National  University School of Medicine, Cheongju, 2Department of Surgery, Dankook University College of Medicine, Cheonan,  3Department of Surgery, Eulji University School of Medicine, Daejeon, 4Department of Surgery, Konyang University College of  Medicine, Daejeon, 5Department of Surgery, Sooncheonhyang  University College of Medicine, Cheonan, Korea The affiliation of the 8th author—corresponding author, Moo  Jun Baek—was misprinted.",Non-OADS,/arxiv_data1/oa_pdf/38/78/astr-87-112.PMC4127906.pdf
"The affiliation should be corrected  as follows: Corrected affiliation of 8th author  5Department of Surgery, Soonchunhyang  University College  of Medicine, Cheonan, Koreahttp://dx.doi.org/10.4174/astr.2014.87.1.9 Ann Surg Treat Res 2014;87(1):9-13 Corrected affiliation in corresponding author  section Department of Surgery, Soonchunhyang  University College of  Medicine, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan 330- 930, Korea",Non-OADS,/arxiv_data1/oa_pdf/38/78/astr-87-112.PMC4127906.pdf
" Annals of Surgical Treatment and Research 53pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2014.87.2.53 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Effects of glucose concentration in the medium on rat  hepatocyte culture Gun Hyung Na, Dong Goo Kim, Young Hui Kim, Jae Hyun Han, Eun Sun Jung1 Departments of Surgery and 1Pathology, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul,  Korea INTRODUCTION Acute liver failure is a life-threatening disease, and is  encountered commonly in clinical practice [1].",Non-OADS,/arxiv_data1/oa_pdf/4c/8e/astr-87-53.PMC4127907.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose: To determine the optimum culture conditions by investigating isolated rat hepatocytes cultured in medium  containing different glucose concentrations.",Non-OADS,/arxiv_data1/oa_pdf/4c/8e/astr-87-53.PMC4127907.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005130).,Non-OADS,/arxiv_data1/oa_pdf/f9/7c/bmjopen-2014-005130.PMC4127915.pdf
"METHODS This review protocol has been published in the PROSPERO International Prospective Register of system- atic reviews (http://www.crd.york.ac.uk/PROSPERO),registration number 2014:CRD42014007531.",Non-OADS,/arxiv_data1/oa_pdf/f9/7c/bmjopen-2014-005130.PMC4127915.pdf
RK will enter the ﬁnal data into the Cochrane Collaboration Review Manager V.5.1 statistical software(http://ims.cochrane.org/RevMan).,OADS,/arxiv_data1/oa_pdf/f9/7c/bmjopen-2014-005130.PMC4127915.pdf
Data synthesis including assessment of heterogeneity Data analysis will be conducted using the CochraneCollaboration Review Manager V.5.1 statistical software (http://ims.cochrane.org/RevMan).,OADS,/arxiv_data1/oa_pdf/f9/7c/bmjopen-2014-005130.PMC4127915.pdf
"The Cochrane Collaboration, 2009. http://www.cochrane-handbook.org.",OADS,/arxiv_data1/oa_pdf/f9/7c/bmjopen-2014-005130.PMC4127915.pdf
http://www.endnote.com.,Non-OADS,/arxiv_data1/oa_pdf/f9/7c/bmjopen-2014-005130.PMC4127915.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005175).,Non-OADS,/arxiv_data1/oa_pdf/0c/93/bmjopen-2014-005175.PMC4127916.pdf
Trial registration number: http://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/0c/93/bmjopen-2014-005175.PMC4127916.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-005824).,Non-OADS,/arxiv_data1/oa_pdf/e5/1d/bmjopen-2014-005824.PMC4127917.pdf
2010. http://www.who.int/dietphysicalactivity/factsheet_recommendations/en/ 32.,Non-OADS,/arxiv_data1/oa_pdf/e5/1d/bmjopen-2014-005824.PMC4127917.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005317).,Non-OADS,/arxiv_data1/oa_pdf/6e/c8/bmjopen-2014-005317.PMC4127918.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6e/c8/bmjopen-2014-005317.PMC4127918.pdf
http://www.doh.gov.ph/node/198.html (accessed 18 Mar 2014).12.,OADS,/arxiv_data1/oa_pdf/6e/c8/bmjopen-2014-005317.PMC4127918.pdf
Rural and Remote (online) 2003.http://www.rrh.org.au/articles/subviewnew.asp?ArticleID=220 (accessed 18 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/6e/c8/bmjopen-2014-005317.PMC4127918.pdf
2014. http://www.doh.gov.ph/annual_calendar.html (accessed 18Mar 2014).,OADS,/arxiv_data1/oa_pdf/6e/c8/bmjopen-2014-005317.PMC4127918.pdf
http://www.census.gov.ph/ sites/default/files/attachments/hsd/pressrelease/Ilocos.pdf (accessed18 Mar 2014).,OADS,/arxiv_data1/oa_pdf/6e/c8/bmjopen-2014-005317.PMC4127918.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004721).,Non-OADS,/arxiv_data1/oa_pdf/0a/a3/bmjopen-2013-004721.PMC4127919.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0a/a3/bmjopen-2013-004721.PMC4127919.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-004892).,Non-OADS,/arxiv_data1/oa_pdf/9d/97/bmjopen-2014-004892.PMC4127920.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.13d31.,OADS,/arxiv_data1/oa_pdf/9d/97/bmjopen-2014-004892.PMC4127920.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005331).,Non-OADS,/arxiv_data1/oa_pdf/f9/41/bmjopen-2014-005331.PMC4127921.pdf
"All data in this study were anonymised, therefore ethics committee approval wasnot required (please see guidance from the National Health Service (NHS) Health Research Authority: http://www.hra.nhs.uk/documents/2013/09/does-my-project-require-rec-review.pdf).",Non-OADS,/arxiv_data1/oa_pdf/f9/41/bmjopen-2014-005331.PMC4127921.pdf
2008. http://www.injuryobservatory.net/documents/why_children_die1.pdf (accessed 30 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/f9/41/bmjopen-2014-005331.PMC4127921.pdf
2013. http://www.rcpch.ac.uk/system/files/protected/page/CHR-UK%20MODULE%20B%20REVISED%20v2%2015112013.pdf (accessed 8 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/f9/41/bmjopen-2014-005331.PMC4127921.pdf
2005. http://www.eurocat-network.eu/content/ EUROCAT-Guide-1.3.pdf (accessed 30 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/f9/41/bmjopen-2014-005331.PMC4127921.pdf
http://www.stata.,Non-OADS,/arxiv_data1/oa_pdf/f9/41/bmjopen-2014-005331.PMC4127921.pdf
http://www.R-project.org(accessed 20 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/f9/41/bmjopen-2014-005331.PMC4127921.pdf
2011. http://www.hcup-us.ahrq.gov/toolssoftware/chronic/chronic.jsp (accessed 22 Apr 2013).,OADS,/arxiv_data1/oa_pdf/f9/41/bmjopen-2014-005331.PMC4127921.pdf
2006. http://archive.audit-commission.gov.uk/auditcommission/subwebs/publications/corporate/publicationPDF/NEW1077.pdf(accessed 25 Apr 2013).,OADS,/arxiv_data1/oa_pdf/f9/41/bmjopen-2014-005331.PMC4127921.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005643).,Non-OADS,/arxiv_data1/oa_pdf/09/a7/bmjopen-2014-005643.PMC4127922.pdf
"Sample size calculation The study includes 100 patients, based on the sample sizeand power calculations for identifying relative risk avail- able at http://www.imim.es/ofertadeserveis/software- public/granmo/.",OADS,/arxiv_data1/oa_pdf/09/a7/bmjopen-2014-005643.PMC4127922.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 004784).,Non-OADS,/arxiv_data1/oa_pdf/67/78/bmjopen-2014-004784.PMC4127923.pdf
"Available at, http://www.micronutrient.org/English/view.asp?x=656&id=37.",Non-OADS,/arxiv_data1/oa_pdf/67/78/bmjopen-2014-004784.PMC4127923.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005823).,Non-OADS,/arxiv_data1/oa_pdf/61/4a/bmjopen-2014-005823.PMC4127924.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/61/4a/bmjopen-2014-005823.PMC4127924.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-004930).,Non-OADS,/arxiv_data1/oa_pdf/e8/3b/bmjopen-2014-004930.PMC4127931.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3e/d0/bmjopen-2013-004714.PMC4127932.pdf
"Malta: World Health Organization, 2011. http://www.who.int/disabilities/world_report/2011/report.pdf 2.",Non-OADS,/arxiv_data1/oa_pdf/3e/d0/bmjopen-2013-004714.PMC4127932.pdf
"London: Office for Disability Issues, 2012. http://odi.dwp.gov.uk/docs/res/factsheets/disability-prevalence.",Non-OADS,/arxiv_data1/oa_pdf/3e/d0/bmjopen-2013-004714.PMC4127932.pdf
https://catalogue.ic.nhs.uk/ publications/public-health/surveys/heal-surv-heal-life-eng-2009/heal-surv-heal-life-eng-2009-rep-v2.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/3e/d0/bmjopen-2013-004714.PMC4127932.pdf
2011. http://www.who.int/mediacentre/factsheets/fs352/en/index.html(accessed Feb 2013).,OADS,/arxiv_data1/oa_pdf/3e/d0/bmjopen-2013-004714.PMC4127932.pdf
"Brussels: European Commission, 2008. http://www.euro.centre.org/data/1237457784_41597.pdf 12.",Non-OADS,/arxiv_data1/oa_pdf/3e/d0/bmjopen-2013-004714.PMC4127932.pdf
"New York: United Nations, 2006. http://www.un.",Non-OADS,/arxiv_data1/oa_pdf/3e/d0/bmjopen-2013-004714.PMC4127932.pdf
"Titchfield: National Statistics, 2001. http://www.ons.gov.uk/ons/guide-method/census/census-2001/about-census-2001/census-2001-forms/index.html 24.",OADS,/arxiv_data1/oa_pdf/3e/d0/bmjopen-2013-004714.PMC4127932.pdf
2009. http://www.ons.gov.uk/ons/guide-method/ geography/products/area-classifications/rural-urban-definition-and-la/rural-urban-definition--england-and-wales-/index.html (accessed Nov2013).,Non-OADS,/arxiv_data1/oa_pdf/3e/d0/bmjopen-2013-004714.PMC4127932.pdf
"London: Department for Communities and Local Government, 2008. http://webarchive.nationalarchives.gov.uk/ 20100410180038/http://communities.gov.uk/documents/ communities/pdf/733520.pdf 26.",Non-OADS,/arxiv_data1/oa_pdf/3e/d0/bmjopen-2013-004714.PMC4127932.pdf
"Washington, DC: Bureau of the Census, 1998. http://www.census.gov/dmd/www/pdf/09h_di.pdf (accessed Nov 2013).",OADS,/arxiv_data1/oa_pdf/3e/d0/bmjopen-2013-004714.PMC4127932.pdf
"Dublin: Stationery Office, 2008. http://www.cso.ie/en/media/csoie/ releasespublications/documents/otherreleases/nationaldisability/ National%20Disability%20Survey%202006%20First%20Results%20full%20report.pdf 30.",Non-OADS,/arxiv_data1/oa_pdf/3e/d0/bmjopen-2013-004714.PMC4127932.pdf
http://www.ifs.org.uk/elsa/report08/ ch3.pdf 40.,Non-OADS,/arxiv_data1/oa_pdf/3e/d0/bmjopen-2013-004714.PMC4127932.pdf
"London: Department for Transport, 2010. http://webarchive.nationalarchives.gov.uk/20100304070241/http://www.dft.gov.uk/pgr/statistics/datatablespublications/personal/ntsfactsheets/NTSHealthrelated.pdf (accessed Mar 2013).",Non-OADS,/arxiv_data1/oa_pdf/3e/d0/bmjopen-2013-004714.PMC4127932.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-005386).,Non-OADS,/arxiv_data1/oa_pdf/90/17/bmjopen-2014-005386.PMC4127933.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005611).,Non-OADS,/arxiv_data1/oa_pdf/60/92/bmjopen-2014-005611.PMC4127935.pdf
2014. http://www.aafp.org/about/the-aafp/family-medicine-facts/table-2.html (accessed 7 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/60/92/bmjopen-2014-005611.PMC4127935.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005780).,Non-OADS,/arxiv_data1/oa_pdf/95/fa/bmjopen-2014-005780.PMC4127936.pdf
Secondary Deskundig over sportdranken 2011. http://sport.infonu.nl/diversen/82903-deskundig-over-sportdranken.html 29.,Non-OADS,/arxiv_data1/oa_pdf/95/fa/bmjopen-2014-005780.PMC4127936.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.rr42f.,OADS,/arxiv_data1/oa_pdf/ca/9d/bmjopen-2014-005953.PMC4127937.pdf
"Mortality and causes of death in South Africa, 2011: findings from death notification: statistics South Africa, 2014. http://beta2.statssa.gov.za/ (accessed 26 Jun 2014).",Non-OADS,/arxiv_data1/oa_pdf/ca/9d/bmjopen-2014-005953.PMC4127937.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cd/36/bmjopen-2014-005593.PMC4127938.pdf
Access Consulting Ltd. 2007. https://www.hscorp.ca/wp-content/uploads/2011/12/Accreditation_in_Health_Care_and_Education1.pdf 19.,Non-OADS,/arxiv_data1/oa_pdf/58/94/bmjopen-2014-005240.PMC4127940.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005405).,Non-OADS,/arxiv_data1/oa_pdf/5e/9e/bmjopen-2014-005405.PMC4127941.pdf
"The duration of a sanction on a doctor ’s registration varies and it is possible for doctors to have more than one sanction against their registra- tion, and this typically represents the outcomes of differ- ent complaints (for further information on sanctions,visit http://www.gmc-uk.org/concerns/index.asp).",Non-OADS,/arxiv_data1/oa_pdf/5e/9e/bmjopen-2014-005405.PMC4127941.pdf
https://www.medicalcareers.nhs.uk/career_options/working_as_a_doctor/non-training_posts.aspx (accessed Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/5e/9e/bmjopen-2014-005405.PMC4127941.pdf
http://www.gmc-uk.org/concerns/doctors_under_investigation/a_guide_for_referred_doctors.asp (accessed Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/5e/9e/bmjopen-2014-005405.PMC4127941.pdf
http://europa.eu/about-eu/countries/ index_en.htm (accessed May 2013).,Non-OADS,/arxiv_data1/oa_pdf/5e/9e/bmjopen-2014-005405.PMC4127941.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005238).,Non-OADS,/arxiv_data1/oa_pdf/b3/38/bmjopen-2014-005238.PMC4127942.pdf
3. http://www.stats.org.uk/statistical-inference/Newcombe1998.pdf (accessed on 5 Jul 2014) 4.,Non-OADS,/arxiv_data1/oa_pdf/b3/38/bmjopen-2014-005238.PMC4127942.pdf
"The extracellular solution contained (in mM): 150 NaCl, 1 CaCl 2, 1 MgCl 2, 10 glucose, 10 sucrose, 10 HEPES (pH =7.4 with NaOH); the pipette solution contained (in mM): 130CsCl, 10 EGTA, 1 MgCl 2, 10 HEPES, 1 ATP and different concentrations of CaCl 2to obtain the desired free Ca2+con- centration (calculated according to the method posted athttp://www.stanford.edu/ ∼cpatton/; 1 mM for 18 nM, 6 mM for 290 nM, 7 mM for 453 nM, 8 mM for 777 nM, 8.5 mM for1.1μM, and 10 mM for 36.5 μM) (pH =7.3 with CsOH), as determined with the Ca-EGTA calculator.",Non-OADS,/arxiv_data1/oa_pdf/70/11/bph0171-3680.PMC4128065.pdf
Supporting information Additional Supporting Information may be found in the online version of this article at the publisher’s web-site: http://dx.doi.org/10.1111/bph.12730BJPAno1 functions as a CaCC in CVECs British Journal of Pharmacology (2014) 171 3680–3692 3691,Non-OADS,/arxiv_data1/oa_pdf/70/11/bph0171-3680.PMC4128065.pdf
"ISBN 3-900051-07-0, URL http://www.R-project.org/).",Non-OADS,/arxiv_data1/oa_pdf/b2/0b/bph0171-3716.PMC4128068.pdf
This  is  an  open  access  article  under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"In accordance  with  the  Tox21  initiative,  we  have  pro- posed to  characterize  immortalized  renal  cells  that  are toxicological targets  of  environmental  chemicals  in  the http://dx.doi.org/10.1016/j.toxrep.2014.05.010 2214-7500/©  2014  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"45  (2005)  106–114,  http://dx.doi.org/10.1002/ em.20095.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"287  (2004) F1067–F1075, http://dx.doi.org/10.1152/ajprenal.00120.2004.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"99 (2005) p105–p110, http://dx.doi.org/10.1159/000083981.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"7  (2010)  245–257,  http://dx.doi.org/ 10.1038/nrurol.2010.46.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"95  (2012)  155–162,  http://dx.doi.org/ 10.3945/ajcn.111.019364.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"Cancer  105  (2011)  1096–1104,  http://dx.doi.org/ 10.1038/bjc.2011.343.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"733 (2012)  69–77,  http://dx.doi.org/10.1016/j.mrfmmm.",OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"238  (2009) 294–300, http://dx.doi.org/10.1016/j.taap.2009.05.004.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"[14]  C.  Genies,  A.  Maitre,  E.  Lefebvre,  A.  Jullien,  M.  Chopard-Lallier,  T. Douki,  The  extreme  variety  of  genotoxic  response  to  benzo[a]pyrene in  three  different  human  cell  lines  from  three  different  organs, PLoS ONE 8 (2013)  e78356,  http://dx.doi.org/10.1371/journal.pone.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"213  (2006)  282–290, http://dx.doi.org/10.1016/j.taap.2006.03.008.",OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"108  (2011)  18708–18713,  http://dx.doi.org/ 10.1073/pnas.1111840108.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"109  (2009)  656–667,  http://dx.doi.org/10.1016/ j.jada.2008.12.020.",OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"111  (2009)  226–232,  http://dx.doi.org/ 10.1093/toxsci/kfp159.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"238  (2009)  201–208, http://dx.doi.org/10.1016/j.taap.2009.04.020.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"10  (2011)  877–886,  http://dx.doi.org/ 10.1016/j.dnarep.2011.06.002.",OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"60 (2011)  615–621, http://dx.doi.org/10.1016/j.eururo.2011.06.049.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"Rasband, ImageJ,  U.S.  National Institutes of  Health,  Bethesda, MD, USA,  1997–2012  http://imagej.nih.gov/ij/ [28]  M.J.  Ryan,  G.  Johnson,  J.  Kirk,  S.M.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"Herak-Kramberger,  Role  of metallothionein  in  cadmium  trafﬁc  and  toxicity  in  kidneys  and  other mammalian  organs,  Biometals  23  (2010)  897–926,  http://dx.doi.org/ 10.1007/s10534-010-9351-z.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"[32] A.  Tarantini,  A.  Maitre,  E.  Lefebvre,  M.  Marques,  A.  Rajhi,  T.  Douki, Polycyclic  aromatic  hydrocarbons  in  binary  mixtures  modulate the  efﬁciency  of  benzo[a]pyrene  to  form  DNA  adducts  in  human cells,  Toxicology  279  (2011)  36–44,  http://dx.doi.org/10.1016/j.tox.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"121  (2013)  756–765,  http://dx.doi.org/10.1289/ehp.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"Muta- gen.  533  (2003)  107–120,  http://dx.doi.org/10.1016/j.mrfmmm.",OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"295  (2008) F1365–F1375,  http://dx.doi.org/10.1152/ajprenal.90405.2008.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
"206  (2005)  73–93,  http://dx.doi.org/10.1016/j.taap.",OADS,/arxiv_data1/oa_pdf/67/4d/main.PMC4128258.pdf
http://dx.doi.org/10.1056/ NEJM199310283291808 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1038/nrmicro818 .,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
301:642– 647. http://dx.doi.org/ 10.1016/j.ijmm.2011.09.006 .,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
199:61– 66. http://dx.doi.org/10.1111/j.1574-6968.2001.tb10651.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
"http://dx.doi.org/10.1073/ pnas.0600938103 .8.Brzuszkiewicz E, Brüggemann H, Liesegang H, Emmerth M, Olschläger T, Nagy G, Albermann K, Wagner C, Buchrieser C, EmodyL, Gottschalk G, Hacker J, Dobrindt U.",OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1128/JB.01717-08 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1093/emboj/19.12.2803 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1126/science.1084550 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
69:4572– 4579. http://dx.doi.org/10.1128/ IAI.69.7.4572-4579.2001 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
72: 6373– 6381. http://dx.doi.org/10.1128/IAI.72.11.6373-6381.2004 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1128/IAI.68.10.5869-5880.2000 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
69: 6179 – 6185. http://dx.doi.org/10.1128/IAI.69.10.6179-6185.2001 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1046/j.1365-2958.2002.03078.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
36:616 – 648. http://dx.doi.org/ 10.1111/j.1574-6976.2012.00339.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1371/ journal.pgen.1000569 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1038/ nature08756 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1128/IAI.06138-11 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1371/ journal.ppat.1002945 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
195:4991– 4998. http://dx.doi.org/10.1128/JB.00875-13 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1371/ journal.pgen.1003495 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1128/AEM.70.9.5698-5700.2004 .,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1007/82_2012_303 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/ 10.1016/j.meegid.2012.01.005 .,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1128/JB.186.12.3911-3921.2004 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
Science 313:848 – 851. http://dx.doi.org/10.1126/science.1127059 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
Cell 43:880 – 891. http://dx.doi.org/ 10.1016/j.molcel.2011.08.022 .,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
Cell 136: 615– 628. http://dx.doi.org/10.1016/j.cell.2009.01.043 .,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1016/j.jmb.2007.07.035 .,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1111/ j.1365-2958.2007.05888.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1074/jbc.272.28.17502 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
48:657– 670. http://dx.doi.org/10.1046/j.1365 -2958.2003.03459.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1099/mic.0.2007/012286 -0.,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/ 10.1128/IAI.00418-09 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1111/j.1365-2958.2005.04648.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1371/ journal.pone.0031092 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2011.07663.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1101/ gad.354405 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1073/ pnas.1004435107 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2001.02329.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1101/ gad.901001 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/ 10.1016/S0960-9822(01)00270-6 .,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1111/j.1365-2958.2012.07976.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1128/ IAI.00069-08 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1128/ JB.184.8.2281-2286.2002 .,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1128/ IAI.72.2.1084-1095.2004 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/ 10.1046/j.1365-2958.2000.01767.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
300: 482– 488. http://dx.doi.org/10.1016/ j.ijmm.2010.04.018 .,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/ 10.1128/IAI.01721-07 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1016/j.micpath.2013.01.004 .,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1016/ j.gene.2011.10.013 .,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1371/ journal.ppat.1001187 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1128/ IAI.01959-05 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1128/IAI.00473-12 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1637/7093 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1111/j.1462 -2920.2010.02202.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1128/ IAI.01428-05 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1002/bies.201000121 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
"150:665– 674. http://dx.doi.org/10.1016/S0923-2508(99)00125-4 .78.Petersen L, Bollback JP, Dimmic M, Hubisz M, Nielsen R. 2007.",OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1101/gr.6254707 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1038/ nature12453 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1371/ journal.ppat.1002954 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
70: 4539 – 4546. http://dx.doi.org/10.1128/IAI.70.8.4539-4546.2002 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1086/340206 .,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
79:4753– 4763. http://dx.doi.org/10.1128/IAI.05621-11 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
19:6697– 6703. http://dx.doi.org/10.1093/ emboj/19.24.6697 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
12:880 – 886. http://dx.doi.org/10.1111/j.1469 -0691.2006.01461.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1128/JCM.01647-12 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1186/gb-2009-10-3 -r25.,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
215:403– 410. http://dx.doi.org/ 10.1016/S0022-2836(05)80360-2 .,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
7:1– 8. http://dx.doi.org/10.2174/1875036201307010001 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1186/gb-2010 -11-10-r106 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/ 10.1093/nar/gks1006 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1093/ bioinformatics/btp352 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1093/bioinformatics/btl446 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1093/nar/gkr1048 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
http://dx.doi.org/10.1093/bioinformatics/ btp536 .,Non-OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
12:229. http://dx.doi.org/10.1186/1471-2180 -12-229 .Bielecki et al.,OADS,/arxiv_data1/oa_pdf/dc/6d/mBio.01075-14.PMC4128348.pdf
A cartoon of this model is provided in reference20 and on our lab website ( http://home.ccr.cancer.gov/Lco/ ImprovedMaturation.htm ).,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
"The difference between the L1models obtained from this procedure and both the models from the trun-cated HPV16 L1 VLP (PDB ID, 1DZL) and those from the high-resolutionBPV1 cryo-EM reconstruction (PDB ID, 3IYJ) (18) were measured as rootmean square deviations (RMSD) using the tool Matchmaker in Chimera.A pseudoatomic model that includes possible arrangements of amino acidside chains is posted on our lab website ( http://home.ccr.cancer.gov/Lco/ L1structure.asp ).",Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1016/S0738-081X(96)00170 -8.,OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1016/j.jcv.2004.04.002 .,OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1128/ JVI.79.7.3938-3948.2005 .,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1099/0022 -1317-76-9-2407 .,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1128/JVI.02726-07 .,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
Chapter 8:Unit 83. http://dx.doi.org/10.1002/0471140864.ps0803s14 .,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
119: 445– 462. http://dx.doi.org/10.1385/1-59259 -982-6:445 .,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
21:4754 – 4762. http://dx.doi.org/10.1093/emboj/ cdf494 .,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1016/S1097 -2765(00)80449-9 .,OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
Biol.4:413– 420. http://dx.doi.org/10.1038/nsb0597-413 .,OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1128/JVI.77.21.11625-11632.2003 .,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
81:8784 – 8792. http://dx.doi.org/10.1128/JVI.00552-07 .,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
82:4638 – 4646. http://dx.doi.org/10.1128/JVI.00143-08 .,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/ 10.1006/jmbi.2000.4464 .,OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1038/nsb922 .,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1126/ science.1058069 .,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
Cell 94:55– 60. http://dx.doi.org/10.1016/S0092-8674(00)81221-0 .,OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1038/sj.emboj.7600613 .,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
Chapter 26:Unit 26.21. http://dx.doi.org/10.1002/0471143030.cb2601s37 .,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1002/1522 -2683(200106)22:10 /H110212058::AID-ELPS2058 /H110223.0.CO;2-Z .,OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1006/ jsbi.1993.1052 .,OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1006/ jsbi.1996.0020 .,OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1002/jcc.20084 .,Non-OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1016/0263 -7855(96)0018-5 .,OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
Structure 16:673– 683. http://dx.doi.org/10.1016/ j.str.2008.03.005 .,OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/10.1016/j.jsb.2007.08.002 .,OADS,/arxiv_data1/oa_pdf/56/65/mBio.01104-14.PMC4128349.pdf
http://dx.doi.org/ 10.1007/3-540-26397-7_8 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
80:483– 493. http://dx.doi.org/10.1128/JVI.80.1.483-493.2006 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.3390/v3081460 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.1126/science.1068284 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/ 10.1128/JVI.75.13.5740-5751.2001 .,OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.1002/rmv.457 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.1099/ 0022-1317-56-2-337 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
Virology 143: 467– 477. http://dx.doi.org/10.1016/0042 -6822(85)90386-1 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/ 10.1002/jmv.1890350415 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
J. Virol.74:8434 – 8443. http://dx.doi.org/10.1128/JVI.74.18.8434-8443.2000 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
Cell 47:433– 443. http://dx.doi.org/10.1016/0092 -8674(86)90600-8 .,OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.1371/journal.ppat.0030191 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.1086/ 587694 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
9:885– 887. http://dx.doi.org/10.3201/eid0907.020692 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.1371/ journal.pone.0024823 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.1093/infdis/jis204 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000412 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
82:8927– 8932. http://dx.doi.org/ 10.1128/JVI.00239-08 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/ 10.1006/viro.1993.1003 .,OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.1261/rna.5111803 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.1073/ pnas.0700451104 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/ 10.1016/0042-6822(86)90180-7 .,OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.1371/ journal.ppat.1003164 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1003228 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.1016/0042-6822(92)90193 -S. 36.,OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/ 10.1126/science.8073288 .Poliovirus-Coxsackievirus Recombination July/August 2014 Volume 5 Issue 4 e01119-14®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
56:835– 852. http://dx.doi.org/10.1016/j.addr.2003.10.042 .,OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
Nucleic Acids Res.12:6587– 6601. http://dx.doi.org/10.1093/nar/12.16.6587 .,OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
76:8920 – 8930. http://dx.doi.org/10.1128/ JVI.76.17.8920-8930.2002 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.1128/JVI.78.24.13512-13521.2004 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
http://dx.doi.org/10.1128/JVI.01076-06 .,Non-OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
354: 484 – 490. http://dx.doi.org/10.1111/j.1749 -6632.1980.tb27987.x .Holmblat et al.,OADS,/arxiv_data1/oa_pdf/0e/4a/mBio.01119-14.PMC4128350.pdf
Sequence reads weremapped to the genome of Salmonella enterica serovar Typhimurium strain SL1344 downloaded from NCBI ( http://www.ncbi.nlm.nih.gov/ nuccore/NC_016810.1 ).,OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1152/ physrev.00045.2009 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1038/nature11551 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/ 10.1038/nature11552 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1038/nature11550 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
4:478 – 485. http://dx.doi.org/10.1038/nri1373 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1126/ scitranslmed.3004184 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
EMBO Rep. 7:688 – 693. http://dx.doi.org/10.1038/sj.embor.7400731 .,OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1128/AAC.01664 -10.,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.2174/ 156652408785160989 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1016/ j.jsbmb.2009.12.015 .,OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/ 10.1159/000072764 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
35:69 – 80. http://dx.doi.org/10.1080/ 10408410902733946 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1038/nature07088 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
Nature 450: 883– 886. http://dx.doi.org/ 10.1038/nature06284 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1128/ IAI.01373-10 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1371/journal.pone.0069759 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1093/nar/ gkn194 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/ 10.1016/S1286-4579(01)01488-5 .,OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1007/s00018-011-0841-0 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1046/j.1365-2958.1996.d01-1718.x .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1128/JB.182.7.1872-1882.2000 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1128/ AEM.00851-10 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
Rep. 3:4.http://dx.doi.org/10.3410/B3 -4.,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1038/nature11623 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
113: 59 – 66. http://dx.doi.org/ 10.1093/infdis/113.1.59 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
13:790 – 801. http://dx.doi.org/10.1038/nri3535 .38.,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/ 10.1038/502S96a .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1371/ journal.pone.0026988 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1111/ j.1574-6941.2002.tb00904.x .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
5:23. http://dx.doi.org/10.1186/1757-4749-5-23 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
190:4233– 4241. http://dx.doi.org/10.1128/JB.00205-08 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1128/ AEM.72.1.946-949.2006 .,OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/ 10.1111/mmi.12149 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1128/IAI.01570-08 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1136/vr.78.21.706 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
88:6667– 6671. http://dx.doi.org/10.1073/ pnas.88.15.6667 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1128/JB.00104-12 .,Non-OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/ 10.1016/j.mimet.2013.08.008 .,OADS,/arxiv_data1/oa_pdf/c3/56/mBio.01183-14.PMC4128352.pdf
http://dx.doi.org/10.1128/mBio.01017-13 .,Non-OADS,/arxiv_data1/oa_pdf/89/1f/mBio.01285-14.PMC4128353.pdf
http://dx.doi.org/ 10.1371/journal.pgen.0020007 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/ 10.1128/AAC.01464-06 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
3:148. http://dx.doi.org/10.3389/ fmicb.2012.00148 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/10.1006/ jmbi.1997.1573 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/ 10.1073/pnas.100127597 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
21:601– 614. http://dx.doi.org/10.1101/gad.1510307 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
76:4960 – 4968. http://dx.doi.org/10.1128/AEM.00911-10 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/ 10.1126/science.1211037 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/10.1016/ j.abb.2012.02.007 .,OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/10.1073/ pnas.86.10.3484 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/10.1128/AAC.45.12.3375-3380.2001 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/10.2478/ v10042-008-0056-x .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
"http://dx.doi.org/10.1128/AAC.00732-07 .23.Harding CM, Tracy EN, Carruthers MD, Rather PN, Actis LA, Munson RS, Jr. 2013.",OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/ 10.1128/mBio.00360-13 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
1(6):e00906- 13.http://dx.doi.org/10.1128/genomeA.00906-13 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/ 10.1146/annurev-micro-092611-150055 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/ 10.1111/j.1365-2958.1994.tb00296.x .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/10.1128/ JB.01390-09 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
2:2006.0008. http://dx.doi.org/10.1038/msb4100050 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
10: 279. http://dx.doi.org/10.1186/1471-2180-10-279 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/10.1128/ MMBR.00048-09 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/10.1016/j.bpj.2011.02.020 .,OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/10.2217/fmb.09.5 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
80: 56 – 60. http://dx.doi.org/10.1016/j.jhin.2011.08.013 .,OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/10.1111/ j.1365-2958.1994.tb00499.x .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/10.1111/j.1365-2958.2010.07135.x .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/10.1038/ nprot.2007.521 .,Non-OADS,/arxiv_data1/oa_pdf/f4/09/mBio.01313-14.PMC4128354.pdf
http://dx.doi.org/10.1126/ science.1244157 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/ 10.1016/S0140-6736(11)60360-7 .,OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/ 10.1126/science.1241800 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
Nature 330: 664 – 666. http://dx.doi.org/10.1038/330664a0 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/ 10.4049/jimmunol.165.3.1453 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/ 10.1111/j.1600-065X.2008.00671.x .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1038/341323a0 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1093/ intimm/3.6.579 .,OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/ 10.1016/j.ijpara.2012.03.011 .,OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1017/S0031182000058273 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
"http://dx.doi.org/10.1073/ pnas.0408442102 .16.Cockburn IA, Tse SW, Radtke AJ, Srinivasan P, Chen YC, Sinnis P, Zavala F. 2011.",Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1371/journal.ppat.1001318 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1002/eji.200535712 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1038/nature05361 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1371/journal.pone.0001371 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1128/IAI.01415-09 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1371/journal.ppat.1003303 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1111/ j.1600-065X.2010.00988.x .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/ 10.1038/nm.3083 .,OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1126/science.1102452 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1111/cmi.12251 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1016/ j.cell.2007.09.013 .,OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.4049/jimmunol.178.11.7054 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1371/ journal.pone.0051875 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1111/tra.12151 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1016/j.ijpara.2007.04.005 .,OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1016/0309-1651(88)90126-9 .,OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1016/0166 -6851(96)02701-6 .,OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1586/erv.12.92 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1086/429635 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1086/ 498536 .,OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.4049/ jimmunol.166.9.5430 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1046/j.0818-9641.2001.01048.x .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1038/ni.2691 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1073/ pnas.1303858110 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1128/ IAI.00570-13 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1016/ j.ijmm.2012.07.011 .,OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
206:399 – 410. http://dx.doi.org/10.1084/jem.20082108 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
65:81– 84. http://dx.doi.org/10.1016/S0165 -2478(98)00128-X .,OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/ 10.1371/journal.pone.0022936 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/ 10.1016/j.molbiopara.2005.09.007 .,OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1007/ BF00932618 .,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
Cell 14:4947– 4957. http://dx.doi.org/ 10.1091/mbc.E03-06-0355 .,OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/ 10.1126/scitranslmed.3001058 .Antigen Presentation during Plasmodium Liver Infection July/August 2014 Volume 5 Issue 4 e01321-14®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/7c/0a/mBio.01321-14.PMC4128355.pdf
http://dx.doi.org/10.1126/science.283.5409.1837 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1016/ j.tim.2004.11.006 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1016/S0966-842X(02)00002-1 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1128/CMR.00029-06 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1128/AAC.01638-09 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1086/651200 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1128/AAC.00227-10 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1128/AAC.01056-06 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1371/journal.ppat.1002848 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1371/ journal.pbio.1000133 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1046/j.1432-1033.2003.03622.x .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/ 10.1248/cpb.58.1386 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/ 10.1042/BJ20070081 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1371/ journal.pone.0027614 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1016/ j.carres.2011.09.029 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1109/ ISVD.2009.33 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1128/AAC.00606-06 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1007/s11046-009-9264-y .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1128/ JB.00858-07 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1038/nature02122 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1099/jmm.0.46569-0 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1128/ CMR.17.2.255-267.2004 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1002257 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1086/ 322972 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
Cell 12: 420 – 429. http://dx.doi.org/10.1128/EC.00287-12 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1371/journal.ppat.1001264 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1111/ j.1462-2920.2011.02657.x .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1128/JB.01214-08 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1128/JB.185.3.1027 -1036.2003 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1093/infdis/ jis594 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1016/ j.micpath.2009.12.003 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1111/j.1365-2958.2005.05020.x .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1002/pmic.200600332 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1002/pmic.200700594 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1371/journal.ppat.0020063 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1016/j.cub.2005.05.047 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1128/ EC.00279-10 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/ 10.1016/S0966-842X(01)02012-1 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1128/ mBio.00127-12 e00127-00112.,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
56:427– 436. http://dx.doi.org/10.1007/s00248-007-9361-8 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1128/AEM.03005-10 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/ 10.1074/jbc.M113.502039 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.4161/ cib.1.1.6639 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1016/ j.tim.2005.11.009 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/ 10.1038/nrm2617 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
2012:528521. http://dx.doi.org/10.1155/ 2012/528521 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1016/ S0966-842X(00)01913-2 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
71: 4333– 4340. http://dx.doi.org/10.1128/IAI.71.8.4333-4340.2003 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1093/jac/dkf049 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
Mycoses 55:80 – 85. http://dx.doi.org/10.1111/j.1439 -0507.2011.02047.x .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
256:419 – 427. http://dx.doi.org/10.1016/S0021 -9673(01)88259-5 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1086/517522 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
45: 429 – 437. http://dx.doi.org/10.1016/j.biocel.2012.10.017 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
Bio-chemistry 31:8726 – 8731. http://dx.doi.org/10.1021/bi00152a007 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/ 10.1016/j.bbrc.2009.02.162 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
2:II: 2.5. http://dx.doi.org/10.1002/ 0471142735.im0205s03 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
59: 39 – 47. http://dx.doi.org/10.1016/j.diagmicrobio.2007.03.020 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
150: 76 – 85. http://dx.doi.org/10.1016/0003-2697(85)90442-7 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
72:4266 – 4274. http://dx.doi.org/10.1021/ac000497v .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1002/ (SICI)1522-2683(19991201)20:18 /H110213551::AID-ELPS3551 /H110223.0.CO;2-2 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1093/nar/ 28.7.e27 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1093/nar/gkr988 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1002/cyto.990060304 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1093/nar/gkr945 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1128/IAI.00480-10 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/ 10.1006/jmre.1998.1598 .,OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
http://dx.doi.org/10.1006/jmra.1995.1047 .,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
5:605– 611. http://dx.doi.org/10.2174/1386207023329923 .Fungal Bioﬁlm Matrix Encyclopedia July/August 2014 Volume 5 Issue 4 e01333-14®mbio.asm.org 13,Non-OADS,/arxiv_data1/oa_pdf/ac/9f/mBio.01333-14.PMC4128356.pdf
75:455– 462. http://dx.doi.org/10.1002/ jmv.20288 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1056/NEJMoa030781 .,OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1016/S0140 -6736(03)13967-0 .,OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1056/ NEJMoa1211721 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.3390/v4061011 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1371/ journal.pbio.0060226 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1371/journal.pone.0006130 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1111/j.1600-0854.2009.00878.x .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
5:424 – 428. http://dx.doi.org/10.1016/S0962-8924(00)89101-1 .,OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/ 10.1242/jcs.033951 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1083/jcb.201007003 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-06-3397 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1016/ S0960-9822(00)00736-3 .,OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1083/jcb.124.5.689 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1016/S0960-9822(01)00474-2 .,OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
291: 487– 494. http://dx.doi.org/10.1078/1438-4221-00157 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1038/ncb0509-510 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
9:639 – 649. http://dx.doi.org/10.1038/nrm2447 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1083/jcb.109.6.2731 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1172/ JCI117747 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1128/JVI.00442-06 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1006/viro.1994.1156 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1083/jcb.83.1.82 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1002754 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/ 10.1073/pnas.1004618107 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1128/ JVI.74.19.9206-9213.2000 .,OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1083/ jcb.105.3.1215 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
Nature 378: 636 – 638. http://dx.doi.org/10.1038/ 378636a0 .39.,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
Science327:873– 876. http://dx.doi.org/10.1126/science.1183173 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1126/ science.1084238 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1126/science.1080115 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
Trafﬁc 7:589 – 603. http://dx.doi.org/10.1111/j.1600 -0854.2006.00412.x .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1074/ jbc.M109.000760 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1128/ JVI.79.6.3391-3400.2005 .,OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1128/JVI.78.11.5957-5965.2004 .,OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/ 10.1073/pnas.1735582100 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1111/j.1348 -0421.1976.tb00978.x .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1128/JVI.74.5.2239 -2246.2000 .,OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1128/JVI.74.7.3379 -3387.2000 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1128/JVI.78.6.2682-2692.2004 .,OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1371/ journal.ppat.1003072 .,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
Neurology 34:597– 603. http://dx.doi.org/10.1212/WNL.34.5.597 .Freeman et al.,Non-OADS,/arxiv_data1/oa_pdf/2c/75/mBio.01340-14.PMC4128357.pdf
http://dx.doi.org/10.1023/B: ANTO.0000047942.69033.24 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/ 10.1038/nrmicro1817 .,OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
"http://dx.doi.org/10.1074/jbc.M110.141788 .4.Martens EC, Lowe EC, Chiang H, Pudlo NA, Wu M, McNulty NP, Abbott DW, Henrissat B, Gilbert HJ, Bolam DN, Gordon JI.",OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/10.1371/ journal.pbio.1001221 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/ 10.1074/jbc.R109.022848 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/10.1371/ journal.pone.0038571 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
Science 331: 463– 467. http://dx.doi.org/10.1126/science.1200387 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
Biotechnol.Biofuels 6:24. http://dx.doi.org/10.1186/1754-6834-6-24 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/10.1074/jbc.M112.397380 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/10.1128/AEM.01164-12 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
12:186. http://dx.doi.org/ 10.1186/1471-2148-12-186 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/10.1371/ journal.pbio.1001637 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/10.1074/ jbc.M605903200 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/10.1073/ pnas.1005297107 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/10.1038/ nature12907 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/10.1073/ pnas.1211002109 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/10.1016/j.cell.2010.05.005 .,OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
Science 333:646 – 648. http://dx.doi.org/10.1126/science.1205760 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
BMC Genomics 9:75. http://dx.doi.org/10.1186/ 1471-2164-9-75 .,OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/10.1093/bioinformatics/btq249 .,OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/10.1110/ps.0303703 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
31:426 – 428. http://dx.doi.org/10.1021/ ac60147a030 .,Non-OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
http://dx.doi.org/10.1016/j.ab.2003.11.011 .Opinion/Hypothesis 6®mbio.asm.org July/August 2014 Volume 5 Issue 4 e01401-14,OADS,/arxiv_data1/oa_pdf/5e/66/mBio.01401-14.PMC4128358.pdf
13(6):838 – 846. http://dx.doi.org/10.3201/ eid1306.061576 .,Non-OADS,/arxiv_data1/oa_pdf/a3/2b/mBio.01421-14.PMC4128359.pdf
http://dx.doi.org/10.1086/674860 .,OADS,/arxiv_data1/oa_pdf/a3/2b/mBio.01421-14.PMC4128359.pdf
http://dx.doi.org/10.1128/mBio.00520-12 .,Non-OADS,/arxiv_data1/oa_pdf/a3/2b/mBio.01421-14.PMC4128359.pdf
http://dx.doi.org/10.1126/science.1240578 .,Non-OADS,/arxiv_data1/oa_pdf/a3/2b/mBio.01421-14.PMC4128359.pdf
http://dx.doi.org/10.3201/ eid1601.090729 .,Non-OADS,/arxiv_data1/oa_pdf/a3/2b/mBio.01421-14.PMC4128359.pdf
http://dx.doi.org/10.1056/NEJM199808203390806 .,OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1172/JCI23825 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.3201/eid0908.030089 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1016/j.jhin.2008.12.001 .,OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
"http://dx.doi.org/10.1038/nrmicro1384 .7.Kahl B, Herrmann M, Everding AS, Koch HG, Becker K, Harms E, Proctor RA, Peters G. 1998.",OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1086/515238 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1086/656047 .,OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1086/320519 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
188:687– 693. http://dx.doi.org/ 10.1128/JB.188.2.687-693.2006 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
52:4017– 4022. http://dx.doi.org/10.1128/AAC.00668-08 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
190:834 – 842. http://dx.doi.org/10.1128/JB.00912-07 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1093/cid/cit270 .,OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000944 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1007/s00109-010 -0597-2 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1128/ IAI.70.10.5428-5437.2002 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1002/emmm.201000115 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1128/ JCM.00847-06 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1128/JCM.01510-06 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
73:4119 – 4126. http://dx.doi.org/10.1128/IAI.73.7.4119-4126.2005 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1128/IAI.01075-07 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1128/ JB.184.19.5457-5467.2002 .,OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1128/JB.00774-06 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
202: 58 – 61. http://dx.doi.org/10.1007/ BF00330517 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1128/JB.187.15.5486-5492.2005 .,OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1007/ s002030050428 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1099/mic.0.26412-0 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
Mi- crobiology 149:643– 654. http://dx.doi.org/10.1099/mic.0.25996-0 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1099/mic.0.29177-0 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1128/JB.01545-10 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1128/JB.00734 -07.,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
46:601– 612. http://dx.doi.org/10.1111/j.1348 -0421.2002.tb02741.x .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/ 10.1016/S0928-8244(03)00309-2 .,OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1016/j.biocel.2007.10.032 .,OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1128/ AAC.00680-10 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1128/JB.01079 -07.,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1007/s002840110215 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
mBio 4(1):e00537- 12.http://dx.doi.org/10.1128/mBio.00537-12 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
Dis.42:647– 656. http://dx.doi.org/10.1086/499815 .,OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1093/jac/19.2.147 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
75: 6910 – 6912. http://dx.doi.org/10.1128/AEM.01211-09 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1136/jcp.27.7.565 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1128/JCM.43.1.502-505.2005 .,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1093/nar/30.1.207 .thyA Mutation Impacts Metabolism and Virulence Gene Expression July/August 2014 Volume 5 Issue 4 e01447-14®mbio.asm.org 15,Non-OADS,/arxiv_data1/oa_pdf/ef/5c/mBio.01447-14.PMC4128360.pdf
http://dx.doi.org/10.1097/QAD.0b013e328322ffac .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1086/ 339202 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1038/ nature08182 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/ 10.1126/science.1061888 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1371/ journal.pgen.1001261 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1371/ journal.pbio.1001653 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1371/ journal.pgen.1004261 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1128/mBio.00941-14 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1038/365274a0 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1002936 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/ 10.1086/597306 .,OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1099/jmm.0.05427-0 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1128/JCM.03392-13 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1371/journal.pone.0074737 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1038/ nature04220 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000850 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1371/journal.pone.0028550 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/ 10.1073/pnas.1300130110 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
77:4345– 4355. http://dx.doi.org/10.1128/IAI.00542-09 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1371/ journal.pgen.1002810 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1128/IAI.00018-13 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
"http://dx.doi.org/10.1016/ j.cell.2008.07.046 .32.Kunadharaju R, Choe U, Harris JR, Lockhart SR, Greene JN.",OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.3201/eid1903.121399 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1371/ journal.pgen.1003771 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
22:4606 – 4618. http://dx.doi.org/10.1111/ mec.12415 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1128/mBio.00342-10 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1093/bioinformatics/ btp352 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1093/ bioinformatics/btr330 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1093/molbev/msr121 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/ 10.1046/j.1365-294x.2000.01020.x .,OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.1093/bib/ bbs017 .,Non-OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
http://dx.doi.org/10.4161/ﬂy.19695 .Billmyre et al.,OADS,/arxiv_data1/oa_pdf/de/b2/mBio.01494-14.PMC4128362.pdf
Completelinkage hierarchical clustering was performed using the University of Chi-cago Center for Research Informatics Web interface speciﬁcally designedfor our data set ( https://biocore.cri.uchicago.edu/ ).,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1086/591855 .,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1016/j.tim.2012.11.002 .,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/ 10.1016/S0966-842X(99)01475-4 .,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1128/ IAI.70.10.5816-5821.2002 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1038/ nrmicro3049 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
3:17. http://dx.doi.org/10.3389/fcimb.2013.00017 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1242/jcs.01382 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1016/ S1574-1400(08)00012-1 .,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1111/ cmi.12213 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
Nature 449:827– 834. http://dx.doi.org/ 10.1038/nature06247 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
2:64. http://dx.doi.org/ 10.3389/fmicb.2011.00064 .,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1007/82_2013_342 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1007/82_2013_342 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1073/ pnas.1207821109 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1128/ IAI.01324-10 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1196/ annals.1355.020 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
J. Cancer126:28 – 40. http://dx.doi.org/10.1002/ijc.24813 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000329 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/ 10.1126/science.1153018 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
70:4818 – 4825. http://dx.doi.org/10.1128/IAI.70.9.4818-4825.2002 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1111/j.1462-5822.2011.01742.x .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1016/0169-4758(90)90227-U .,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
11:476 – 483. http://dx.doi.org/10.1016/ j.micinf.2009.01.010 .,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
276: 44976 – 44983. http://dx.doi.org/10.1074/ jbc.M106455200 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1021/jm301749y .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1038/nchembio718 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1128/IAI.00805-10 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
Methods 9:671– 675. http://dx.doi.org/ 10.1038/nmeth.2089 .,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1007/978-1-62703-287-2_21 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/ 10.1128/AAC.00607-08 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1016/j.ijantimicag.2009.10.011 .,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1111/j.1462-5822.2007.00985.x .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
Microbiol.5:809 – 820. http://dx.doi.org/10.1046/j.1462-5822.2003.00322.x .,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
204:685– 694. http://dx.doi.org/10.1093/infdis/jir395 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1016/S0924-8579(00)00136-9 .,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1016/j.ijantimicag.2009.12.019 .,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.2174/157489111796064614 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
67:473– 477. http://dx.doi.org/10.1093/jac/dkr500 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1371/journal.ppat.1002689 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
Cell Host Microbe 10: 475– 485. http://dx.doi.org/10.1016/j.chom.2011.09.010 .,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1126/ scitranslmed.3003045 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1016/j.ijantimicag.2012.05.009 .,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1038/ja.2011.79 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1086/ 380798 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
273:75– 80. http://dx.doi.org/10.1016/j.jns.2008.06.021 .Host-Targeted Antimicrobials July/August 2014 Volume 5 Issue 4 e01534-14®mbio.asm.org 13,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1097/PSY.0b013e3181f883ce .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
"81:4955– 4959. http://dx.doi.org/10.1073/ pnas.81.15.4955 .65.Dorobantu C, Macovei A, Lazar C, Dwek RA, Zitzmann N, Branza- Nichita N. 2011.",Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1128/JVI.05423-11 .,Non-OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1016/j.intimp.2010.08.024 .Czyz˙ et al.,OADS,/arxiv_data1/oa_pdf/81/05/mBio.01534-14.PMC4128363.pdf
http://dx.doi.org/10.1038/nrmicro821 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1128/ JB.00858-07 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1111/ j.1574-695X.2010.00690.x .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
8:623– 633. http://dx.doi.org/10.1038/nrmicro2415 .,OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1002/(SICI)1097 -0290(19991005)65:1 /H1102183::AID-BIT10 /H110223.0.CO;2-B .,OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/ 10.1086/501795 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
6:471– 474. http://dx.doi.org/ 10.1038/ismej.2011.104 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
19:80 – 88. http://dx.doi.org/10.1111/j.1524-475X.2010.00628.x .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1136/thx.47.1.6 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/ 10.1073/pnas.1231792100 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
186:4457– 4465. http://dx.doi.org/10.1128/ JB.186.14.4457-4465.2004 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
51:675– 690. http://dx.doi.org/10.1046/j.1365-2958.2003.03877.x .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/ 10.1111/j.1462-2920.2011.02503.x .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1371/journal.ppat.1001264 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1371/ journal.ppat.1000354 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1038/nature12155 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1088/0034-4885/68/3/R04 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
88:623– 638. http://dx.doi.org/10.1529/ biophysj.104.042457 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1039/c2sm06745e .,OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1002/ pol.1974.180120601 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1021/bm3005808 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1016/j.bpj.2010.07.013 .,OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1021/la802442d .,OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1016/ j.bpj.2012.07.001 .,OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1111/j.1574 -695X.2012.00936.x .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1111/ j.1462-2920.2011.02657.x .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
50:61– 68. http://dx.doi.org/10.1046/j.1365-2958.2003.03677.x .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2005.05008.x .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1128/JB.00137-07 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1016/S0008-6215(03)00045-4 .,OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1111/1462-2920.12095 .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1016/S0167-7012(01)00246-9 .,OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1111/j.1574 -695X.2011.00820.x .,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
http://dx.doi.org/10.1039/ c2sm27229f .Dynamic Remodeling of Bioﬁlms by Exopolysaccharides July/August 2014 Volume 5 Issue 4 e01536-14®mbio.asm.org 11,Non-OADS,/arxiv_data1/oa_pdf/9d/9a/mBio.01536-14.PMC4128364.pdf
111:4988 – 4993. http://dx.doi.org/ 10.1073/pnas.1321364111 .,Non-OADS,/arxiv_data1/oa_pdf/85/c7/mBio.01550-14.PMC4128365.pdf
http://dx.doi.org/10.1371/ journal.pgen.0020031 .,Non-OADS,/arxiv_data1/oa_pdf/85/c7/mBio.01550-14.PMC4128365.pdf
Sci-ence 331:430 – 434. http://dx.doi.org/10.1126/science.1198545 .,Non-OADS,/arxiv_data1/oa_pdf/85/c7/mBio.01550-14.PMC4128365.pdf
45: 656 – 663. http://dx.doi.org/10.1038/ng.2625 .,Non-OADS,/arxiv_data1/oa_pdf/85/c7/mBio.01550-14.PMC4128365.pdf
http://dx.doi.org/10.1016/ S1473-3099(04)01251-4 .,OADS,/arxiv_data1/oa_pdf/85/c7/mBio.01550-14.PMC4128365.pdf
http://dx.doi.org/10.1093/infdis/ jis605 .,Non-OADS,/arxiv_data1/oa_pdf/85/c7/mBio.01550-14.PMC4128365.pdf
207:675– 686. http://dx.doi.org/10.1093/infdis/jis734 .,OADS,/arxiv_data1/oa_pdf/85/c7/mBio.01550-14.PMC4128365.pdf
192:888 – 892. http://dx.doi.org/ 10.1128/JB.01255-09 .,Non-OADS,/arxiv_data1/oa_pdf/85/c7/mBio.01550-14.PMC4128365.pdf
17:61– 68. http://dx.doi.org/10.1101/gr.5512906 .,Non-OADS,/arxiv_data1/oa_pdf/85/c7/mBio.01550-14.PMC4128365.pdf
http://dx.doi.org/ 10.1073/pnas.0803654105 .,Non-OADS,/arxiv_data1/oa_pdf/85/c7/mBio.01550-14.PMC4128365.pdf
http://dx.doi.org/10.1371/journal.pgen.1004300 .,Non-OADS,/arxiv_data1/oa_pdf/85/c7/mBio.01550-14.PMC4128365.pdf
http://dx.doi.org/10.1186/gb-2012-13-11-r103 .,Non-OADS,/arxiv_data1/oa_pdf/85/c7/mBio.01550-14.PMC4128365.pdf
http://dx.doi.org/10.1126/science.78.2033.539 .,Non-OADS,/arxiv_data1/oa_pdf/85/c7/mBio.01550-14.PMC4128365.pdf
"With thisbackdrop, GOF experiments have been severely criticized in thegeneral media, and 18 individuals, including both authors of thiseditorial, signed a statement of concern involving inﬂuenza virusGOF experiments ( http://www.cambridgeworkinggroup.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
"The CWG statement hasbeen criticized, but there appears to be some agreement on theneed for an Asilomar-type conference to explore the many issuesinvolved in GOF experiments ( http://www.twiv.tv/2014/07/20/ twiv-294/ ).",Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
http://dx.doi.org/ 10.1126/science.1213362 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
Nature 486:420 – 428. http://dx.doi.org/10.1038/nature10831 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
Nature 500:151. http://dx.doi.org/10.1038/500151c .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
http://dx.doi.org/10.1126/ science.1236194 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
88:6623– 6635. http://dx.doi.org/ 10.1128/JVI.02765-13 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
http://dx.doi.org/10.1016/j.chom.2014.05.006 .,OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
87:4826 – 4834. http://dx.doi.org/10.1128/ JVI.03110-12 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
87:4795– 4796. http://dx.doi.org/10.1128/JVI.00474-13 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
88:6533– 6534. http://dx.doi.org/10.1128/JVI.00886-14 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
88:6535– 6537. http://dx.doi.org/10.1128/JVI.00875-14 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
http://dx.doi.org/10.1028/ mBio.00360-12 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
http://dx.doi.org/10.1128/ JCM.00813-13 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
77: 4177– 4180. http://dx.doi.org/10.1128/IAI.00757-09 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
http://dx.doi.org/10.1073/ pnas.1121297109 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
http://dx.doi.org/10.3390/v4020276 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
http://dx.doi.org/10.1371/journal.ppat.1002136 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
http://dx.doi.org/10.1126/science.342.6156.310 -b.00354-12 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
http://dx.doi.org/10.1073/ pnas.72.6.1981 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
http://dx.doi.org/10.1128/mBio.00354-12 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
http://dx.doi.org/10.7754/eLife.03401 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
Science http://dx.doi.org/10.1126/science.1254287 .,Non-OADS,/arxiv_data1/oa_pdf/39/45/mBio.01730-14.PMC4128368.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/da/main.PMC4128500.pdf
Speci ﬁcations Organism/cell line/tissue Drosophila melanogaster eye–antennal imaginal disc Strain(s) w1118 Sequence or array type Illumina Genome Analyzer IIx Data format FASTQ and WIGExperimental features ChIP-seqConsent N/A http://dx.doi.org/10.1016/j.gdata.2014.06.016 2213-5960/© 2014 The Authors.,OADS,/arxiv_data1/oa_pdf/af/da/main.PMC4128500.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/da/main.PMC4128500.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/af/da/main.PMC4128500.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4b/51/rmhp-7-139.PMC4128598.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpRisk Management and Healthcare Policy 2014:7 139–153Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  139ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RMHP .S6601 1Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/4b/51/rmhp-7-139.PMC4128598.pdf
"Or use: http://dvpr.es/1pHeOC s“One for all and all for one”: consensus-building  within communities in rural india on their health  microinsurance package David M Dror1,2 Pradeep Panda1 christina May3 atanu Majumdar1 Ruth Koren4 1Micro insurance academy, new Delhi,   india;  2erasmus University, Rotterdam,   the netherlands;  3University of  cologne, cologne, germany;  4Tel aviv  University, Ramat aviv, israel correspondence: Pradeep Panda   Micro insurance academy,  52-B,   Okhla industrial estate, Phase iii,   new Delhi –  110020, Delhi, india   Tel +91 11 4379 9100  Fax +91 11 4379 9117  email pradeep@mia.org.i nIntroduction:  This study deals with consensus by poor persons in the informal sector in rural  India on the benefit-package of their community-based health insurance (CBHI).",Non-OADS,/arxiv_data1/oa_pdf/4b/51/rmhp-7-139.PMC4128598.pdf
"Available from: http://www.rynekpracy.pl/pliki/pdf/34.pd f. Accessed   July 21, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4b/51/rmhp-7-139.PMC4128598.pdf
Available at http://www.ilo.org/public/english/region/asro/ bangkok /feature/inf_sect.ht m May 2013.,Non-OADS,/arxiv_data1/oa_pdf/4b/51/rmhp-7-139.PMC4128598.pdf
Available  from: http://www.ilo.org/public/english/protection/socsec/wlrblurb.,Non-OADS,/arxiv_data1/oa_pdf/4b/51/rmhp-7-139.PMC4128598.pdf
"Available from: http://www.microinsurancenetwork.org/publication/ fichier/The_Landscape_of_MI_in_Africa_2012_full_study_web.pd f.  Accessed July  7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4b/51/rmhp-7-139.PMC4128598.pdf
"Available from: http://www.microinsurancecentre.org/resources/docu - ments/market-development/the-landscape-of-microinsurance-in-latin- america-and-the-caribbean.htm l. Accessed July  16, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4b/51/rmhp-7-139.PMC4128598.pdf
"Available from: http://www.microfinancegateway.org/gm/docu - ment-1.9.29195/40285_file_15.pd f. Accessed April  10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4b/51/rmhp-7-139.PMC4128598.pdf
"Available from: http://www.ilo.org/public/english/employment/ mifacility /download/repaper4.pd f. Accessed July  7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4b/51/rmhp-7-139.PMC4128598.pdf
Available from: http://icmr.nic.in/ ethical_guidelines.,Non-OADS,/arxiv_data1/oa_pdf/4b/51/rmhp-7-139.PMC4128598.pdf
Available from http://www.sup.org/search/blogthis.,Non-OADS,/arxiv_data1/oa_pdf/4b/51/rmhp-7-139.PMC4128598.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/4b/51/rmhp-7-139.PMC4128598.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/51/rmhp-7-139.PMC4128598.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/63/amep-5-237.PMC4128687.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2014:5 237–239Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  237LEttEropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/AMEP .S6853 4Empathy levels among first year Malaysian medical  students: an observational study Aji Gopakumar1 Jayadevan Sreedharan1 Gamini Premadasa2 Jayakumary  Muttappallymyalil3 1Statistical Support Facility,  2Medical  Education Unit,  3Department of  Community Medicine, Gulf Medical  University, Ajman, United Arab  Emirates Correspondence: Aji Gopakumar   Statistical Support Facility, Gulf Medical  University, PO Box-4184, Ajman,   United Arab Emirates   Email aji@gmu.ac.a eDear editor This letter is in response to the article by Williams et al titled “Empathy levels among  first year Malaysian medical students: An observational study” published in Advances  in Medical Education and Practice , May  2014.1 This observational study addresses the issue of educating medical students about  empathy as an attribute – a matter which is often not given enough importance – and  including the topic in the academic curriculum, in view of the declining empathy  levels observed in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/71/63/amep-5-237.PMC4128687.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/71/63/amep-5-237.PMC4128687.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/63/amep-5-237.PMC4128687.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1b/c1/cia-9-1261.PMC4128688.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1261–1268Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1261OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S6582 3Fuzhong li1,2 1Oregon research Institute,    eugene, Or, UsA; 2shanghai University  of sport, shanghai, People’s republic  of China Correspondence: Fuzhong li   Key laboratory of exercise and health  sciences, shanghai University of sport,   no 650, Qing Yuan huan road,   Yangpu District, shanghai 200438,   People’s republic of China   email fuzhongl@gmail.co m;   fuzhongl @ori.orgThe effects of Tai Ji Quan training on limits   of stability in older adults Background:  Limits of stability, defined as the ability to maintain the center of gravity within  the boundary of the base of support, is critically important for older adults in performing their  activities of daily living.",Non-OADS,/arxiv_data1/oa_pdf/1b/c1/cia-9-1261.PMC4128688.pdf
"However, effective  displacement of the center of gravity during either self-initiated voluntary movements  or externally triggered perturbations requires the capacity to remain within the limits  of stability, which is described as the maximum distance a person can intentionally  displace his or her center of gravity from a midline vertical position in any direction  without losing balance and stepping or grasping for support.1–4 Thus, a constricted limits of stability boundary or uncontrolled center of gravity  movement can impair functional balance of older adults and constrain safe perfor - mance of their daily activities such as reaching, bending, walking, gait initiation, Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Li Running head recto: Limits of stability training in older adults DOI: http://dx.doi.org/10.2147/CIA.S65823",Non-OADS,/arxiv_data1/oa_pdf/1b/c1/cia-9-1261.PMC4128688.pdf
"Available from: http://www.cdc.gov/Homeand  RecreationalSafety/Falls/adultfalls.htm l. Accessed January 5, 2014.",Non-OADS,/arxiv_data1/oa_pdf/1b/c1/cia-9-1261.PMC4128688.pdf
Available from:  http://www.who.int/ageing/publications/Falls_prevention7March.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1b/c1/cia-9-1261.PMC4128688.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/1b/c1/cia-9-1261.PMC4128688.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/1b/c1/cia-9-1261.PMC4128688.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/b0/bctt-6-123.PMC4128689.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBreast Cancer: Targets and Therapy 2014:6 123–133Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  123Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S4672 5Palbociclib: an evidence-based review   of its potential in the treatment of breast cancer Karen A Cadoo Ayca Gucalp Tiffany A Traina Breast Cancer Medicine Service,    Memorial Sloan Kettering Cancer   Center and weill Medical College   of Cornell University, New Y ork,    NY, USA Correspondence: Tiffany A Traina   Breast Cancer Medicine Service,   Memorial Sloan Kettering Cancer   Center and weill Medical College   of Cornell University, evelyn H Lauder   Breast Center,  300 east  66th Street,   New York, NY  10065, USA   Tel +1 646 888 4558  Fax +1 646 888 4917Abstract:  Cellular proliferation, growth, and division following DNA (deoxyribonucleic acid)  damage are tightly controlled by the cell-cycle regulatory machinery.",Non-OADS,/arxiv_data1/oa_pdf/7b/b0/bctt-6-123.PMC4128689.pdf
Or use: http://dvpr.es/1o0Fub q,Non-OADS,/arxiv_data1/oa_pdf/7b/b0/bctt-6-123.PMC4128689.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/7b/b0/bctt-6-123.PMC4128689.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/1c/bctt-6-135.PMC4128690.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2014:6 135–143Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  135Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BCTT .S6611 0Breast carcinomas: variations in sonoelastographic  appearance eduardo de Faria Castro  Fleury1 Maria do Carmo guedes  alcoforado assunção- Queiros2 Decio roveda Jr1 1Faculdade de Cências Médicas da  santa Casa de são Paulo, são Paulo,   Brazil; 2Faculdade de Medicina  da Universidade de são Paulo,   são Paulo, BrazilBackground:  This study assessed factors influencing the sonoelastographic presentation of  breast carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/5c/1c/bctt-6-135.PMC4128690.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/5c/1c/bctt-6-135.PMC4128690.pdf
"Available from: http://www.acr.org/ ∼/media/ ACR/Documents/PDF/QualitySafety/Resources/BIRADS/ Posters/ BIRADS%20Reference%20Card_web_F .pd f. Accessed May  13,  2014.",Non-OADS,/arxiv_data1/oa_pdf/5c/1c/bctt-6-135.PMC4128690.pdf
"Available from: http://www.itl.nist.gov/div898/hand - book/eda/section3/eda35i.ht m. Accessed July 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/5c/1c/bctt-6-135.PMC4128690.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/a2/hmer-6-095.PMC4128691.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpHepatic Medicine: Evidence and Research 2014:6 95–101Hepatic Medicine: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  95ORiginal REsEaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/HMER.S6703 6systemic vascular resistance in cirrhosis:   a predictor of severity?,Non-OADS,/arxiv_data1/oa_pdf/47/a2/hmer-6-095.PMC4128691.pdf
"Hepatic Medicine: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hepatic­medicine­evidence­and­research­journa lHepatic Medicine: Evidence and Research is an international, peer- reviewed, open access journal covering all aspects of adult and pedi - atric hepatology in the clinic and laboratory including the following  topics: Pathology, pathophysiology of hepatic disease; Investigation  and treatment of hepatic disease; Pharmacology of drugs used for the treatment of hepatic disease.",Non-OADS,/arxiv_data1/oa_pdf/47/a2/hmer-6-095.PMC4128691.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/a2/hmer-6-095.PMC4128691.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/77/eb/cia-9-1247.PMC4128692.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1247–1259Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1247OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6701 6Kok-Y ong Chin soelaiman Ima-n irwana Department of Pharmacology, Faculty  of Medicine, Universiti Kebangsaan  Malaysia, Kuala lumpur, Malaysia Correspondence: soelaiman Ima-nirwana   Department of Pharmacology, Faculty of  Medicine, Universiti Kebangsaan Malaysia,  Jalan raja Muda Abdul Aziz, 50300 Kuala  lumpur, Malaysia   Tel +603 4040 5514   Fax +603 2693 8205   email imasoel@ppukm.ukm.edu.m y effects of annatto-derived tocotrienol  supplementation on osteoporosis induced  by testosterone deficiency in ratsJournal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Chin and Ima-Nirwana Running head recto: Effects of tocotrienol in male osteoporosis DOI: http://dx.doi.org/10.2147/CIA.S67016 Background:  Previous animal models have demonstrated that tocotrienol is a potential treatment  for postmenopausal osteoporosis.",Non-OADS,/arxiv_data1/oa_pdf/77/eb/cia-9-1247.PMC4128692.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/77/eb/cia-9-1247.PMC4128692.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/77/eb/cia-9-1247.PMC4128692.pdf
"ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttributionLicense(http://creativecommons.org/licenses/by-nc/.0/),whichpermitsnon- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/da/bht064.PMC4128699.pdf
"Gray/white matter tissue classi ﬁcation and automatic cortical segmentation was performed using the Freesurfer suite (V5, http://surfer.nmr.mgh.harvard.edu/ )(Fischl et al.",OADS,/arxiv_data1/oa_pdf/56/da/bht064.PMC4128699.pdf
"and the anatomicaltemplate map used in this study (i.e., de ﬁning the nodes of the network) was determined by using the Talairach Daemon (TalD) (http://www.talairach.org/daemon.html ).",OADS,/arxiv_data1/oa_pdf/56/da/bht064.PMC4128699.pdf
"ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttributionNon-CommercialLicense(http://creativecommons.org/licenses/by-nc/.0/),which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/99/bht083.PMC4128702.pdf
Data were extracted from 7 × 7 × 7 voxel c u b e s ( 1 4m m×1 4m m×1 4m m=2 7 4 4m m 3)u s i n gt h eM a r s b a r toolbox ( http://marsbar.sourceforge.net/ )(Brett et al.,OADS,/arxiv_data1/oa_pdf/dc/99/bht083.PMC4128702.pdf
"ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttributionNon-CommercialLicense(http://creativecommons.org/licenses/by-nc/.0/),which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/12/bht101.PMC4128707.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/42/12/bht101.PMC4128707.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/.0/),whichpermitsnon-commercialre-use,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited.Forcommercialre-use, please contact journals.permissions@oup.com TX & MCSEuropean Journal of Cardio-Thoracic Surgery 46 (2014) e35 –e40 ORIGINAL ARTICLE doi:10.1093/ejcts/ezu258 Advance Access publication 30 June 2014 4",Non-OADS,/arxiv_data1/oa_pdf/c8/cb/ezu258.PMC4128784.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/72/99/dddt-8-1047.PMC4128789.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 1047–1059Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1047Original rESEarCHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6322 8Design, synthesis, and anticancer activity of novel   berberine derivatives prepared via Cuaa C “click”  chemistry as potential anticancer agents Xin Jin1,2,* Tian-Hua Yan3,* lan Yan1 Qian li4 rui-lian Wang1 Zhen-lin Hu1 Yuan-Ying Jiang1 Qing-Yan Sun1 Y ong-Bing Cao1 1School of Pharmacy, Second   Military Medical University,    Shanghai, People’s republic of   China;  2School of Pharmacy, FuJian   University of Traditional Chinese   Medicine, Fuzhou, People’s republic   of China;  3Department of   Pharmacology, School of Pharmacy,    China Pharmaceutical University,   nanjing, People’s republic of China;    4Diakite Biological T echnology Co.,    ltd, Shanghai, People’s republic of   China *These authors contributed equally   to this work Correspondence: Qing-Yan Sun,   Yong-Bing Cao   School of Pharmacy, Second Military   Medical University, Shanghai  200433,   People’s republic of China   Tel +86 21 8187 1275   Fax +86 21 8187 1275   Email sqy_2000@163.co m, ybcao@vip.",Non-OADS,/arxiv_data1/oa_pdf/72/99/dddt-8-1047.PMC4128789.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/72/99/dddt-8-1047.PMC4128789.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/99/dddt-8-1047.PMC4128789.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/bd/cia-9-1277.PMC4128790.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1277–1286Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1277OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S6671 4Jwa-Kyung Kim1 Y oung rim song1 Y oung-Jun Kwon2 hyung Jik Kim1 sung gyun Kim1 Y oung-su Ju2 1Department of Internal Medicine,   Kidney research Institute,   2Department of Occupational   and environmental Medicine, hallym  University sacred heart hospital,   Anyang-si, south Korea Correspondence: Young-su Ju   Department of Occupational   and environmental Medicine, hallym  University sacred heart hospital, 896,  Pyeongchon-dong, Dongan-gu,   Anyang-si, 431-070, south Korea   Tel +82 31 380 6035   Fax +82 31 380 1583   email zorro@hallym.or.k r    sung gyun Kim   Department of Internal Medicine   and Kidney research Institute, hallym  University sacred heart hospital, 896,  Pyeongchon-dong, Dongan-gu,   Anyang-si, 431-070, south Korea   Tel +82 31 380 3720   Fax +82 31 386 2269   email imnksk@gmail.co mIncreased body fat rather than body weight  has harmful effects on 4-year changes of renal  function in the general elderly population  with a normal or mildly impaired renal function Background:  With increasing age, body fat increases and muscle mass reduces.",Non-OADS,/arxiv_data1/oa_pdf/8d/bd/cia-9-1277.PMC4128790.pdf
"Compared to the subjects with estimated glomerular filtration rate  (eGFR) 60 mL/minute/1.73 m2 who were usually referred to nephrologists, most  patients with eGFR 60 mL/minute/1.73 m2 are not referred to the renal team, and  little attention has been paid to their renal function unless they have specific risk factors Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Kim et al Running head recto: Increased body fat and renal function decline DOI: http://dx.doi.org/10.2147/CIA.S66714",Non-OADS,/arxiv_data1/oa_pdf/8d/bd/cia-9-1277.PMC4128790.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/8d/bd/cia-9-1277.PMC4128790.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/8d/bd/cia-9-1277.PMC4128790.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/f1/ijn-9-3623.PMC4128791.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3623–3630International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3623OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6631 2Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Wei et al Running head recto: Pharmacokinetics and biodistribution of baicalin-loaded liposomes DOI: http://dx.doi.org/10.2147/IJN.S66312 Preparation, pharmacokinetics and biodistribution  of baicalin-loaded liposomes Yumeng Wei1,* Jianmin guo2,* Xiaoli Zheng2,* Jun Wu3 Yang Zhou1 Yu Yu4 Yun Ye1 liangke Zhang4 ling Zhao1 1school of Pharmacy, 2Institute   of Basic Medical sciences, luzhou  Medical college, luzhou city, sichuan  Province, People’s republic of china;   3Department of clinical Pharmacy  and Outcomes sciences, college  of Pharmacy, University of south  carolina, greenville, sc, Usa; 4school  of Pharmacy, chongqing Medical  University, chongqing, People’s  republic of china *These authors contributed equally   to this work correspondence: ling Zhao   school of Pharmacy, luzhou Medical  college, No 3-319, Zhongshan road,  Jiangyang District, luzhou city, sichuan  Province, 646000, People’s republic   of china   Tel +86 830 316 2291   Fax +86 830 316 2291   email zhaoling-998@163.co mAbstract:  Baicalin (BA) is a major constituent of Scutellaria baicalensis Georgi , a medicinal  herb.",Non-OADS,/arxiv_data1/oa_pdf/29/f1/ijn-9-3623.PMC4128791.pdf
Data analysis The plasma drug concentration–time curve was analyzed  using the software program DAS 2.0 (Drug and Stas - tistics) was provided from Anhui Provincial Center for  Drug Clinical Evaluation http://www.drugsina.com /.,OADS,/arxiv_data1/oa_pdf/29/f1/ijn-9-3623.PMC4128791.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/29/f1/ijn-9-3623.PMC4128791.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3630Wei et al  14.,Non-OADS,/arxiv_data1/oa_pdf/29/f1/ijn-9-3623.PMC4128791.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/ea/ijn-9-3631.PMC4128792.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3631–3643International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3631OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6665 1Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Pan et al Running head recto: Proteomic profiling of alteration in cell viability by ZnONPs DOI: http://dx.doi.org/10.2147/IJN.S66651 effects of size and surface of zinc oxide   and aluminum-doped zinc oxide nanoparticles   on cell viability inferred by proteomic analyses chih-hong Pan1,2,* Wen-T e liu3,4,* Mauo-Ying Bien4,5 I-chan lin6 Ta-chih hsiao7 chih-Ming Ma8 ching-huang lai2 Mei-chieh chen9 Kai-Jen chuang10,11 hsiao-chi chuang3,4 On behalf of the Taiwan  cardioPulmonary research   (T -cP r) group 1Institute of labor, Occupational  safety and health, Ministry of labor,  2school of Public health, National  Defense Medical center, 3Division of  Pulmonary Medicine, Department of  Internal Medicine, shuang ho hospital,  4school of respiratory Therapy,  college of Medicine, 5Division of  Pulmonary Medicine, Department  of Internal Medicine, Taipei Medical  University hospital, 6Department of  Ophthalmology, shuang ho hospital,  Taipei Medical University, Taipei,  7graduate Institute of environmental  engineering, National central  University, Taoyuan, 8Department  of cosmetic application and  Management, st Mary’s Junior college  of Medicine, Nursing and Management,  sanxing, 9Department of Microbiology  and Immunology, college of Medicine,  10Department of Public health, school  of Medicine, college of Medicine,  11school of Public health, college of  Public health and Nutrition, Taipei  Medical University, Taipei, Taiwan *These authors contributed equally   to this workAbstract:  Although the health effects of zinc oxide nanoparticles (ZnONPs) on the  respiratory  system have been reported, the fate, potential toxicity, and mechanisms in biological cells of these  particles, as related to particle size and surface characteristics, have not been well elucidated.",Non-OADS,/arxiv_data1/oa_pdf/af/ea/ijn-9-3631.PMC4128792.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/af/ea/ijn-9-3631.PMC4128792.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3643Proteomic profiling of alteration in cell viability by ZnONPs  6.,Non-OADS,/arxiv_data1/oa_pdf/af/ea/ijn-9-3631.PMC4128792.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/dmso-7-381.PMC4128793.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 381–389Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  381Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S6581 8Diabetes disease progression in goto-Kakizaki  rats: effects of salsalate treatment Xi Wang1 Debra c DuBois1,2 Yanguang cao2 William J Jusko2,3 richard r almon1–3 1Department of Biological   Sciences, University at Buffalo, Buffalo,    nY, USa;  2Department of   Pharmaceutical Sciences,    University at Buffalo,    Buffalo, nY, USa;  3new Y ork  State center of excellence in  Bioinformatics and life Sciences,   Buffalo, nY, USa correspondence: richard r almon   Department of Biological Sciences,   107 hochstetter hall, University   at Buffalo, Buffalo, nY  14260, USa   Tel +1 716 645 4907  Fax +1 716 645 2975  email almon@buffalo.ed uAbstract:  This study investigates the antidiabetic effects of salsalate on disease progression  of diabetes in non-obese diabetic Goto-Kakizaki (GK) rats, an experimental model of type  2  diabetes.",Non-OADS,/arxiv_data1/oa_pdf/95/1b/dmso-7-381.PMC4128793.pdf
"Available from: http://www.who.int/nmh/ publications/ncd_report_full_en.pd f. Accessed July 24, 2014.",OADS,/arxiv_data1/oa_pdf/95/1b/dmso-7-381.PMC4128793.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/95/1b/dmso-7-381.PMC4128793.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/1b/dmso-7-381.PMC4128793.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/45/9f/ijn-9-3611.PMC4128794.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3611–3621International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3611OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6460 2The application of eDT a in drug delivery   systems: doxorubicin liposomes loaded   via Nh4eDTa gradient Yanzhi song1 Zhenjun huang1 Yang song2 Qingjing Tian1 Xinrong liu1 Zhennan she1 Jiao Jiao1 eliza lu3 Yihui Deng1 1college of Pharmacy, shenyang  Pharmaceutical University, shenyang,   People’s republic of china; 2Jiangsu  hansoh Pharmaceutical co., ltd.,   lianyungang, People’s republic of  china; 3livzon Mabpharm Inc.,    Zhuhai, People’s republic of china correspondence: Yihui Deng college of Pharmacy, shenyang  Pharmaceutical University,   103 Wenhua road, shenyang,   110016, People’s republic of china Tel +86 024 2398 6316 Fax +86 024 2398 6316 email pharmdeng@gmail.co mAbstract:  The applications of ethylenediaminetetraacetic acid (EDTA) have been expanded  from the treatment of heavy metal poisoning to chelation therapies for atherosclerosis, heart  disease, and cancers, in which EDTA reduces morbidity and mortality by chelating toxic  metal ions.",Non-OADS,/arxiv_data1/oa_pdf/45/9f/ijn-9-3611.PMC4128794.pdf
It was first introduced in the 1960s and was widely utilized against Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Song et al Running head recto: Doxorubicin liposomes loaded via NH4EDTA gradient DOI: http://dx.doi.org/10.2147/IJN.S64602,Non-OADS,/arxiv_data1/oa_pdf/45/9f/ijn-9-3611.PMC4128794.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/45/9f/ijn-9-3611.PMC4128794.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3621Doxorubicin liposomes loaded via Nh4eDTa gradient  20.,Non-OADS,/arxiv_data1/oa_pdf/45/9f/ijn-9-3611.PMC4128794.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3b/3b/ijn-9-3645.PMC4128795.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3645–3657International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3645OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6631 8Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Wang et al Running head recto: Tolerance-like innate immunity and spleen injury DOI: http://dx.doi.org/10.2147/IJN.S66318 T olerance-like innate immunity and spleen injury:  a novel discovery via the weekly administrations  and consecutive injections of Pegylated  emulsions long Wang* chunling Wang* Jiao Jiao Yuqing su Xiaobo cheng Zhenjun huang Xinrong liu Yihui Deng college of Pharmacy, shenyang  Pharmaceutical University, shenyang,   People’s republic of china *These authors contributed equally   to this work correspondence: Yihui Deng   college of Pharmacy, shenyang  Pharmaceutical University, 103 Wenhua  road, shenyang, 110016, People’s  republic of china   Tel +86 24 23986316   Fax +86 24 23986316   email pharmdeng@gmail.co m Abstract:  There has been an increasing interest in the study of the innate immune system in  recent years.",Non-OADS,/arxiv_data1/oa_pdf/3b/3b/ijn-9-3645.PMC4128795.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3b/3b/ijn-9-3645.PMC4128795.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3657T olerance-like innate immunity and spleen injury Study of the in vitro release of  tocopheryl nicotinate (TN) from  the PEGylated emulsions Method PEGylated emulsion (PE) samples (1 mL) and 0.5% sodium  dodecyl sulfate (SDS, 1 mL), enclosed in dialysis bags (cellu - lose membrane, molecular weight cutoff 100 kDa; Spectrum  Laboratories, Inc., Rancho Dominguez, CA, USA), were  incubated in 100 mL dialysis medium (pH 7.4 phosphate  buffered saline (PBS) containing 0.25% SDS) at 37 °C±0.5°C  under an agitation with 100 rpm in a water bath.",Non-OADS,/arxiv_data1/oa_pdf/3b/3b/ijn-9-3645.PMC4128795.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/68/ijn-9-3659.PMC4128796.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3659–3676International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3659OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6343 3Development and characterization of magnetic  iron oxide nanoparticles with a cisplatin-bearing  polymer coating for targeted drug delivery correspondence: christoph alexiou   hNO Klinik erlangen, Waldstrasse 1,   91054 erlangen, germany   Tel +49 913 1853 4769   Fax +49 913 1853 4808   email c.alexiou@web.d eharald Unterweger1 rainer Tietze1 christina Janko1 Jan Zaloga1 stefan lyer1 stephan Dürr1 Nicola Taccardi2 Ourania-Menti goudouri3 alexander hoppe3 Dietmar eberbeck4 Dirk W schubert5 aldo r Boccaccini3 christoph alexiou1 1eNT Department, section of experimental  Oncology and Nanomedicine (seON), else Kroener- Fresenius-stiftung-Professorship, University hospital  erlangen, 2chair of chemical engineering I (reaction  engineering), 3Institute of Biomaterials, Department  of Materials science and engineering, University  erlangen-Nuremberg, erlangen, 4Physikalisch- T echnische Bundesanstalt, Berlin, 5Institute   of Polymer Materials, Department of Materials  science and engineering, University erlangen- Nuremberg, erlangen, germanyAbstract:  A highly selective and efficient cancer therapy can be achieved using magnetically  directed superparamagnetic iron oxide nanoparticles (SPIONs) bearing a sufficient amount of the  therapeutic agent.",Non-OADS,/arxiv_data1/oa_pdf/b3/68/ijn-9-3659.PMC4128796.pdf
Or use: http://dvpr.es/1koOtR s Video abstractJournal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Unterweger et al Running head recto: Cisplatin-bearing SPIONs for targeted drug delivery DOI: http://dx.doi.org/10.2147/IJN.S63433,Non-OADS,/arxiv_data1/oa_pdf/b3/68/ijn-9-3659.PMC4128796.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b3/68/ijn-9-3659.PMC4128796.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 3676Unterweger et al Water control PBS control 100 80 60 40 20 0Cells [%] 100 80 60 40 20 0Cells [%] 100 80 60 40 20 0Cells [%] 100 80 60 40 20 0Cells [%] 100 80 60 40 20 0 02 43 64 8Cells [%]Fe-conc.,Non-OADS,/arxiv_data1/oa_pdf/b3/68/ijn-9-3659.PMC4128796.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e9/58/cia-9-1287.PMC4128797.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1287–1294Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1287OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6705 2Xu-gang Tang1 Ji-hang Zhang1 Jun Qin1 Xu-bin gao1 Qian-ning li2 Jie Yu1 Xiao-han Ding1 lan huang1 1Institute of Cardiovascular Diseases,   2Department of neurology, Xinqiao  hospital, Third Military Medical  University, Chongqing, People’s  republic of China Correspondence: lan huang   Institute of Cardiovascular Diseases,  Xinqiao hospital, Third Military Medical  University, 183 Xinqiao Main st, shapingba  District, Chongqing 400037, People’s  republic of China   T el +86 23 6875 5601   Fax +86 23 6875 5601   email huanglan260@126.co m Age as a risk factor for acute mountain sickness  upon rapid ascent to 3,700 m among young   adult Chinese men Background:  The aim of this study was to explore the relationship between age and acute  mountain sickness (AMS) when subjects are exposed suddenly to high altitude.",Non-OADS,/arxiv_data1/oa_pdf/e9/58/cia-9-1287.PMC4128797.pdf
"However, as yet, there has been no large-scale epidemiological  investigation into the relationship between age and AMS upon rapid ascent to high Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Tang et al Running head recto: Age and acute mountain sickness DOI: http://dx.doi.org/10.2147/CIA.S67052",Non-OADS,/arxiv_data1/oa_pdf/e9/58/cia-9-1287.PMC4128797.pdf
The  study protocol was registered in the Chinese Clinical Trial  Registry ( http://www.chictr.org ; registration no.,Non-OADS,/arxiv_data1/oa_pdf/e9/58/cia-9-1287.PMC4128797.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/e9/58/cia-9-1287.PMC4128797.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/e9/58/cia-9-1287.PMC4128797.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/4a/dmso-7-369.PMC4128798.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 369–380Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  369Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S6744 1a community-based exercise intervention  transitions metabolically abnormal obese adults   to a metabolically healthy obese phenotype lance c Dalleck1,3 gary P Van guilder2,3 Tara B richardson1 Donald l Bredle3 Jeffrey M Janot3 1recreation, exercise, and Sport  Science Department, Western State  colorado University, gunnison, cO,   USa; 2Department of health and  nutritional Sciences, South Dakota  State University, Brookings, SD,   USa; 3Department of Kinesiology,   University of Wisconsin-eau claire,   eau claire, Wi, USa correspondence: lance c Dalleck   recreation, exercise, and Sport Science  Department, Western State colorado  University, 600 n adams St, gunnison,  cO 81230, USa   Tel +1 970 943 7132   Fax +1 970 943 7125   email ldalleck@western.ed uBackground:  Lower habitual physical activity and poor cardiorespiratory fitness are common  features of the metabolically abnormal obese (MAO) phenotype that contribute to increased  cardiovascular disease risk.",Non-OADS,/arxiv_data1/oa_pdf/9c/4a/dmso-7-369.PMC4128798.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/9c/4a/dmso-7-369.PMC4128798.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/4a/dmso-7-369.PMC4128798.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/18/13/oajsm-5-183.PMC4128835.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Journal of Sports Medicine 2014:5 183–189Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  183O r i g i n Al  reSeAr c h open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S6587 7effect of compensatory acceleration training   in combination with accommodating resistance   on upper body strength in collegiate athletes Margaret T Jones Sports Medicine Assessment,   rehabilitation, and T esting laboratory,   School of recreation, health, and  T ourism, george Mason University,   Manassas, VA, USA correspondence: Margaret T Jones   Sports Medicine Assessment,  rehabilitation, and Testing laboratory,  School of recreation, health, and  Tourism,  george Mason University,  10900 University Blvd, MS  4e5,   Manassas, VA  20110-2203, USA   Tel +1 703 993 3247  Fax +1 703 993 2025  email mjones15@gmu.ed uPurpose:  To determine the impact of inclusion of a band or chain compensatory acceleration  training (CAT), in a  5-week training phase, on maximal upper body strength during a  14-week  off-season strength and conditioning program for collegiate male athletes.",Non-OADS,/arxiv_data1/oa_pdf/18/13/oajsm-5-183.PMC4128835.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/18/13/oajsm-5-183.PMC4128835.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/13/oajsm-5-183.PMC4128835.pdf
"Available from: http://www.westside- barbell.com/index.php/articles-by-louie-simmons/articles-published-in- 2003/355-chain-reaction-accommodating-leverage s. Accessed June  17,   2014.",OADS,/arxiv_data1/oa_pdf/18/13/oajsm-5-183.PMC4128835.pdf
"Available from: http://www.westside-barbell.com/index.php/articles- by-louie-simmons/articles-published-in-2004/367-chains-and-band s.  Accessed June  17, 2014.",Non-OADS,/arxiv_data1/oa_pdf/18/13/oajsm-5-183.PMC4128835.pdf
Available from: http://www.westside-barbell.,Non-OADS,/arxiv_data1/oa_pdf/18/13/oajsm-5-183.PMC4128835.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/86/jmdh-7-333.PMC4128836.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2014:7 333–339Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  333SHort reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/JMDH.S6671 2The difficulties of interprofessional teamwork   in diabetes care: a questionnaire survey Miyako Kishimoto1,2 Mitsuhiko Noda2,3 1Department of Diabetes,   endocrinology, and Me tabolism,   Center Hospital, National Center  for Global Health and Medicine,   T okyo, Japan;  2Diabetes and  Metabolism Information Center,   Diabetes research Center, research  Institute, National Center for Global  Health and Medicine, T okyo, Japan;   3Department of Diabetes research,   Diabetes research Center, research  Institute, National Center for Global  Health and Medicine, T okyo, Japan Correspondence: Miyako Kishimoto   National Center for Global Health and  Medicine,  1-21-1 Toyama Shinjuku-ku,  Tokyo  162-8655, Japan   tel +81 3 3202 7181  Fax +81 3 3207 1038  email mkishimo@hosp.ncgm.go.j pBackground:  Diabetes is a multifactorial disease and its nature means that interprofessional  teamwork is essential for its treatment.",Non-OADS,/arxiv_data1/oa_pdf/c0/86/jmdh-7-333.PMC4128836.pdf
"Available from: http://www.idf.org/diabetesatla s. Accessed July  2,  2014.",Non-OADS,/arxiv_data1/oa_pdf/c0/86/jmdh-7-333.PMC4128836.pdf
Available from: http://www.who.int/hrh/ resources/framework_action/en /.,OADS,/arxiv_data1/oa_pdf/c0/86/jmdh-7-333.PMC4128836.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/c0/86/jmdh-7-333.PMC4128836.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/01/jpr-7-449.PMC4128837.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2014:7 449–454Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  449ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S6674 1Transdermal fentanyl patch for postoperative  analgesia in total knee arthroplasty: a randomized  double-blind controlled trial Thepakorn  sathitkarnmanee1 sirirat Tribuddharat1 Kanlayarat noiphitak2 sunchai Theerapongpakdee1 sasiwimon Pongjanyakul1 Yuwadee huntula1 Maneerat Thananun1 1Department of anesthesiology,   Faculty of Medicine, Khon Kaen  University, Khon Kaen,  2chulabhorn  hospital, Bangkok, Thailand correspondence: Thepakorn  sathitkarnmanee   Department of anesthesiology, Faculty  of Medicine, Khon Kaen University,   123 Moo  16 Mittraphap Road, Tambon  Muang, Khon Kaen  40002, Thailand   Tel +66 81 954 7622  Fax +66 43 348 390  email thepakorns@gmail.co mPurpose:  To assess the efficacy of a transdermal fentanyl patch (TFP) (50 µg/hour) applied   10–12 hours before surgery versus placebo for postoperative pain control of total knee   arthroplasty (TKA).",Non-OADS,/arxiv_data1/oa_pdf/36/01/jpr-7-449.PMC4128837.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/36/01/jpr-7-449.PMC4128837.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/01/jpr-7-449.PMC4128837.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/c5/rru-6-097.PMC4128838.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpResearch and Reports in Urology 2014:6 97–105Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  97Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S2900 3Clinical use of abiraterone in the treatment   of metastatic castration-resistant prostate cancer Chrystia M Zobniw1 Alanna Causebrook2 Mei Ka Fong1 1Department of Pharmacy, Roswell  Park Cancer institute, Buffalo, NY,   USA;  2School of Pharmacy, Lake erie  College of Osteopathic Medicine, erie,   PA, USA Correspondence: Mei Ka Fong   Department of Pharmacy, Roswell Park  Cancer institute, elm and Carlton Streets,  Buffalo, NY  14263  Tel +1 716 845 4416  Fax +1 716 845 8737  email m eika.fong@ roswell park.orgAbstract:  Prostate cancer remains the most common type of cancer among men in the  United States.",Non-OADS,/arxiv_data1/oa_pdf/c6/c5/rru-6-097.PMC4128838.pdf
Available from: http://seer.cancer.,Non-OADS,/arxiv_data1/oa_pdf/c6/c5/rru-6-097.PMC4128838.pdf
"http://www.nccn.org/professionals/physician_gls/pdf/prostate.pd f.  Accessed  March 20, 2014 .",Non-OADS,/arxiv_data1/oa_pdf/c6/c5/rru-6-097.PMC4128838.pdf
Available from:  http://gucasym.org/prevail-trial-demonstrates-dramatic-os-and-pfs- improvements-enzalutamide-metastatic-prostate-cancer .,Non-OADS,/arxiv_data1/oa_pdf/c6/c5/rru-6-097.PMC4128838.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/c6/c5/rru-6-097.PMC4128838.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/c5/rru-6-097.PMC4128838.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/7f/opth-8-1459.PMC4128839.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1459–1466Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1459Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6366 7Neuroretinitis in ocular bartonellosis:   a case series abdul-rahim raihan1 embong Zunaina1,2 Wan-Hitam Wan- Hazabbah1,2 Hussein adil1,2 Thavaratnam Lakana- Kumar1  1Department of Ophthalmology,   school of Medical sciences, Universiti  sains Malaysia, Kubang Kerian,   Kelantan, Malaysia; 2Hospital Universiti  sains Malaysia, Kubang Kerian,   Kelantan, Malaysia Correspondence: embong Zunaina   Department of Ophthalmology,   school of Medical sciences, Universiti  sains Malaysia, 16150 Kubang Kerian,  Kelantan, Malaysia   Tel +60 9 767 6362   Fax +60 9 765 3370   email zunaina@usm.m yAbstract:  We report a case series of neuroretinitis in ocular bartonellosis and describe the  serologic verification for Bartonella henselae.",Non-OADS,/arxiv_data1/oa_pdf/4c/7f/opth-8-1459.PMC4128839.pdf
An increase in  immunoglobulin (Ig) M titer with a significant increase in IgG antibodies titer can be  considered an acute Bartonella  infection.10Journal name: Clinical Ophthalmology Journal Designation: Case Series Y ear: 2014 Volume: 8 Running head verso: Raihan et al Running head recto: Ocular bartonellosis DOI: http://dx.doi.org/10.2147/OPTH.S63667,Non-OADS,/arxiv_data1/oa_pdf/4c/7f/opth-8-1459.PMC4128839.pdf
"Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1466raihan et al Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/4c/7f/opth-8-1459.PMC4128839.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s15.,Non-OADS,/arxiv_data1/oa_pdf/4c/7f/opth-8-1459.PMC4128839.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/f3/opth-8-1441.PMC4128840.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1441–1445Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1441Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6565 4evaluation of dacryocystorhinostomy using  optical coherence tomography and rebamipide  ophthalmic suspension Masahiro Fujimoto1 Ken Ogino1 Chika Miyazaki1,2 Miou hirose1,3 hiroko Matsuyama1,4 Takeshi Moritera1,5 nagahisa Y oshimura1 1Department of Ophthalmology   and Visual sciences, Kyoto University  graduate school of Medicine, Kyoto,   Japan; 2Department of Ophthalmology,   hyogo Prefectural Tsukaguchi  hospital, hyogo, Japan; 3Department  of Ophthalmology, hyogo Prefectural  amagasaki hospital, hyogo, Japan;   4Department of Ophthalmology,   national hospital Organization  himeji Medical Center, hyogo, Japan;   5Moritera eye Clinic, shiga, Japan Correspondence: Ken Ogino Department of Ophthalmology   and Visual sciences, Kyoto University  graduate school of Medicine, 54 shogoin  Kawaharacho, sakyo-ku, Kyoto 606-8507,  Japan T el +81 75 751 3250 Fax +81 75 751 0933 email kenboo@kuhp.kyoto-u.ac.j pJournal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Fujimoto et al Running head recto: Evaluation of DCR with OCT and rebamipide DOI: http://dx.doi.org/10.2147/OPTH.S65654 Purpose:  To evaluate the surgical outcome of dacryocystorhinostomy (DCR) by measuring the  tear meniscus, using optical coherence tomography and rebamipide ophthalmic suspension.",Non-OADS,/arxiv_data1/oa_pdf/d0/f3/opth-8-1441.PMC4128840.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d0/f3/opth-8-1441.PMC4128840.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1445evaluation of DCr with OCT and rebamipide References  1.,Non-OADS,/arxiv_data1/oa_pdf/d0/f3/opth-8-1441.PMC4128840.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/ad/prbm-7-201.PMC4128841.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2014:7 201–212Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  201Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S6557 8Spiritual and religious aspects of skin and skin  disorders Philip D Shenefelt1 Debrah A Shenefelt2 1Dermatology and Cutaneous Surgery,   University of South Florida, Tampa,   2Congregation Or Ahavah, Lutz,    FL, USA Correspondence: Philip D Shenefelt   Dermatology and Cutaneous Surgery  MDC  79, University of South Florida,   12901 Bruce B Downs Blvd, Tampa,   FL 33612, USA   Tel +1 813 974 4270  Fax +1 813 974 4272  email pshenefe@health.usf.ed uAbstract:  Skin and skin disorders have had spiritual aspects since ancient times.",Non-OADS,/arxiv_data1/oa_pdf/ae/ad/prbm-7-201.PMC4128841.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/ae/ad/prbm-7-201.PMC4128841.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ae/ad/prbm-7-201.PMC4128841.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f2/34/tcrm-10-603.PMC4128842.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 603–614Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  603Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S3566 4Clinical and economic studies of eptifibatide   in coronary stenting Tilak Pasala Prasongchai Sattayaprasert Pradeep K Bhat Ganesh Athappan Sanjay Gandhi The Heart and vascular Center,   Case western Reserve University/ MetroHealth, Cleveland, OH, USA Correspondence: Sanjay Gandhi   The Heart and vascular Center,  Case western Reserve University/ MetroHealth,  2500 Metrohealth Drive,  H330, Cleveland, OH  44109-1998, USA   Tel +1 216 778 2357  Fax +1 216 778 3927  email sgandhi@metrohealth.or gAbstract:  Platelet adhesion and aggregation at the site of coronary stenting can have catastrophic  clinical and economic consequences.",Non-OADS,/arxiv_data1/oa_pdf/f2/34/tcrm-10-603.PMC4128842.pdf
Or use: http://dvpr.es/1ktMFb d,Non-OADS,/arxiv_data1/oa_pdf/f2/34/tcrm-10-603.PMC4128842.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/f2/34/tcrm-10-603.PMC4128842.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/34/tcrm-10-603.PMC4128842.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cb/13/tcrm-10-615.PMC4128843.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 615–620Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  615Case seRiesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S6257 4Double-balloon tamponade in the management   of postpartum hemorrhage: a case series salih Burçin Kavak1 ebru Çelik Kavak2 ismail Demirel3 Raşit Ilhan1 1Department of Obstetrics and  Gynecology, school of Medicine, Firat  Medical Center, Firat University, elazig,   T urkey;  2Department of Obstetrics  and Gynecology, special Medical Park  Hospital, elazig, T urkey;  3Department  of anesthesiology, school of Medicine,   Firat Medical Center, Firat University,   elazig, T urkey Correspondence: salih Burcin Kavak   Firat University, school of Medicine,   Firat Medical Center, Department of   Obstetrics and Gynecology  23100,   elazig, Turkey   Tel +90 424 233 35 55 2124  Fax +90 424 237 91 38  email burcinkavak@gmail.co mAbstract : To show the efficacy of double-balloon cervical ripening catheter in the  management  of postpartum hemorrhage originating from the lower segment of the uterus or the upper parts  of the vagina.",Non-OADS,/arxiv_data1/oa_pdf/cb/13/tcrm-10-615.PMC4128843.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/cb/13/tcrm-10-615.PMC4128843.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cb/13/tcrm-10-615.PMC4128843.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijwh-6-711.PMC4128844.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 711–718International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  711revIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S6548 1Noncontraceptive benefits of the estradiol   valerate/dienogest combined oral contraceptive:   a review of the literature rossella e Nappi1 Marco Serrani2 Jeffrey T Jensen3 1Department of Obstetrics and  Gynecology, research Centre for  reproductive Medicine, IrCCS  Policlinico San Matteo Foundation,   University of Pavia, Pavia, Italy;  2Global  Medical Affairs Women’s Healthcare,   Bayer HealthCare Pharmaceuticals,   Berlin, Germany;  3Department of  Obstetrics and Gynecology, Oregon  Health and Science University,   Portland, Or, USA Correspondence: rossella e Nappi   research Center for reproductive   Medicine, Obstetrics and Gynecology   Unit, IrCCS Policlinico San Matteo  Foundation, Piazzale Golgi  2,   27100 Pavia, Italy   Tel +39 0382 50 1561  Fax +39 0382 42 3233  email renappi@tin.i tAbstract:  Combined oral contraceptives formulated to include estradiol (E2) have recently  become available for the indication of pregnancy prevention.",Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijwh-6-711.PMC4128844.pdf
"Available from: http://www.pharmaline.co.il/images/ newsletterregistration/bayer/11022011/dianedr.pd f. Accessed March  20,  2014.",OADS,/arxiv_data1/oa_pdf/a9/34/ijwh-6-711.PMC4128844.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijwh-6-711.PMC4128844.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/34/ijwh-6-711.PMC4128844.pdf
"http://www.accessdata.fda.gov/drug - satfda_docs/nda/2010/022252_Orig-1_StatR.pd f. U.S. Department of  Health and Human Services, Food and Drug Administration; 2010.",OADS,/arxiv_data1/oa_pdf/a9/34/ijwh-6-711.PMC4128844.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/c7/ndt-10-1433.PMC4128845.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1433–1438Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1433OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6700 8correspondence: Khalaf aljumah   al amal Psychiatric hospital, Department  of Pharmacy, PO Box 33626, riyadh  11458, saudi arabia   email khalafaljumaah@yahoo.co mexamining the relationship between adherence  and satisfaction with antidepressant treatment Khalaf aljumah1 azmi ahmad hassali2 saed alQhatani1 1al amal Psychiatric hospital,   Department of Pharmacy, riyadh,   saudi arabia; 2Universiti sains  Malaysia, school of Pharmaceutical  sciences, Penang, MalaysiaJournal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Aljumah et al Running head recto: Patient satisfaction and adherence to antidepressants DOI: http://dx.doi.org/10.2147/NDT.S67008 Background:  Adherence to antidepressant treatment is an essential step in the management  of patients with major depressive disorder, and several factors can contribute to antidepressant  nonadherence.",Non-OADS,/arxiv_data1/oa_pdf/5f/c7/ndt-10-1433.PMC4128845.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/5f/c7/ndt-10-1433.PMC4128845.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1438aljumah et al  3.,Non-OADS,/arxiv_data1/oa_pdf/5f/c7/ndt-10-1433.PMC4128845.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9e/0f/ppa-8-1051.PMC4128846.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1051–1059Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1051Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S3495 8Potential patient benefit of a subcutaneous  formulation of tocilizumab for the treatment   of rheumatoid arthritis: a critical review emilio Besada Bone and Joint Research Group,   Department of Clinical Medicine,   Faculty of Health Sciences, UiT  the Arctic University of Norway,   Tromsø, Norway Correspondence: emilio Besada   Bone and Joint Research Group, institute  of Clinical Medicine, University of Tromsø,   9037 Tromsø, Norway   T el +47 7762 7294   Fax +47 7762 7258   email emilio.besada@uit.n o Abstract:  Treatment of rheumatoid arthritis (RA) was revolutionized during the last decade  with the development of new biologic disease-modifying anti-rheumatic drugs (DMARDs)  enabling the targeting of immune cells and cytokines other than tumor necrosis factor (TNF).",Non-OADS,/arxiv_data1/oa_pdf/9e/0f/ppa-8-1051.PMC4128846.pdf
Clinical features of RA include  symmetric polyarthritis of small joints and morning stiffness.1 More than a third of  RA patients eventually experience work disability2 and life expectancy is shortened  by 3–5 years due to disease and treatment-related adverse effects.3 Major advances in the management of RA are early diagnosis4 and prompt aggres - sive treatment aiming at remission.5 European League Against Rheumatism (EULAR) Journal name: Patient Preference and Adherence Journal Designation: Review Y ear: 2014 Volume: 8 Running head verso: Besada Running head recto: SC tocilizumab in RA DOI: http://dx.doi.org/10.2147/PPA.S34958,Non-OADS,/arxiv_data1/oa_pdf/9e/0f/ppa-8-1051.PMC4128846.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9e/0f/ppa-8-1051.PMC4128846.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bd/0b/opth-8-1435.PMC4128847.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1435–1440Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1435Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5984 0accelerated versus conventional corneal   collagen cross-linking in the treatment   of mild keratoconus: a comparative study ahmed Mohamed sherif Faculty of Medicine, Cairo University,   egypt Correspondence: ahmed Mohamed  sherif   Department of Ophthalmology,   Faculty of Medicine, Cairo University,   7 awad amer street, Mohandessin,   giza, egypt   Tel +20 122 108 8299   email asherif1975@yahoo.co mAim:  To evaluate the use of accelerated corneal collagen cross-linking in the management of  mild and moderate progressive keratoconus in comparison with conventional cross-linking.",Non-OADS,/arxiv_data1/oa_pdf/bd/0b/opth-8-1435.PMC4128847.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/bd/0b/opth-8-1435.PMC4128847.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/0b/opth-8-1435.PMC4128847.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/a4/opth-8-1447.PMC4128848.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1447–1458Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1447Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/OPTH.S3568 5Managing Sjögren’s Syndrome and non-Sjögren  Syndrome dry eye with anti-inflammatory therapy Correspondence: Cintia S de Paiva Cullen eye institute, Baylor College   of Medicine, 6565 Fannin Street,  NC 505G Houston, TX, USA 77030 Tel +1 713 798 2124 Fax +1 713 798 1457 email cintiadp@bcm.ed uT erry G Coursey Cintia S de Paiva Cullen eye institute, Baylor College   of Medicine, Houston, TX, USAAbstract:  Dry eye from Sjögren’s syndrome is a multifactorial disease that results in dysfunc - tion of the lacrimal functional unit.",Non-OADS,/arxiv_data1/oa_pdf/cd/a4/opth-8-1447.PMC4128848.pdf
"These hypoth - eses are based on findings that showed high antibody titers against viral infections  in patients with SS compared to normal controls.7 Acinar apoptosis and production  of autoantibodies such as anti-muscarinic 3  receptor, anti-SSA, and  anti-SSB are  frequent events.2,8,9 Increased lymphocytic infiltration leads to secondary B-cell activation and genera - tion of autoantibodies both in situ (salivary and LG) and in lymphoid organs.9 Although  infrequent, 5%–10% of SS patients will develop B-cell lymphoma, demonstrating that  clonal activation of B-cells favors the development of malignancies over time.10 The  risk of developing non–Hodgkin’s lymphoma, which is equivalent in both primary and  secondary SS patients, has been estimated to be 44 times greater than that observed  in a comparable normal population.11Journal name: Clinical Ophthalmology Journal Designation: Review Y ear: 2014 Volume: 8 Running head verso: Coursey and de Paiva Running head recto: Managing dry eye in Sjögren syndrome with anti-inflammatory therapy DOI: http://dx.doi.org/10.2147/OPTH.S35685",Non-OADS,/arxiv_data1/oa_pdf/cd/a4/opth-8-1447.PMC4128848.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/cd/a4/opth-8-1447.PMC4128848.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1458Coursey and de Paiva  161.,Non-OADS,/arxiv_data1/oa_pdf/cd/a4/opth-8-1447.PMC4128848.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/20/oajsm-5-173.PMC4128849.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Journal of Sports Medicine 2014:5 173–182Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  173Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S4156 4Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/4c/20/oajsm-5-173.PMC4128849.pdf
"Or use: http://dvpr.es/RfKdg lOptimal management of ankle syndesmosis injuries David A Porter Ryan R Jaggers Adam Fitzgerald Barnes Angela M Rund Methodist Sports Medicine/The  Orthopedic Specialists, indianapolis,   iN, USA Correspondence: David A Porter   Methodist Sports Medicine/The  Orthopedic Specialists, 201 Pennsylvania  Parkway, Suite 100, indianapolis, iN  46280, USA   Tel +1 317 817 1285   email dporter@methodistsports.co mAbstract:  Syndesmosis injuries occur when there is a disruption of the distal attachment  of the tibia and fibula.",Non-OADS,/arxiv_data1/oa_pdf/4c/20/oajsm-5-173.PMC4128849.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/4c/20/oajsm-5-173.PMC4128849.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/20/oajsm-5-173.PMC4128849.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9e/7a/ott-7-1389.PMC4128850.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1389–1396OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1389Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6536 7silencing B7-h1 enhances the anti-tumor   effect of bladder cancer antigen-loaded   dendritic cell vaccine in vitro shuo Wang1 Y onghua Wang1 Jing liu2 shixiu shao1 Xianjun li1 Jiannan gao1 haitao niu1 Xinsheng Wang1 1Department of Urology,  2Department  of Pediatrics, The affiliated hospital of  Qingdao University, Qingdao, People’s  republic of china correspondence: Yonghua Wang   Department of Urology, The Affiliated  hospital of Qingdao University, Qingdao   266000, People’s republic of china   Tel +86 186 6180 5829  email doctorwangyonghua@163.co mObjective:  The aim of this study was to examine whether short hairpin RNA (shRNA)  expressing lentiviral particles targeting B7-H1 infection could result in B7-H1 knockdown on  dendritic cells (DCs) and to investigate whether B7-H1 silencing could augment the immune  function of DCs and further elicit a more potent anti-tumor immune effect against bladder  cancer cells in vitro.",Non-OADS,/arxiv_data1/oa_pdf/9e/7a/ott-7-1389.PMC4128850.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9e/7a/ott-7-1389.PMC4128850.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/7a/ott-7-1389.PMC4128850.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/ae/ott-7-1397.PMC4128851.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1397–1408OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1397Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6505 1PKn1 modulates TgF β and egF signaling   in hec-1-a endometrial cancer cell line sanaz attarha1,2 ravi Kanth rao saini3 sonia andersson2 Miriam Mints2 serhiy souchelnytskyi1,4,5 1Department of Oncology–Pathology,   2Department of Women’s and  children’s health, Karolinska  institutet, stockholm,  3Department  of Biomedicine, sahlgrenska cancer  center, University of gothenburg,   gothenburg, sweden; 4OcD-aB,   Uppsala, sweden; 5neurocentrum,   Karolinska University hospital, solna,   sweden correspondence: serhiy souchelnytskyi   Z5:01, Karolinska University hospital,   solna, se-17  176, stockholm, sweden   Tel +46 735777168   Fax +46 8 5177 5000  email serhiy8085@gmail.co mBackground:  The response of cells to TGF β and EGF is mediated by a network of various  intracellular regulators.",Non-OADS,/arxiv_data1/oa_pdf/50/ae/ott-7-1397.PMC4128851.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/50/ae/ott-7-1397.PMC4128851.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/ae/ott-7-1397.PMC4128851.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/19/ec/ndt-10-1439.PMC4128852.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1439–1449Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1439OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6271 4Narong Maneeton1 Benchalak Maneeton1 suthi intaprasert1 Pakapan Woottiluk2 1Department of Psychiatry, Faculty  of Medicine, 2Psychiatric Nursing  Division, Faculty of Nursing, chiang  Mai University, chiang Mai, Thailand correspondence: Benchalak Maneeton   Department of Psychiatry, Faculty   of Medicine, chiang Mai University,   amphur Muang, chiang Mai 50200,  Thailand  Tel +66 53 945 422 Fax +66 53 217 144   email benchalak.maneeton@cmu.ac.t ha systematic review of randomized controlled   trials of bupropion versus methylphenidate   in the treatment of attention-deficit/   hyperactivity disorder Background:  Some trials have suggested that bupropion, as well as methylphenidate, is bene­ ficial in the treatment of attention­deficit/hyperactivity disorder (ADHD).",Non-OADS,/arxiv_data1/oa_pdf/19/ec/ndt-10-1439.PMC4128852.pdf
"Keywords:  bupropion, methylphenidate, systematic review, ADHD, acceptability, tolerabilityJournal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Maneeton et al Running head recto: Review of RCTs of bupropion vs methylphenidate in ADHD DOI: http://dx.doi.org/10.2147/NDT.S62714",Non-OADS,/arxiv_data1/oa_pdf/19/ec/ndt-10-1439.PMC4128852.pdf
Available from: http://www.cochrane­ handbook.org.,OADS,/arxiv_data1/oa_pdf/19/ec/ndt-10-1439.PMC4128852.pdf
Available from: http://www.cochrane­ handbook.org.,OADS,/arxiv_data1/oa_pdf/19/ec/ndt-10-1439.PMC4128852.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer­ reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre ­clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/19/ec/ndt-10-1439.PMC4128852.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1449review of rcTs of bupropion vs methylphenidate in aDhD  42.,Non-OADS,/arxiv_data1/oa_pdf/19/ec/ndt-10-1439.PMC4128852.pdf
"A recent study suggests that amplification of MET and KRAS genes may mediate resistance to MET kinase inhibitors by subsequently inducing high activity  *Correspondence to: Neelu Puri; Email: neelupur@uic.edu Submitted: 09/18/2013; Revised: 06/02/2014; Accepted: 06/04/2014; Published Online: 06/11/2014http://dx.doi.org/10.4161/cbt.29451Targeting c-Met in melanoma Mechanism of resistance and efficacy   of novel combinatorial inhibitor therapy Deven etnyre†, amanda L Stone, Jason T Fong, Ryan J Jacobs, Srijayaprakash B Uppada, Gregory M Botting, Supriya Rajanna,  D avid N Moravec, Manohar R Shambannagari, Zachary Crees, Jennifer Girard, Ceyda Bertram, and Neelu Puri*,† Department of Biomedical Sciences; University of Illinois College of Medicine; Rockford, IL US a †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
"Several studies using c-Met inhibitors, alone or in combina - tion therapy, for melanoma are also presently in clinical trials and may prove to be effective in improving efficacy and overcom - ing resistance (http://www.clinicaltrials.gov; NCT00940225, NCT01820364, and NCT01835184).",Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Clin Cancer Res 2007; 13:2246-53;  PMID:17404109 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Ann Dermatol  2011 ; 23:33-8;  PMID:21738360 ; http://dx.doi.org/10.5021/ ad.2011.23.1.33 3.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Oncogene  2000 ; 19:4947 - 53; PMID:11042681 ; http://dx.doi.org/10.1038/ sj.onc.1203874 4.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Drugs  2012 ;  72:2207 -22; PMID:23116250 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Curr Opin Oncol 2012 ; 24:150- 4; PMID:22316627 ; http://dx.doi.org/10.1097/ CCO.0b013e32834fca92 8.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Nat Genet 2003 ; 33:19- 20; PMID:12447372 ; http://dx.doi.org/10.1038/ ng1054 9.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Cancer J 2012 ; 18:132-6;  PMID:22453013 ; http://dx.doi.org/10.1097/ PPO.0b013e31824ba4df 10.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Int J Cancer 2  012; 131:E56-65;  PMID:22020736 ; http://dx.doi.org/10.1002/ ijc.26487 11.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Curr Oncol Rep 2007 ; 9:102-8; PMID:17288874 ;  http://dx.doi.org/10.1007/s11912-007-0005-4 12.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
J Thorac Oncol 2009 ; 4:444-7;  PMID:19333071 ; http://dx.doi.org/10.1097/ JTO.0b013e31819d6f9113.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Oncology   2003 ; 65:72-82; PMID:12837985 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Cancer Res   2010 ; 70:7580 -90; PMID:20841479 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Available from:  http://cancerres.aacrjournals.org/cgi/content/meeting_abstract/70/8_MeetingAbstracts/3628 18.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Cancer Res   2011 ; 71:1081 -91; PMID:21266357 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Mol Cancer  2010 ; 9:75; PMID:20385023 ;  http://dx.doi.org/10.1186/1476-4598-9-75 21.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Mol Cancer Ther   2011 ; 10:2298 -308; PMID:21926191 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Development  2004 ; 131:1663 - 77; PMID :15084453 ; http://dx.doi.org/10.1242/ dev.01117 25.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Development   2008 ; 135:367-75; PMID:18077588 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
PLoS  Biol 2003 ; 1:E10; PMID:14551908 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Mol  Cell 2000 ; 5:523-32; PMID:10882137 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
FASEB J   2008 ; 22:3785 -94; PMID:18632848 ;   http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Oncogene   2008 ; 27:4921 -32; PMID:18454176 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Tumour Biol  2009 ;  30:185-99; PMID:19752603 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
J Biol Chem   2002 ; 277:21061 -70; PMID:11914369 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Oncogene  2001 ; 20:8125 -35; PMID:11781826 ;  http://dx.doi.org/10.1038/sj.onc.1205034 34.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Clin Cancer Res 2011 ; 17:1658 -63;  PMID:21447722 ; http://dx.doi.org/10.1158/1078- 0432.CCR-10-0174,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Mol Cancer Ther 2010 ;  9:1544 -53; PMID:20484018 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
J Carcinog 2008 ; 7:9; PMID:19240370 ;  http://dx.doi.org/10.4103/1477-3163.44372 38.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
J Clin Oncol   2011 ; 29:1271 -9; PMID:21383285 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Expert Rev Anticancer Ther 2013 ; 13:513-22;  PMID:23617343 ; http://dx.doi.org/10.1586/ era.13.24 40.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Mol Cancer   2010 ; 9:236; PMID:20828404 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Curr Opin Cell Biol 2010 ;  22:169-76; PMID:19945836 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Cancer Cell  2007 ; 12:9-22;  PMID:17613433 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
PLoS One  2011 ; 6:e23429 ; PMID:21858114 ;  http://dx.doi.org/10.1371/journal.pone.0023429 46.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Transl Oncol  2010 ; 3:65- 79; PMID:20360931 ; http://dx.doi.org/10.1593/ tlo.09277 50.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
BMC Cancer 2013 ; 13:211; PMID:23621985 ;  http://dx.doi.org/10.1186/1471-2407-13-21151.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Cancer Res 2007 ; 67:3529 -34;  PMID:17440059 ; http://dx.doi.org/10.1158/0008- 5472.CAN-06-4416 52.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Mol Cancer Res   2010 ; 8:1142 -51; PMID:20647329 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
J Proteome Res   2011 ; 10:5084 -94; PMID:21936566 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Br J Cancer   2010 ; 103:622-8; PMID:20683448 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Cell 2012 ; 149:274- 93; PMID:22500797 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Curr  Opin Cell Biol 2011 ; 23:744-55; PMID:21963299 ;  http://dx.doi.org/10.1016/j.ceb.2011.09.003 58.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
J Invest Dermatol  2008 ;  128:980-7; PMID:17914450 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Pigment Cell Melanoma  Res 2011 ; 24:254-7; PMID:21029395 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Nat Cell Biol 2002 ; 4:648-57;  PMID:12172553 ; http://dx.doi.org/10.1038/ncb839 61.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
J Biol Chem 2005 ; 280:32081 - 9; PMID:16027121 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Cell 2006 ; 126:834- 6; PMID:16959561 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
J Biol Chem   2007 ; 282:11221 -9; PMID:17287208 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Cancer Cell  2002; 1:2  79- 88; PMID:12086864 ; http://dx.doi.org/10.1016/ S1535-6108(02)00045-465.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Mol Pathol  2003 ; 56:280- 5; PMID:14514922 ; http://dx.doi.org/10.1136/ mp.56.5.280 66.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Clin Cancer Res   2006 ; 12:2366s -70s; PMID:16609060 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Nature  2012 ; 487:500-4; PMID:22763439 ;  http://dx.doi.org/10.1038/nature11183 69.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
PLoS One  2013 ; 8:e78398 ; PMID:24223799 ;  http://dx.doi.org/10.1371/journal.pone.0078398 70.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Hepatology   2006 ; 44:992- 1002 ; PMID:17006939 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Carcinogenesis  2012 ; 33:1142 -8;  PMID:22436613 ; http://dx.doi.org/10.1093/carcin/ bgs131 73.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Nat Rev Cancer 2004 ; 4:335- 48; PMID:15122205 ; http://dx.doi.org/10.1038/ nrc1362 74.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Methods Mol Biol  2008 ;  468:5-15; PMID:19099242 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Dev  Cell 2009 ; 17:9-26; PMID:19619488 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
J Cell Sci 2006 ; 119:395-402;  PMID:16443747 ; http://dx.doi.org/10.1242/ jcs.02826 77.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Cancer Res   2014 ; 74:884-95; PMID:24305878 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Trends Biochem Sci 2010 ; 35:161- 8; PMID:19884009 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
J Cell Sci 2005 ; 118:313- 22; PMID :15615777 ; http://dx.doi.org/10.1242/ jcs.01601,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
FASEB J   2004 ; 18:1373 -81; PMID:15333580 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Clin Exp Immunol 2000 ; 119:11-8; PMID:10606959 ;  http://dx.doi.org/10.1046/j.1365-2249.2000.01089.x 83.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Cancer  1992 ; 69:1165 - 73; PMID:1739916 ; http://dx.doi.org/10.1002/ cncr.282069051784.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Cancer Res 2005 ; 65:1479 -88;  PMID :15735036 ; http://dx.doi.org/10.1158/0008- 5472.CAN-04-2650 85.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
Cancer Lett 2014 ; 343:14- 23; PMID:24041868 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
J Cutan Pathol 2005 ; 32:334-9; PMID:15811117 ;  http://dx.doi.org/10.1111/j.0303-6987.2005.00338.x 89.,Non-OADS,/arxiv_data1/oa_pdf/28/af/cbt-15-1129.PMC4128856.pdf
"6 Similar to miR-34/449  miRNAs in  MCCs, miR-129  negatively regulates  *Correspondence to: Lin He; Email: lhe@berkeley.edu Submitted: 06/26/2014; Accepted: 07/01/2014; Published Online: 07/15/2014http://dx.doi.org/10.4161/cc.29827Comment on: Song R, et al.",OADS,/arxiv_data1/oa_pdf/49/9e/cc-13-2315.PMC4128872.pdf
"Nature 2014; 510:115-20; PMID:24899310; http://dx.doi.org/10.1038/nature13413microRNAs and cilia An ancient connection Peter Walentek1, rui song2, and l in He2,* 1division of Genetics, Genomics and d evelopment, Center for i ntegrative Genomics, Molecular and Cell Biology d epartment; u niversity of California at Berkeley; Berkeley, C a  usa ; 2division of Cellular and d evelopmental Biology, Molecular and Cell Biology d epartment; u niversity of California at Berkeley; Berkeley, C a usa",Non-OADS,/arxiv_data1/oa_pdf/49/9e/cc-13-2315.PMC4128872.pdf
Nature 2014; 510:115-20;  PMID:24899310; http://dx.doi.org/10.1038/nature13413 2.,Non-OADS,/arxiv_data1/oa_pdf/49/9e/cc-13-2315.PMC4128872.pdf
Nat Cell Biol 2011; 13:694-701; http://dx.doi.org/10.1038/ncb2241 3.,OADS,/arxiv_data1/oa_pdf/49/9e/cc-13-2315.PMC4128872.pdf
Development 2013; 140:2755-64; PMID:23698347; http://dx.doi.org/10.1242/dev.092825 4.,OADS,/arxiv_data1/oa_pdf/49/9e/cc-13-2315.PMC4128872.pdf
Nat Cell Biol 2012; 14:697-706; PMID:22684256; http://dx.doi.org/10.1038/ ncb2512 5.,OADS,/arxiv_data1/oa_pdf/49/9e/cc-13-2315.PMC4128872.pdf
Am J Respir Crit Care Med  2012; 186:965-74; PMID:22955319; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/49/9e/cc-13-2315.PMC4128872.pdf
Nature 2010; 463:1084- 8; PMID:20118916; http://dx.doi.org/10.1038/ nature08744 7.,Non-OADS,/arxiv_data1/oa_pdf/49/9e/cc-13-2315.PMC4128872.pdf
Evol Dev 2008; 10:106-13; PMID:18184361; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/49/9e/cc-13-2315.PMC4128872.pdf
"First, it challenges the  *Correspondence to: Olga Ritz; Email: oritz1@gmx.de Submitted: 07/01/2014; Accepted: 07/02/2014; Published Online: 07/15/2014http://dx.doi.org/10.4161/cc.29828Comment on: Häberle MT, et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/55/cc-13-2317.PMC4128873.pdf
Blood 2011; 118:2659-69;  PMID:21700770; http://dx.doi.org/10.1182/ blood-2011-05-326538 2.,Non-OADS,/arxiv_data1/oa_pdf/dd/55/cc-13-2317.PMC4128873.pdf
Cancer Cell 2010; 18:590-605; PMID:21156283; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dd/55/cc-13-2317.PMC4128873.pdf
Leuk Lymphoma 2003; 44:21-6;  http://dx.doi.org/10.1080/10428190310001623810 4.,Non-OADS,/arxiv_data1/oa_pdf/dd/55/cc-13-2317.PMC4128873.pdf
Blood 2004; 104:543-9; PMID:15044251; http://dx.doi.org/10.1182/ blood-2003-10-3545 5.,Non-OADS,/arxiv_data1/oa_pdf/dd/55/cc-13-2317.PMC4128873.pdf
Annu Rev Pathol 2013; 8:277- 302; PMID:23092187; http://dx.doi.org/10.1146/ annurev-pathol-020712-163923 7.,Non-OADS,/arxiv_data1/oa_pdf/dd/55/cc-13-2317.PMC4128873.pdf
Int J Clin Oncol 2011; 16:395-400; PMID:21347629; http://dx.doi.org/10.1007/ s10147-011-0199-1 3.,Non-OADS,/arxiv_data1/oa_pdf/24/ae/cc-13-2319.PMC4128874.pdf
Int J Gynecol Cancer 2006;  16:1536-44; PMID:16884362; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/ae/cc-13-2319.PMC4128874.pdf
"Anticancer Res 2012; 32:2353-7;  PMID:22641674 *Correspondence to: Marie Cohen; Email: marie.cohen@hcuge.ch Submitted: 07/09/2014; Accepted: 07/10/2014; Published Online: 07/17/2014http://dx.doi.org/10.4161/cc.29951Comment on: Cohen M, et al.",Non-OADS,/arxiv_data1/oa_pdf/24/ae/cc-13-2319.PMC4128874.pdf
"Cell Cycle 2014; 13:2400-14;  PMID:24945502; http://dx.doi.org/10.4161/cc.29339 Antonio  García de Herreros1,* and Aristidis  Moustakas2; 1Cancer Research Program; Institut Hospital del Mar d’Investigacions Mèdiques and Departament  de Ciències Experimentals i de la Salut; Universitat Pompeu Fabra; Barcelona, Spain; 2Department of Medical Biochemistry and Microbiology and Ludwig  Institute for Cancer Research; Science for Life Laboratory; Uppsala University; Uppsala, Sweden; *Email: agarcia@imim.es ; http://dx.doi.org/10.4161/cc.29831 The term epithelial to mesenchymal  transition ( eMT) designs the conversion of  an epithelial cell in another cell with a fibro - blastic-like shape.",Non-OADS,/arxiv_data1/oa_pdf/d4/4f/cc-13-2320.PMC4128875.pdf
Reviews on Cancer  2012; 1825:223-228; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d4/4f/cc-13-2320.PMC4128875.pdf
Oncogene 2013; 32:3381-9; PMiD:22869142; http://dx.doi.org/10.1038/ onc.2012.342 3.,Non-OADS,/arxiv_data1/oa_pdf/d4/4f/cc-13-2320.PMC4128875.pdf
Cell Cycle 2014; 13:2400-14; PMiD:24945502; http://dx.doi.org/10.4161/ cc.29339 4.,OADS,/arxiv_data1/oa_pdf/d4/4f/cc-13-2320.PMC4128875.pdf
s emin Cancer Biol 2012; 22:446- 54; PM iD:22548724; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d4/4f/cc-13-2320.PMC4128875.pdf
Mol Cell 2013; 51:559-72;  PMiD:23973329; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/4f/cc-13-2320.PMC4128875.pdf
Oncogene 2013; 32:3606- 15; PM iD:22926518; http://dx.doi.org/10.1038/ onc.2012.370 7.,OADS,/arxiv_data1/oa_pdf/d4/4f/cc-13-2320.PMC4128875.pdf
"GSK-3 exists in 2 isoforms, GSK-3 α and GSK-3 β, and  *Correspondence to: Marene Landström; Email: Marene.Landstrom@medbio.umu.se Submitted: 05/16/2014; Accepted: 05/22/2014; Published Online: 06/19/2014http://dx.doi.org/10.4161/cc.29339TGFβ-induced invasion of prostate cancer cells  is promoted by c-Jun-dependent transcriptional  activation of Snail1 Noopur t hakur1, Shyam Kumar Gudey2, Anders Marcusson1, Jing Yi Fu3, Anders Bergh2, Carl-Henrik Heldin1,   and Marene Landström2,* 1Ludwig Institute for Cancer Research; Science for Life Laboratory; Uppsala University; Uppsala, Sweden; 2Department of Medical Biosciences; Unit of p athology;   Umeå University; Umeå, Sweden; 3Rudbeck Laboratory; Department of Immunology, Genetics, and p athology; Uppsala University; Uppsala, Sweden Keywords:  c-Jun, invasion, p38 MAPK, prostate cancer, Smads, Snail1, TGF β, TRAF6 High levels of transforming growth factor- β (tGFβ) correlate with poor prognosis for patients with prostate cancer  and other cancers.",Non-OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
www.landesbioscience.com Cell Cycle 2411c-Jun and c-Fos were constructed with the aid of the Primer3plus  free software http://www.bioinformatics.nl/cgiin/primer3plus/primer3plus.cgi and the primers were purchased from Sigma Aldrich.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Cell 2008; 134:215-30; PMID:18662538 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Int J Biochem Cell Biol 2008; 40:383-408;  PMID :18061509 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Mol Biol Cell 2003; 14:529-44;  PMID:12589052 ; http://dx.doi.org/10.1091/ mbc.02-03-0037 6.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
J Biol Chem 1999; 274:37413-20; PMID:10601313 ;  http://dx.doi.org/10.1074/jbc.274.52.37413 8.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Cell Tissue Res 2012; 347:11- 20; PMID:21701805 ; http://dx.doi.org/10.1007/ s00441-011-1201-y 9.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Int J Biochem Cell Biol 2010; 42:585- 9; PMID:20060931 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Nat Cell Biol 2008; 10:1199- 207; PMID:18758450 ; http://dx.doi.org/10.1038/ ncb1780 12.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Mol Cell  2008; 31:918-24;  PMID:18922473 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Oncogene 2007;  26:3214-26;  PMID:17496917 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Nat Cell Biol 2004; 6:97- 105; PMID:14743216 ; http://dx.doi.org/10.1038/ ncb1086 15.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Oncogene 2001;  20:6482-91;  PMID:11607847 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Cell Signal 2001; 13:389-400; PMID:11384837 ;  http://dx.doi.org/10.1016/S0898-6568(01)00160-717.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Cytokine Growth Factor Rev 2003;  14:193-209;  PMID:12787559 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Future  Oncol 2009; 5:1-3; PMID:19243289 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Proc Natl Acad Sci U S A 1999; 96:11217-22;  PMID :10500157 ; http://dx.doi.org/10.1073/ pnas.96.20.11217 23.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Oncogene 2001; 20:2390-400; PMID:11402335 ; http://dx.doi.org/10.1038/ sj.onc.1204383 24.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Mol Cell Biol 2003; 23:6027-36;  PMID:12917327 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
J Cell Sci  2004; 117:5965-73;  PMID :15564374 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Oncogene  2001; 20:2336-46;  PMID:11402331 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Cell 1996; 87:929- 39; PMID:8945519 ; http://dx.doi.org/10.1016/ S0092-8674(00)81999-6 28.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Nat Rev  Mol Cell Biol 2012; 13:616-30; PMID:22992590 ;  http://dx.doi.org/10.1038/nrm3434 29.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Mol Cell 2013; 51:555-6; PMID:24034692 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Future Oncol 2014;  PMID:24597658 ; http://dx.doi.org/10.2217/ fon.14.45 31.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
J Biol Chem 2003; 278:21113- 23; PMID:12665527 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
EMBO J 1998; 17:3091-100; PMID:9606191 ;  http://dx.doi.org/10.1093/emboj/17.11.3091 35.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Oncogene 2013; 32:3606-15; PMID:22926518 ;  http://dx.doi.org/10.1038/onc.2012.37036.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
J Cell Sci 2008; 121:3598-607; PMID:18946023 ;  http://dx.doi.org/10.1242/jcs.032854 37.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Mol Biol Cell 2012; 23:2109-21; PMID:22496417 ;  http://dx.doi.org/10.1091/mbc.E10-12-1000 38.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Cell 2007; 131:980- 93; PMID:18045539 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Nat Rev Cancer 2009; 9:537-49; PMID:19629069 ;  http://dx.doi.org/10.1038/nrc2694 40.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Curr Opin Cell Biol 1997; 9:240- 6; PMID:9069263 ; http://dx.doi.org/10.1016/ S0955-0674(97)80068-3 41.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
J Cell Sci 2004; 117:1291-300; PMID:15020669 ;  http://dx.doi.org/10.1242/jcs.01115 42.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Biochemistry 1987; 26:2406- 10; PMID:3475130 ; http://dx.doi.org/10.1021/ bi00383a002 43.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Cell 2009; 139:871-90; PMID:19945376 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Cell Tissue Res 2012; 347:21- 36; PMID:21643690 ; http://dx.doi.org/10.1007/ s00441-011-1190-x 45.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Science 2013;  342:1234850;  PMID:24202173 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Dev Cell 2008; 14:818-29;  PMID:18539112 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Cytokine Growth Factor Rev 2006; 17:41-58; PMID:16310402 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Sci Signal 2014; 7:ra2; PMID:24399296 ; http://dx.doi.org/10.1126/ scisignal.2004207 49.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Nature 1998; 394:909-13;  PMID:9732876 ; http://dx.doi.org/10.1038/29814 51.,Non-OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Proc Natl Acad Sci U S A 1999; 96:4844-9; PMID:10220381 ; http://dx.doi.org/10.1073/ pnas.96.9.4844 53.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
J Biol Chem 2008;  283:33437-46;  PMID:18832382 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
Exp Cell Res 1993;  207:1-7;  PMID:7686495 ; http://dx.doi.org/10.1006/ excr.1993.1156,OADS,/arxiv_data1/oa_pdf/ad/ca/cc-13-2400.PMC4128885.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Unfounded Reports on Thyroid Cancer Jae Hoon Chung Division of Endocrinology & Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Koreahttp://dx.doi.org/10.3346/jkms.2014.29.8.1033  • J Korean Med Sci 2014; 29: 1033-1034 The incidence of thyroid cancer is on the rise in Korea as well as  in the rest of the world.",Non-OADS,/arxiv_data1/oa_pdf/1c/e9/jkms-29-1033.PMC4129191.pdf
Chung JH • Unfounded Reports on Thyroid Cancer 1034  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1033that people check his or her health paying his money.,Non-OADS,/arxiv_data1/oa_pdf/1c/e9/jkms-29-1033.PMC4129191.pdf
ORCID Jae Hoon Chung http://orcid.org/0000-0002-9563-5046  REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/1c/e9/jkms-29-1033.PMC4129191.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Ten Tips for Authors of Scientific Articles Writing a good quality scientific article takes experience and skill.",Non-OADS,/arxiv_data1/oa_pdf/17/80/jkms-29-1035.PMC4129192.pdf
"Keywords:  Science Communication; Scientific Article; Periodicals as Topic; Publishing;   Ten TipsSung-Tae Hong Department of Parasitology and Tropical Medicine,  Seoul National University College of Medicine,  Journal of Korean Medical Science, Korean Academy  of Medical Sciences, Seoul, Korea Received: 29 May 2014 Accepted: 10 June 2014 Address for Correspondence: Sung-Tae Hong, MD Department of Parasitology and Tropical Medicine,   Seoul National University College of Medicine, 103 Daehak-ro,  Jongno-gu, Seoul 110-799, Korea Tel: +82.2-740-8343, Fax: +82.2-765-6142 E-mail: hst@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.8.1035  • J Korean Med Sci 2014; 29: 1035-1037 INTRODUCTION Scientific articles are means for scholarly communication.",Non-OADS,/arxiv_data1/oa_pdf/17/80/jkms-29-1035.PMC4129192.pdf
Hong S-T • Ten Tips in Writing 1036  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1035Formatting in compliance with target journal instructions Careful (re)drafting and formatting is strongly advisable to meet  the requirements of the target journal.,Non-OADS,/arxiv_data1/oa_pdf/17/80/jkms-29-1035.PMC4129192.pdf
"Hong S-T • Ten Tips in Writing http://jkms.org   1037 http://dx.doi.org/10.3346/jkms.2014.29.8.1035place connecting words, and particularly to provide links be - tween sentences within a paragraph.",Non-OADS,/arxiv_data1/oa_pdf/17/80/jkms-29-1035.PMC4129192.pdf
ORCID Sung-Tae Hong http://orcid.org/0000-0002-0300-1944 REFERENCES 1. International Committee of Medical Journal Editors.,Non-OADS,/arxiv_data1/oa_pdf/17/80/jkms-29-1035.PMC4129192.pdf
Available at http://www.icmje.org/icmje-recommen - dations.pdf [accessed on 2 May 2014].,Non-OADS,/arxiv_data1/oa_pdf/17/80/jkms-29-1035.PMC4129192.pdf
Available  at http://www.ease.org.uk/sites/default/files/ease_guidelines-june2013- english.pdf [accessed on 2 May 2014].,Non-OADS,/arxiv_data1/oa_pdf/17/80/jkms-29-1035.PMC4129192.pdf
Available at http://am.ascb.org/dora/ files/SFDeclarationFINAL.pdf [accessed on 2 May 2014].,Non-OADS,/arxiv_data1/oa_pdf/17/80/jkms-29-1035.PMC4129192.pdf
Available at http://www.biomedcen - tral.com/about/editorialpolicies#Citations [accessed on 2 May 2014].,Non-OADS,/arxiv_data1/oa_pdf/17/80/jkms-29-1035.PMC4129192.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Role of Innate Immunity in the Pathogenesis of Type 1 and Type  2 Diabetes The importance of innate immunity in host defense is becoming clear after discovery of  innate immune receptors such as Toll-like receptor or Nod-like receptor.",Non-OADS,/arxiv_data1/oa_pdf/b5/e7/jkms-29-1038.PMC4129193.pdf
"Keywords:  Immunity, Innate; Diabetes Mellitus; Autoimmunity; Lipids; Toll-like Receptor;  Nod-like Receptor Myung-Shik Lee Department of Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul, Korea Received: 31 December 2013 Accepted: 10 April 2014 Address for Correspondence: Myung-Shik Lee, MD Department of Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 135-710, Korea Tel: +82.2-3410-3436, Fax: +82.2-3410-6491 E-mail: mslee0923@skku.edu Funding: This study is supported by the Global Research  Laboratory Grant of the National Research Foundation of Korea  (K21004000003-10A0500-00310) and the Bio Research &  Development Program (2008-04090).http://dx.doi.org/10.3346/jkms.2014.29.8.1038  • J Korean Med Sci 2014; 29: 1038-1041 INTRODUCTION Type 1 diabetes (T1D) is one of the classical examples of organ- specific autoimmune diseases characterized by autoimmunity  against β-cell autoantigens.",Non-OADS,/arxiv_data1/oa_pdf/b5/e7/jkms-29-1038.PMC4129193.pdf
"Lee M-S • Innate Immunity in Diabetes http://jkms.org   1039 http://dx.doi.org/10.3346/jkms.2014.29.8.1038munity in those mice, which was reflected by the proliferation  of naïve diabetogenic T cells specifically in the pancreatic lymph  nodes of NOD mice at 3 weeks of age (6).",Non-OADS,/arxiv_data1/oa_pdf/b5/e7/jkms-29-1038.PMC4129193.pdf
"Lee M-S • Innate Immunity in Diabetes 1040  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1038demonstrated in vitro, together with the evidence indicating  the involvement of NLRP3 in such in vitro IL-1 β release (21).",OADS,/arxiv_data1/oa_pdf/b5/e7/jkms-29-1038.PMC4129193.pdf
Lee M-S • Innate Immunity in Diabetes http://jkms.org   1041 http://dx.doi.org/10.3346/jkms.2014.29.8.1038obese diabetic (NOD) mouse.,Non-OADS,/arxiv_data1/oa_pdf/b5/e7/jkms-29-1038.PMC4129193.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Withaferin A-Caused Production of Intracellular Reactive Oxygen  Species Modulates Apoptosis via PI3K/Akt and JNKinase in  Rabbit Articular Chondrocytes Withaferin A (WFA) is known as a constituent of Ayurvedic medicinal plant, Withania  somnifera , and has been used for thousands of years.",Non-OADS,/arxiv_data1/oa_pdf/9e/45/jkms-29-1042.PMC4129194.pdf
"Keywords:  Apoptosis; Chondrocytes; Reactive Oxygen SpeciesSeon-Mi Yu and Song-Ja Kim* Department of Biological Sciences, Kongju National  University, Gongju, Korea Received: 25 February 2014 Accepted: 12 May 2014 Address for Correspondence: Song-Ja Kim, PhD Department of Biological Sciences, Kongju National University,  56 Daehakro, Gongju 314-701, Korea Tel: +82.41-850-8507, Fax: +82.41-850-0927 E-mail: ksj85@kongju.ac.kr Funding:  This work was supported by the Korean Health  Technology R&D project, Ministry of Health & Welfare, Republic  of Korea (A120960-1201-0000300) and the Korea Foundation  for the Advancement of Science & Creativity (KOFAC), and  funded by the Korean Government (MOE), and also by the  National Research Foundation of Korea (NRF) Grant funded by  the Korea Government (MEST)(NRF-2012R1A1A2043276).http://dx.doi.org/10.3346/jkms.2014.29.8.1042  • J Korean Med Sci 2014; 29: 1042-1053 INTRODUCTION Osteoarthritis (OA) is the most common form of arthritis relat - ed with various risk factors including age, gender, obesity, and  mechanical factors, such as malalignment and abnormal joint  shape and is characterized by progressive degradation of artic - ular cartilage, and apoptosis and death of chondrocytes (1).",Non-OADS,/arxiv_data1/oa_pdf/9e/45/jkms-29-1042.PMC4129194.pdf
"• WFA Causes Apoptosis http://jkms.org   1043 http://dx.doi.org/10.3346/jkms.2014.29.8.1042MATERIALS AND METHODS Reagents Withaferin A was purchased from Calbiochem (San Diego, CA,  USA), and SP600125 (SP) to inhibit JNKinase was obtained from  ENZO Life science (Plymouth Meeting, PA, USA).",Non-OADS,/arxiv_data1/oa_pdf/9e/45/jkms-29-1042.PMC4129194.pdf
"• WFA Causes Apoptosis 1044  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1042three times with PBS, and observed under a fluorescence mi - croscope (BX51, Olympus, Tokyo, Japan).",OADS,/arxiv_data1/oa_pdf/9e/45/jkms-29-1042.PMC4129194.pdf
"• WFA Causes Apoptosis http://jkms.org   1045 http://dx.doi.org/10.3346/jkms.2014.29.8.1042RESULTS WFA and induction of apoptosis in rabbit articular  chondrocytes To investigate the role of WFA in proliferation of chondrocytes,  cells were treated with 1-5 μM WFA and levels of proliferation  were measured using MTT assay (Fig.",OADS,/arxiv_data1/oa_pdf/9e/45/jkms-29-1042.PMC4129194.pdf
• WFA Causes Apoptosis 1046  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1042used as a positive control (Fig.,Non-OADS,/arxiv_data1/oa_pdf/9e/45/jkms-29-1042.PMC4129194.pdf
• WFA Causes Apoptosis http://jkms.org   1047 http://dx.doi.org/10.3346/jkms.2014.29.8.1042WFA-induced apoptosis was triggered by ROS (Fig.,Non-OADS,/arxiv_data1/oa_pdf/9e/45/jkms-29-1042.PMC4129194.pdf
• WFA Causes Apoptosis 1048  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1042Fig.,Non-OADS,/arxiv_data1/oa_pdf/9e/45/jkms-29-1042.PMC4129194.pdf
• WFA Causes Apoptosis http://jkms.org   1049 http://dx.doi.org/10.3346/jkms.2014.29.8.1042 0 1 3 5 WFA (μM) pAkt (6 hr)  pJNK (10 min)  pc-JUN (3 hr)  Actin (24 hr)  Fig.,Non-OADS,/arxiv_data1/oa_pdf/9e/45/jkms-29-1042.PMC4129194.pdf
• WFA Causes Apoptosis 1050  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1042Fig.,Non-OADS,/arxiv_data1/oa_pdf/9e/45/jkms-29-1042.PMC4129194.pdf
• WFA Causes Apoptosis http://jkms.org   1051 http://dx.doi.org/10.3346/jkms.2014.29.8.1042Fig.,Non-OADS,/arxiv_data1/oa_pdf/9e/45/jkms-29-1042.PMC4129194.pdf
• WFA Causes Apoptosis 1052  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.104218 15 12 9 6 3 0  - + - + WFA (5 μM)  - - + + DIDS (200 μM) p53 p21 Actin p53 p21 ** * A Cell viability (% of control)  - + - +  WFA (5 μM)  - - + +  DIDS (200 μM)120 100 80 60 40 20 0* B Counts FL2-CON 0 50 100 150 200 250400 320 240 160 80 0Sub-G 1 1.2% G1/G0 53.2% S 22.6% G2/M 23.0% Counts FL2-WFA/DIDS 0 50 100 150 200 250400 320 240 160 80 0Sub-G 1 2.3% G1/G0 47.1% S 25.0% G2/M 25.6% FL2-DIDS 0 50 100 150 200 250400 320 240 160 80 0Sub-G 1 1.7% G1/G0 52.4% S 24.1% G2/M 21.8%CountsCounts FL2-WFA 0 50 100 150 200 250400 320 240 160 80 0Sub-G 1 39.3% G1/G0 18.8% S 24.3% G2/M 17.6% C Fig.,Non-OADS,/arxiv_data1/oa_pdf/9e/45/jkms-29-1042.PMC4129194.pdf
• WFA Causes Apoptosis http://jkms.org   1053 http://dx.doi.org/10.3346/jkms.2014.29.8.1042Akt and JNK pathways and its pathways might be important for  regulating apoptosis of chondrocytes.,Non-OADS,/arxiv_data1/oa_pdf/9e/45/jkms-29-1042.PMC4129194.pdf
ORCID Seon-Mi Yu http://orcid.org/0000-0002-3556-2199  Song-Ja Kim http://orcid.org/0000-0001-6380-256X  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/45/jkms-29-1042.PMC4129194.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinicopathological Features of Rare BRAF  Mutations in Korean  Thyroid Cancer Patients The most common BRAF mutation in thyroid cancer is c.1799T > A (p.Val600Glu), and  other BRAF mutations are rarely reported.",Non-OADS,/arxiv_data1/oa_pdf/98/ec/jkms-29-1054.PMC4129195.pdf
"Keywords:  Thyroid Neoplasms; BRAF; Mutation; Pathology; Biomarkers Uiju Cho,1 Woo Jin Oh,1 Ja Seong Bae,2  Sohee Lee,2 Young Sub Lee,1   Gyeong Sin Park,1 Youn Soo Lee,1   and Chan Kwon Jung1 Departments of 1Hospital Pathology and 2Surgery,  College of Medicine, The Catholic University of  Korea, Seoul, Korea  Received: 12 March 2014 Accepted: 14 May 2014 Address for Correspondence: Chan Kwon Jung, MD Department of Hospital Pathology, The Catholic University of  Korea, Seoul St. Mary’s Hospital, 222 Banpo-daero, Seocho-gu,  Seoul 137-701, Korea Tel: +82.2-2258-1622, Fax: +82.2-2258-1627 E-mail: ckjung@catholic.ac.kr Funding:  This research was supported by the Basic Science  Research Program through the National Research Foundation of  Korea (NRF) funded by the Ministry of Science, ICT and Future  Planning (2013R1A2A2A01068570).http://dx.doi.org/10.3346/jkms.2014.29.8.1054  • J Korean Med Sci 2014; 29: 1054-1060 INTRODUCTION Mutations in the BRAF  gene are the most common genetic al - teration in papillary thyroid carcinomas (PTC) and are present  in 30%-87% of these carcinomas in different populations (1).",Non-OADS,/arxiv_data1/oa_pdf/98/ec/jkms-29-1054.PMC4129195.pdf
• Rare BRAF Mutations in Thyroid Cancer http://jkms.org   1055 http://dx.doi.org/10.3346/jkms.2014.29.8.1054reverse (5 ´-GGCCAAAAATTTAATCAGTGGA-3 ´).,Non-OADS,/arxiv_data1/oa_pdf/98/ec/jkms-29-1054.PMC4129195.pdf
• Rare BRAF Mutations in Thyroid Cancer 1056  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1054Fig.,Non-OADS,/arxiv_data1/oa_pdf/98/ec/jkms-29-1054.PMC4129195.pdf
"• Rare BRAF Mutations in Thyroid Cancer http://jkms.org   1057 http://dx.doi.org/10.3346/jkms.2014.29.8.1054 Regarding the prevalence of mutation other than BRAF  V600E,  BRAF  K601E was found the most common mutation, which is  in agreement with a past report (1).",Non-OADS,/arxiv_data1/oa_pdf/98/ec/jkms-29-1054.PMC4129195.pdf
• Rare BRAF Mutations in Thyroid Cancer 1058  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1054type PCR productions.,Non-OADS,/arxiv_data1/oa_pdf/98/ec/jkms-29-1054.PMC4129195.pdf
• Rare BRAF Mutations in Thyroid Cancer http://jkms.org   1059 http://dx.doi.org/10.3346/jkms.2014.29.8.1054tic factor is generally accepted.,Non-OADS,/arxiv_data1/oa_pdf/98/ec/jkms-29-1054.PMC4129195.pdf
ORCID Uiju Cho http://orcid.org/0000-0002-6229-8418Woo Jin Oh http://orcid.org/0000-0001-6130-9210 Ja Seong Bae http://orcid.org/0000-0003-3904-6519 Sohee Lee http://orcid.org/0000-0003-1559-8853  Young Sub Lee http://orcid.org/0000-0003-0841-1122 Gyeong Sin Park https://orcid.org/0000-0002-9727-5566 Youn Soo Lee https://orcid.org/0000-0002-1653-6315 Chan Kwon Jung http://orcid.org/0000-0001-6843-3708  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/98/ec/jkms-29-1054.PMC4129195.pdf
• Rare BRAF Mutations in Thyroid Cancer 1060  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1054Gazouli M. BRAF and K-RAS mutation in a Greek papillary and medul - lary thyroid carcinoma cohort.,Non-OADS,/arxiv_data1/oa_pdf/98/ec/jkms-29-1054.PMC4129195.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Influenza Vaccination and Associated Factors among Korean  Cancer Survivors : A Cross-Sectional Analysis of the Fourth &  Fifth Korea National Health and Nutrition Examination Surveys Influenza vaccination is important for cancer survivors, a population with impaired  immunity.",Non-OADS,/arxiv_data1/oa_pdf/7f/56/jkms-29-1061.PMC4129196.pdf
"Keywords:  Influenza Vaccines; Cancer Survivors; KoreanKyung-Hyun Choi,1 Sang Min Park,2  Kiheon Lee,3 Ju Hyun Lee,4 and Joo-Sung Park5 1Center for Health Promotion & Cancer Prevention,  Dongnam Institute of Radiological & Medical  Sciences, Busan; 2Department of Family Medicine,  Seoul National University Hospital, Seoul National  University College of Medicine, Seoul; 3JW LEE  Center for Global Medicine and Department of  Family Medicine, Seoul National University College  of Medicine and Seoul National University Bundang  Hospital, Seongnam; 4Department of Family  Medicine, National Police Hospital, Seoul;  5Department of Family Medicine, Dong-A University  College of Medicine, Busan, Korea Received: 11 March 2014 Accepted: 7 May 2014 Address for Correspondence:  Sang Min Park, MD Department of Family Medicine, Seoul National University  Hospital, Seoul National University College of Medicine,  101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea  Tel: +82.2-2072-3331, Fax: +82.2-766-3276  E-mail: smpark.snuh@gmail.comhttp://dx.doi.org/10.3346/jkms.2014.29.8.1061  • J Korean Med Sci 2014; 29: 1061-1068 INTRODUCTION Five-year relative cancer survival rates have been improving  worldwide (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/7f/56/jkms-29-1061.PMC4129196.pdf
"• Influenza Vaccination and Associated Factors among Korean Cancer Survivors 1062  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1061dictors of vaccination such as age, educational level, time since  cancer diagnosis, and comorbidities (17).",Non-OADS,/arxiv_data1/oa_pdf/7f/56/jkms-29-1061.PMC4129196.pdf
• Influenza Vaccination and Associated Factors among Korean Cancer Survivors http://jkms.org   1063 http://dx.doi.org/10.3346/jkms.2014.29.8.1061Table 1.,Non-OADS,/arxiv_data1/oa_pdf/7f/56/jkms-29-1061.PMC4129196.pdf
• Influenza Vaccination and Associated Factors among Korean Cancer Survivors 1064  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1061types.,Non-OADS,/arxiv_data1/oa_pdf/7f/56/jkms-29-1061.PMC4129196.pdf
• Influenza Vaccination and Associated Factors among Korean Cancer Survivors http://jkms.org   1065 http://dx.doi.org/10.3346/jkms.2014.29.8.1061as 31.5%.,Non-OADS,/arxiv_data1/oa_pdf/7f/56/jkms-29-1061.PMC4129196.pdf
"• Influenza Vaccination and Associated Factors among Korean Cancer Survivors 1066  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1061status, perceived health status, and years since the cancer diag - nosis were associated with the influenza vaccination rate among  cancer survivors.",Non-OADS,/arxiv_data1/oa_pdf/7f/56/jkms-29-1061.PMC4129196.pdf
• Influenza Vaccination and Associated Factors among Korean Cancer Survivors http://jkms.org   1067 http://dx.doi.org/10.3346/jkms.2014.29.8.1061H1N1 in 2009) more individuals may receive the influenza vac - cine than in years with less threatening influenza.,Non-OADS,/arxiv_data1/oa_pdf/7f/56/jkms-29-1061.PMC4129196.pdf
ORCID Kyung-Hyun Choi http://orcid.org/0000-0002-0097-4361 Sang Min Park http://orcid.org/0000-0002-7498-4829 Kiheon Lee http://orcid.org/0000-0002-7139-2342 Ju Hyun Lee http://orcid.org/0000-0001-8623-0744 Joo-Sung Park http://orcid.org/0000-0001-7032-5298 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7f/56/jkms-29-1061.PMC4129196.pdf
Available at  http://www.cancer.go.kr/ncic/cics_f/01/011/index.html [accessed on 1  November 2012].,Non-OADS,/arxiv_data1/oa_pdf/7f/56/jkms-29-1061.PMC4129196.pdf
• Influenza Vaccination and Associated Factors among Korean Cancer Survivors 1068  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1061enza vaccination in adults ≥65 years: a systematic review of qualitative  and quantitative data.,Non-OADS,/arxiv_data1/oa_pdf/7f/56/jkms-29-1061.PMC4129196.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Sirolimus Conversion Efficacy for Graft Function Improvement  and Histopathology in Renal Recipients with Mild to Moderate  Renal Insufficiency This study was designed to evaluate whether sirolimus (SRL) conversion effectively improves  renal function and histopathology in calcineurin inhibitor (CNI)-treated renal recipients  with mild to moderate renal insufficiency.",Non-OADS,/arxiv_data1/oa_pdf/35/89/jkms-29-1069.PMC4129197.pdf
"Received: 24 January 2014 Accepted: 30 April 2014 Address for Correspondence: Yu Seun Kim, MD Department of Transplantation Surgery, Severance Hospital,  Yonsei University Health System, 50-1 Yonsei-ro, Seodaemun- gu, Seoul 120-752, Korea Tel: +82.2-2228-2115, Fax: +82.2-313-8289  E-mail: yukim@yuhs.ac Funding:  This investigator-initiated study was supported by  Wyeth Korea, which was acquired by Pfizer Pharmaceuticals in  2010 (#102299[WS1234412], 2006).http://dx.doi.org/10.3346/jkms.2014.29.8.1069  • J Korean Med Sci 2014; 29: 1069-1076 INTRODUCTION Calcineurin inhibitors (CNI) are widely used immunosuppressants that greatly de - crease the incidence of acute rejection and improve both graft and patient survival  rates in kidney transplantation patients.",Non-OADS,/arxiv_data1/oa_pdf/35/89/jkms-29-1069.PMC4129197.pdf
"• Sirolimus Conversion Efficacy 1070  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1069MATERIALS AND METHODS Study design This study was a 12-month, prospective, nonrandomized, two- center, open-label, noncomparative study that included a screen - ing period, conversion of immunosuppressive agent, and a treat - ment period.",Non-OADS,/arxiv_data1/oa_pdf/35/89/jkms-29-1069.PMC4129197.pdf
• Sirolimus Conversion Efficacy http://jkms.org   1071 http://dx.doi.org/10.3346/jkms.2014.29.8.1069tion (“ah” score) suggested by Sis et al.,Non-OADS,/arxiv_data1/oa_pdf/35/89/jkms-29-1069.PMC4129197.pdf
• Sirolimus Conversion Efficacy 1072  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1069were observed according to CNI exposure duration (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/35/89/jkms-29-1069.PMC4129197.pdf
• Sirolimus Conversion Efficacy http://jkms.org   1073 http://dx.doi.org/10.3346/jkms.2014.29.8.1069observed in 11 patients (29.8%).,Non-OADS,/arxiv_data1/oa_pdf/35/89/jkms-29-1069.PMC4129197.pdf
• Sirolimus Conversion Efficacy 1074  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1069ed modified “ah” scores.,Non-OADS,/arxiv_data1/oa_pdf/35/89/jkms-29-1069.PMC4129197.pdf
"• Sirolimus Conversion Efficacy http://jkms.org   1075 http://dx.doi.org/10.3346/jkms.2014.29.8.1069gain, long-term pain?",Non-OADS,/arxiv_data1/oa_pdf/35/89/jkms-29-1069.PMC4129197.pdf
"• Sirolimus Conversion Efficacy 1076  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1069Castro-Henriques A, Reimao-Pinto J, Garcia J, Morales JM, et al.",OADS,/arxiv_data1/oa_pdf/35/89/jkms-29-1069.PMC4129197.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Four-Week Effects of Allopurinol and Febuxostat Treatments on  Blood Pressure and Serum Creatinine Level in Gouty Men  The aim of this study was to observe the effects of uric acid lowering therapy (UALT),  febuxostat and allopurinol, on blood pressure (BP) and serum creatinine level.",Non-OADS,/arxiv_data1/oa_pdf/8f/b2/jkms-29-1077.PMC4129198.pdf
"http://dx.doi.org/10.3346/jkms.2014.29.8.1077  • J Korean Med Sci 2014; 29: 1077-1081 INTRODUCTION Recent reports have linked hyperuricemia to the increased risk  of hypertension, and the progression of renal disease (1).",Non-OADS,/arxiv_data1/oa_pdf/8f/b2/jkms-29-1077.PMC4129198.pdf
"• Effect of Uric Acid Lowering on Blood Pressure and Creatinine  1078  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1077d, and a control group receiving a placebo.",Non-OADS,/arxiv_data1/oa_pdf/8f/b2/jkms-29-1077.PMC4129198.pdf
• Effect of Uric Acid Lowering on Blood Pressure and Creatinine  http://jkms.org   1079 http://dx.doi.org/10.3346/jkms.2014.29.8.1077 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/8f/b2/jkms-29-1077.PMC4129198.pdf
• Effect of Uric Acid Lowering on Blood Pressure and Creatinine  1080  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1077Table 3.,Non-OADS,/arxiv_data1/oa_pdf/8f/b2/jkms-29-1077.PMC4129198.pdf
• Effect of Uric Acid Lowering on Blood Pressure and Creatinine  http://jkms.org   1081 http://dx.doi.org/10.3346/jkms.2014.29.8.1077Han for assistance with statistics.,Non-OADS,/arxiv_data1/oa_pdf/8f/b2/jkms-29-1077.PMC4129198.pdf
ORCID Hyun Ah Kim http://orcid.org/0000-0002-9318-7446 Young-Il Seo http://orcid.org/0000-0001-6550-3440  Yeong W. Song http://orcid.org/0000-0002-5384-3437 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8f/b2/jkms-29-1077.PMC4129198.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Risk of Osteoporotic Fractures According to the FRAX Model  in Korean Patients with Rheumatoid Arthritis The aim of the current study is to identify patients without osteoporosis who met the  criteria of the fracture risk assessment tool (FRAX) of the National Osteoporosis Foundation  (NOF) only.",Non-OADS,/arxiv_data1/oa_pdf/d8/7e/jkms-29-1082.PMC4129199.pdf
http://dx.doi.org/10.3346/jkms.2014.29.8.1082  • J Korean Med Sci 2014; 29: 1082-1089 INTRODUCTION Rheumatoid arthritis (RA) is a systemic inflammatory disease  which is associated with osteoporosis.,Non-OADS,/arxiv_data1/oa_pdf/d8/7e/jkms-29-1082.PMC4129199.pdf
• FRAX in Rheumatoid Arthritis http://jkms.org   1083 http://dx.doi.org/10.3346/jkms.2014.29.8.1082patients who meet the FRAX criteria are different from those who  are diagnosed with osteoporosis based on BMD values (15).,Non-OADS,/arxiv_data1/oa_pdf/d8/7e/jkms-29-1082.PMC4129199.pdf
The FRAX calculation was  done including femur neck BMD (g/cm2) and using the model  for Korea (http://www.shef.ac.uk/FRAX/tool.aspx?country = 25).,OADS,/arxiv_data1/oa_pdf/d8/7e/jkms-29-1082.PMC4129199.pdf
• FRAX in Rheumatoid Arthritis 1084  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1082RESULTS Patients and baseline characteristics  The characteristics of the 545 patients with RA are presented in  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/d8/7e/jkms-29-1082.PMC4129199.pdf
• FRAX in Rheumatoid Arthritis http://jkms.org   1085 http://dx.doi.org/10.3346/jkms.2014.29.8.1082by the FRAX criteria of the NOF were evaluated in the classified  groups.,Non-OADS,/arxiv_data1/oa_pdf/d8/7e/jkms-29-1082.PMC4129199.pdf
• FRAX in Rheumatoid Arthritis 1086  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1082age of men (8 of 39 patients [20.5%]).,Non-OADS,/arxiv_data1/oa_pdf/d8/7e/jkms-29-1082.PMC4129199.pdf
• FRAX in Rheumatoid Arthritis http://jkms.org   1087 http://dx.doi.org/10.3346/jkms.2014.29.8.1082ture without trauma.,Non-OADS,/arxiv_data1/oa_pdf/d8/7e/jkms-29-1082.PMC4129199.pdf
• FRAX in Rheumatoid Arthritis 1088  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.10823 months.,Non-OADS,/arxiv_data1/oa_pdf/d8/7e/jkms-29-1082.PMC4129199.pdf
ORCID Young Sun Suh http://orcid.org/0000-0002-5378-2590  Jung Hee Koh http://orcid.org/0000-0002-6617-1449  Seung-Min Jung http://orcid.org/0000-0003-3465-2181  Sung-Hwan Park http://orcid.org/0000-0003-1711-2060  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d8/7e/jkms-29-1082.PMC4129199.pdf
"• FRAX in Rheumatoid Arthritis http://jkms.org   1089 http://dx.doi.org/10.3346/jkms.2014.29.8.1082OD, Hernández J, Jaller-Raad JJ, Quevedo-Solidoro H, Radominski SC.",Non-OADS,/arxiv_data1/oa_pdf/d8/7e/jkms-29-1082.PMC4129199.pdf
Available at http://knhanes.cdc.go.kr [accessed on 20 May  2010].,Non-OADS,/arxiv_data1/oa_pdf/d8/7e/jkms-29-1082.PMC4129199.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Follow-up Testing of Interferon-Gamma Release Assays Are  Useful in Ankylosing Spondylitis Patients Receiving Anti-Tumor  Necrosis Factor Alpha for Latent Tuberculosis Infection We evaluated the utility of follow-up interferon-gamma release assays (IGRAs) for the  diagnosis of reactivation of latent tuberculosis infection (LTBI) or new tuberculosis in  ankylosing spondylitis (AS) patients receiving anti-tumor necrosis factor alpha (anti-TNF α).",Non-OADS,/arxiv_data1/oa_pdf/31/95/jkms-29-1090.PMC4129200.pdf
"Received: 17 February 2014 Accepted: 8 May 2014 Address for Correspondence: Tae-Hwan Kim, MD Department of Rheumatology, Hanyang University Hospital for  Rheumatic Diseases, 222 Wangsimni-ro, Seongdong-gu,   Seoul 133-792, Korea Tel: +82.2-2290-9244, Fax: +82.2-2298-8231 E-mail: thkim@hanyang.ac.kr Funding:  This work was supported by the research fund of  Hanyang University (HY-2013-G).http://dx.doi.org/10.3346/jkms.2014.29.8.1090  • J Korean Med Sci 2014; 29: 1090-1093 INTRODUCTION Anti-tumor necrosis factor alpha (TNF α) is often used in patients  with rheumatic disease who do not respond to conventional  treatments, such as non-steroidal anti-inflammatory drugs  (NSAIDs), corticosteroid, or disease modifying anti-rheumatic  drugs (DMARDs) (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/31/95/jkms-29-1090.PMC4129200.pdf
• Follow-up Testing of Interferon-Gamma Release Assays http://jkms.org   1091 http://dx.doi.org/10.3346/jkms.2014.29.8.1090are no country-specific guidelines for IGRA testing.,Non-OADS,/arxiv_data1/oa_pdf/31/95/jkms-29-1090.PMC4129200.pdf
"• Follow-up Testing of Interferon-Gamma Release Assays 1092  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.109023.1%) than in younger patients ( < 40 yr) (1/88, 1.1%) ( P< 0.05).",Non-OADS,/arxiv_data1/oa_pdf/31/95/jkms-29-1090.PMC4129200.pdf
• Follow-up Testing of Interferon-Gamma Release Assays http://jkms.org   1093 http://dx.doi.org/10.3346/jkms.2014.29.8.1090all of the patients with positive results will be diagnosed with  TB.,Non-OADS,/arxiv_data1/oa_pdf/31/95/jkms-29-1090.PMC4129200.pdf
ORCID Chang-Nam Son http://orcid.org/0000-0002-1722-2190 Jae-Bum Jun http://orcid.org/0000-0002-0208-0505 Jong-Heon Kim http://orcid.org/0000-0002-9648-0066 Il-Hoon Sung http://orcid.org/0000-0002-4757-5210 Dae-Hyun Yoo http://orcid.org/0000-0002-0643-4008 Tae-Hwan Kim http://orcid.org/0000-0002-3542-2276 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/31/95/jkms-29-1090.PMC4129200.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Impact of Multimodality Approach for Patients with  Leptomeningeal Metastases from Solid Tumors The purpose of this study was to evaluate treatment patterns, outcome and  prognosticators for patients with leptomeningeal metastases from solid tumor.",Non-OADS,/arxiv_data1/oa_pdf/5e/fc/jkms-29-1094.PMC4129201.pdf
"Keywords:  Leptomeningeal Metastases; Prognostic Factor; Solid Tumor Jeanny Kwon,1 Eui Kyu Chie,1,2   Kyubo Kim,1,2 Hak Jae Kim,1,2   Hong-Gyun Wu,1,2 Il Han Kim,1,2   Do-Youn Oh,3 Se-Hoon Lee,3   Dong-Wan Kim,3 Seock-Ah Im,3   Tae-You Kim,3 Dae-Seog Heo,3   Yung-Jue Bang,3 and Sung W. Ha1,2 1Department of Radiation Oncology, Seoul National  University College of Medicine, Seoul; 2Institute of  Radiation Medicine, Medical Research Center, Seoul  National University, Seoul; 3Department of Internal  Medicine, Seoul National University College of  Medicine, Seoul, Korea Received: 23 January 2014 Accepted: 8 May 2014 Address for Correspondence: Eui Kyu Chie, MD Department of Radiation Oncology, Seoul National University  College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744,  Korea Tel: +82.2-2072-3705, Fax: +82.2-765-3317 E-mail: ekchie93@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.8.1094  • J Korean Med Sci 2014; 29: 1094-1101 INTRODUCTION Leptomeningeal metastasis (LM) is dissemination of malignant  tumor cells into the subarachnoid space.",Non-OADS,/arxiv_data1/oa_pdf/5e/fc/jkms-29-1094.PMC4129201.pdf
• Combined Therapy for Leptomeningeal Seeding http://jkms.org   1095 http://dx.doi.org/10.3346/jkms.2014.29.8.1094nosed with sepsis simultaneously and expired prior to treatment  of LM due to sepsis.,Non-OADS,/arxiv_data1/oa_pdf/5e/fc/jkms-29-1094.PMC4129201.pdf
• Combined Therapy for Leptomeningeal Seeding 1096  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1094tients.,Non-OADS,/arxiv_data1/oa_pdf/5e/fc/jkms-29-1094.PMC4129201.pdf
• Combined Therapy for Leptomeningeal Seeding http://jkms.org   1097 http://dx.doi.org/10.3346/jkms.2014.29.8.1094TKI and its associated factors.,Non-OADS,/arxiv_data1/oa_pdf/5e/fc/jkms-29-1094.PMC4129201.pdf
• Combined Therapy for Leptomeningeal Seeding 1098  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1094Table 5.,Non-OADS,/arxiv_data1/oa_pdf/5e/fc/jkms-29-1094.PMC4129201.pdf
"• Combined Therapy for Leptomeningeal Seeding http://jkms.org   1099 http://dx.doi.org/10.3346/jkms.2014.29.8.1094CMT for LM, after adjusting for other possibly related clinical  factors.",Non-OADS,/arxiv_data1/oa_pdf/5e/fc/jkms-29-1094.PMC4129201.pdf
• Combined Therapy for Leptomeningeal Seeding 1100  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1094est series in this regard by Patrick et al.,Non-OADS,/arxiv_data1/oa_pdf/5e/fc/jkms-29-1094.PMC4129201.pdf
DISCLOSURE Authors have no conflict of interest to disclose.ORCID Jeanny Kwon http://orcid.org/0000-0003-0461-2138 Eui Kyu Chie http://orcid.org/0000-0003-2027-7472 Kyubo Kim http://orcid.org/0000-0001-6093-1294 Hak Jae Kim http://orcid.org/0000-0003-3602-2263 Hong Gyun Wu http://orcid.org/0000-0002-0167-7991 Il Han Kim http://orcid.org/0000-0002-4755-5201 Do-Youn Oh http://orcid.org/0000-0003-1663-9901 Se-Hoon Lee http://orcid.org/0000-0002-9219-3350 Dong Wan Kim http://orcid.org/0000-0001-5124-7132 Seock-Ah Im http://orcid.org/0000-0002-5396-6533 Tae-You Kim http://orcid.org/0000-0002-9986-2684 Dae-Seog Heo http://orcid.org/0000-0001-5221-173X Yung-Jue Bang http://orcid.org/0000-0001-6000-4597 Sung W. Ha http://orcid.org/0000-0001-8066-7232 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/fc/jkms-29-1094.PMC4129201.pdf
Available at http://www.nccn.org/professionals/ physician_gls/pdf/cns.pdf [accessed on 4 April 2013].,Non-OADS,/arxiv_data1/oa_pdf/5e/fc/jkms-29-1094.PMC4129201.pdf
• Combined Therapy for Leptomeningeal Seeding http://jkms.org   1101 http://dx.doi.org/10.3346/jkms.2014.29.8.1094tosis in solid tumors of adulthood.,Non-OADS,/arxiv_data1/oa_pdf/5e/fc/jkms-29-1094.PMC4129201.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Acute Kidney Injury after Using Contrast during Cardiac  Catheterization in Children with Heart Disease Acute kidney injury (AKI) is closely associated with the mortality of hospitalized patients  and long-term development of chronic kidney disease, especially in children.",Non-OADS,/arxiv_data1/oa_pdf/ad/69/jkms-29-1102.PMC4129202.pdf
"Keywords:  Acute Kidney Injury; Kidney Injury Molecule-1; Liver-type Fatty Acid-Binding  Protein; ContrastYoung Ju Hwang,1 Myung Chul Hyun,1  Bong Seok Choi,1 So Young Chun,2   and Min Hyun Cho1 1Department of Pediatrics, Kyungpook National  University School of Medicine; 2Joint Institute for  Regenerative Medicine, Kyungpook National  University Hospital, Daegu, Korea Received: 11 February 2014 Accepted: 20 May 2014 Address for Correspondence: Min Hyun Cho, MD Department of Pediatrics, Kyungpook National University  Medical Center, 807 Hoguk-ro, Buk-gu, Daegu 702-210, Korea Tel: +82.53-200-2741, Fax: +82.53-200-2029 E-mail: chomh@knu.ac.kr Funding:  This work was supported by Biomedical Research  Institute grant, Kyungpook National University Hospital (2011).http://dx.doi.org/10.3346/jkms.2014.29.8.1102  • J Korean Med Sci 2014; 29: 1102-1107 INTRODUCTION Acute kidney injury (AKI) is closely associated with mortality of  hospitalized patients and long-term development of chronic  kidney disease (1).",Non-OADS,/arxiv_data1/oa_pdf/ad/69/jkms-29-1102.PMC4129202.pdf
• Acute Kidney Injury after Cardiac Catheterization in Children http://jkms.org   1103 http://dx.doi.org/10.3346/jkms.2014.29.8.1102then 6 hr and 24 hr after the procedure; the change of KIM-1  level of the urine samples were analyzed.,Non-OADS,/arxiv_data1/oa_pdf/ad/69/jkms-29-1102.PMC4129202.pdf
"• Acute Kidney Injury after Cardiac Catheterization in Children 1104  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.11020.40, respectively.",Non-OADS,/arxiv_data1/oa_pdf/ad/69/jkms-29-1102.PMC4129202.pdf
"• Acute Kidney Injury after Cardiac Catheterization in Children http://jkms.org   1105 http://dx.doi.org/10.3346/jkms.2014.29.8.1102risk factors of CIN including intra-arterial administration, ionic  high-osmolality agents, chronic kidney disease and diabetes  mellitus (4).",Non-OADS,/arxiv_data1/oa_pdf/ad/69/jkms-29-1102.PMC4129202.pdf
• Acute Kidney Injury after Cardiac Catheterization in Children 1106  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1102that L-FABP has the effect on the reduction of oxidative stress  originated from ischemic reperfusion injury in an in vitro study.,Non-OADS,/arxiv_data1/oa_pdf/ad/69/jkms-29-1102.PMC4129202.pdf
ORCID Min Hyun Cho http://orcid.org/0000-0002-7965-7587 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ad/69/jkms-29-1102.PMC4129202.pdf
• Acute Kidney Injury after Cardiac Catheterization in Children http://jkms.org   1107 http://dx.doi.org/10.3346/jkms.2014.29.8.1102level are associated with adverse outcomes in acute renal failure.,Non-OADS,/arxiv_data1/oa_pdf/ad/69/jkms-29-1102.PMC4129202.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Comparison of Korean COPD Guideline and GOLD Initiative  Report in Term of Acute Exacerbation: A Validation Study for  Korean COPD Guideline  The purpose of this study was to compare the Korean COPD guideline to GOLD consensus  report in terms of acute exacerbation.",Non-OADS,/arxiv_data1/oa_pdf/95/0a/jkms-29-1108.PMC4129203.pdf
"Keywords:  COPD; Guidelines; Assessment; Exacerbation; FEV 1Yong Il Hwang,1 Yong Bum Park,1   Yeon Mok Oh,2 Ji Hyun Lee,3   Tae Hyung Kim,4 Kwang Ha Yoo,5   Hyoung Kyu Yoon,6 Chin Kook Rhee,7  Deog Kyeom Kim,8 Kyeong Cheol Shin,9  Sang Yeub Lee,10 and Ki-Suck Jung1 1Department of Pulmonary, Allergy and Critical Care  Medicine, Hallym University Medical Center, Hallym  University College of Medicine, Anyang;  2Department of Pulmonary and Critical Care  Medicine, Asan Medical Center, University of Ulsan  College of Medicine, Seoul; 3Department of Internal  Medicine, CHA Bundang Medical Center, CHA  University, Seongnam; 4Department of Internal  Medicine, Hanyang University Guri Hospital,  Hanyang University College of Medicine, Guri;  5Department of Internal Medicine, Konkuk  University College of Medicine, Seoul; 6Department  of Internal Medicine, Yeouido St. Marry’s Hosital,  The Catholic University of Korea College of  Medicine, Seoul; 7Department of Internal Medicine,  St. Mary’s Hospital, The Catholic University of Korea  College of Medicine, Seoul; 8Department of Internal  Medicine, Seoul Metropolitan Government-Seoul  National University Boramae Medical Center, Seoul;  9Department of Internal Medicine, Yeungnam  University College of Medicine, Daegu;  10Department of Internal Medicine, Korea University  Anam Hospital, Korea University College of  Medicine, Seoul, Korea Received: 24 February 2014 Accepted: 8 May 2014 Address for Correspondence: Ki-Suck Jung, MD Division of Pulmonary, Allergy and Critical Care Medicine,  Department of Internal Medicine, Hallym University Sacred  Heart Hospital, 22 Gwanpyeong-ro 170 beon-gil, Dongan-gu,  Anyang 431-796, Korea Tel: +82.31-380-3715, Fax: +82.31-380-3973 E-mail: pulmoks@hallym.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.8.1108  • J Korean Med Sci 2014; 29: 1108-1112 INTRODUCTION Spirometry is required to make diagnosis of chronic obstructive pulmonary disease  (COPD).",Non-OADS,/arxiv_data1/oa_pdf/95/0a/jkms-29-1108.PMC4129203.pdf
"• Comparison of Korean COPD Guideline with GOLD Report http://jkms.org   1109 http://dx.doi.org/10.3346/jkms.2014.29.8.1108 In Korea, a revised COPD guideline was released in 2012 by  the Korean Academy of Tuberculosis and Respiratory diseases  (8).",Non-OADS,/arxiv_data1/oa_pdf/95/0a/jkms-29-1108.PMC4129203.pdf
"• Comparison of Korean COPD Guideline with GOLD Report 1110  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1108lowed; 17.5% in GOLD A, 34.9% in GOLD B, 3.6% in GOLD C  and 44.0% in GOLD D. The Korean COPD guideline used dif - ferent FEV 1 cut-off values for high risk of exacerbation from that  of GOLD report.",OADS,/arxiv_data1/oa_pdf/95/0a/jkms-29-1108.PMC4129203.pdf
"• Comparison of Korean COPD Guideline with GOLD Report http://jkms.org   1111 http://dx.doi.org/10.3346/jkms.2014.29.8.110817.0% of patient from GOLD D to Korean group ‘da’ had exacer - bation during follow-up period, respectively (Fig.",Non-OADS,/arxiv_data1/oa_pdf/95/0a/jkms-29-1108.PMC4129203.pdf
"• Comparison of Korean COPD Guideline with GOLD Report 1112  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1108 In summary, we showed that 60% of FEV 1 predicted was use - ful to differentiate between the high risk and low risk for exac - erbation in terms of spirometry.",OADS,/arxiv_data1/oa_pdf/95/0a/jkms-29-1108.PMC4129203.pdf
ORCID Yong Il Hwang http://orcid.org/0000-0002-3502-5211 Yong Bum Park http://orcid.org/0000-0001-8810-6077 Yeon Mok Oh http://orcid.org/0000-0003-0116-4683 Ji Hyun Lee http://orcid.org/0000-0002-8287-5470 Tae Hyung Kim http://orcid.org/0000-0002-3863-7854 Kwang Ha Yoo http://orcid.org/0000-0001-9969-2657 Chin Kook Rhee http://orcid.org/0000-0003-4533-7937 Deog Kyeom Kim http://orcid.org/0000-0001-9379-8098 Sang Yeub Lee http://orcid.org/0000-0001-7565-1076 Ki-Suck Jung http://orcid.org/0000-0002-6878-6543 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/95/0a/jkms-29-1108.PMC4129203.pdf
Available at http://www.goldcopd.org  [accessed on 5 February 2014].4.,Non-OADS,/arxiv_data1/oa_pdf/95/0a/jkms-29-1108.PMC4129203.pdf
Available at http://www.lungkorea.org/thesis/guide.,Non-OADS,/arxiv_data1/oa_pdf/95/0a/jkms-29-1108.PMC4129203.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Relationship of Liver Stiffness and Controlled Attenuation  Parameter Measured by Transient Elastography with Diabetes  Mellitus in Patients with Chronic Liver Disease  High prevalence of diabetes mellitus in patients with liver cirrhosis has been reported in  many studies.",Non-OADS,/arxiv_data1/oa_pdf/91/34/jkms-29-1113.PMC4129204.pdf
"Keywords:  Chronic Liver Disease; Diabetes Mellitus; Transient Elastography; Fibrosis;  SteatosisJem Ma Ahn, Yong-Han Paik,   So Hyun Kim, Jun Hee Lee, Ju Yeon Cho,  Won Sohn, Geum-Youn Gwak,   Moon Seok Choi, Joon Hyeok Lee,   Kwang Cheol Koh, Seung Woon Paik,   and Byung Chul Yoo Department of Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul, Korea  Received: 22 January 2014 Accepted: 7 May 2014 Address for Correspondence: Yong-Han Paik, MD Department of Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 135-710, Korea  Tel: +82.2-3410-3878, Fax: +82.2-3410-6983 E-mail: yh.paik@skku.eduhttp://dx.doi.org/10.3346/jkms.2014.29.8.1113  • J Korean Med Sci 2014; 29: 1113-1119 INTRODUCTION The prevalence of diabetes mellitus in patients with liver cir - rhosis is higher compared to that in the general population.",Non-OADS,/arxiv_data1/oa_pdf/91/34/jkms-29-1113.PMC4129204.pdf
"• Relationship of Chronic Liver Disease with Diabetes by Transient Elastography 1114  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1113raphy has several advantages; it is quick, inexpensive, repro - ducible, and noninvasive and it can sample about 100 times  larger portion of liver tissue than liver biopsy (16, 18).",Non-OADS,/arxiv_data1/oa_pdf/91/34/jkms-29-1113.PMC4129204.pdf
• Relationship of Chronic Liver Disease with Diabetes by Transient Elastography http://jkms.org   1115 http://dx.doi.org/10.3346/jkms.2014.29.8.1113and the non-diabetes groups ( P= 0.001).,Non-OADS,/arxiv_data1/oa_pdf/91/34/jkms-29-1113.PMC4129204.pdf
"• Relationship of Chronic Liver Disease with Diabetes by Transient Elastography 1116  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.11130.005), BMI > 25 kg/m2 (OR, 1.69; P= 0.002), hypercholesterol - emia (OR, 1.68; P= 0.040), and ALT > 40 U/L (OR, 1.67; P= 0.015).",Non-OADS,/arxiv_data1/oa_pdf/91/34/jkms-29-1113.PMC4129204.pdf
"• Relationship of Chronic Liver Disease with Diabetes by Transient Elastography http://jkms.org   1117 http://dx.doi.org/10.3346/jkms.2014.29.8.1113in F0/1 group and F2/3 group (OR, 3.48; P< 0.001, OR, 2.79;  P= 0.001).",OADS,/arxiv_data1/oa_pdf/91/34/jkms-29-1113.PMC4129204.pdf
"• Relationship of Chronic Liver Disease with Diabetes by Transient Elastography 1118  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1113with NAFLD, steatosis might have been an independent pre - dictive factor of diabetes.",Non-OADS,/arxiv_data1/oa_pdf/91/34/jkms-29-1113.PMC4129204.pdf
ORCID  Jem Ma Ahn http://orcid.org/0000-0002-3161-5492 Yong-Han Paik http://orcid.org/0000-0002-3076-2327 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/91/34/jkms-29-1113.PMC4129204.pdf
• Relationship of Chronic Liver Disease with Diabetes by Transient Elastography http://jkms.org   1119 http://dx.doi.org/10.3346/jkms.2014.29.8.1113assessment of liver fibrosis by measurement of stiffness in patients with  chronic hepatitis C. Hepatology 2005; 41: 48-54.,Non-OADS,/arxiv_data1/oa_pdf/91/34/jkms-29-1113.PMC4129204.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357KISS1  Gene Polymorphisms in Korean Girls with Central  Precocious Puberty Kisspeptin/G-protein couple receptor-54 (GPR54) system plays a key role in the activation  of the gonadotropic axis at puberty.",Non-OADS,/arxiv_data1/oa_pdf/73/dc/jkms-29-1120.PMC4129205.pdf
"Keywords:  KISS1  Gene; Kisspeptins; G-Protein Coupled Receptor-54; Precocious Puberty,  CentralYoung-Jun Rhie,1 Kee-Hyoung Lee,1   Jung Min Ko,2 Woo Jung Lee,3   Jung Hyun Kim,3 and Ho-Seong Kim3  1Department of Pediatrics, Korea University College  of Medicine, Seoul; 2Department of Pediatrics, Seoul  National University College of Medicine, Seoul;  3Department of Pediatrics, Institute of  Endocrinology, Yonsei University College of  Medicine, Seoul, Korea Received: 25 March 2014 Accepted: 20 May 2014 Address for Correspondence: Ho-Seong Kim, MD Department of Pediatrics, Yonsei University College of Medicine,  50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea Tel: +82.2-2228-2055, Fax: +82.2-393-9118 E-mail: kimho@yuhs.ac Funding:  This study was supported by the research fund of the  Korean Society of Pediatric Endocrinology (2011-2).http://dx.doi.org/10.3346/jkms.2014.29.8.1120  • J Korean Med Sci 2014; 29: 1120-1125 INTRODUCTION Puberty is a complex and coordinated biologic process of sexual  development that leads to complete gonadal maturation and  function, and attainment of reproductive capacity.",Non-OADS,/arxiv_data1/oa_pdf/73/dc/jkms-29-1120.PMC4129205.pdf
"• KISS1  Polymorphisms in Korean Precocious Girls http://jkms.org   1121 http://dx.doi.org/10.3346/jkms.2014.29.8.1120three exons, and only parts of the second and third exons are  ultimately translated into the 145-amino acid precursor peptide  (21).",Non-OADS,/arxiv_data1/oa_pdf/73/dc/jkms-29-1120.PMC4129205.pdf
• KISS1  Polymorphisms in Korean Precocious Girls 1122  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1120the chronological age was 1.84 ± 1.48 yr.,Non-OADS,/arxiv_data1/oa_pdf/73/dc/jkms-29-1120.PMC4129205.pdf
• KISS1  Polymorphisms in Korean Precocious Girls http://jkms.org   1123 http://dx.doi.org/10.3346/jkms.2014.29.8.1120results and their relationships with CPP were also investigated  (Table 5).,Non-OADS,/arxiv_data1/oa_pdf/73/dc/jkms-29-1120.PMC4129205.pdf
"• KISS1  Polymorphisms in Korean Precocious Girls 1124  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1120 SNP 55648343 C/A  was first reported in a study of Chinese  CPP patients in 2007 (19), which demonstrated that p.P110T  was an infrequent polymorphism with an allele frequency of  0.057 in all sequenced subjects.",Non-OADS,/arxiv_data1/oa_pdf/73/dc/jkms-29-1120.PMC4129205.pdf
ORCID Young-Jun Rhie http://orcid.org/0000-0002-1250-6469 Kee-Hyoung Lee http://orcid.org/0000-0002-4319-9019 Jung Min Ko http://orcid.org/0000-0002-0407-7828 Woo Jung Lee http://orcid.org/000-0001-7347-2605 Jung Hyun Kim http://orcid.org/0000-0001-8659-8135 Ho-Seong Kim http://orcid.org/0000-0003-1135-099X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/73/dc/jkms-29-1120.PMC4129205.pdf
• KISS1  Polymorphisms in Korean Precocious Girls http://jkms.org   1125 http://dx.doi.org/10.3346/jkms.2014.29.8.11203.,Non-OADS,/arxiv_data1/oa_pdf/73/dc/jkms-29-1120.PMC4129205.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Early Prophylactic versus Late Selective Use of Surfactant for  Respiratory Distress Syndrome in Very Preterm Infants: A  Collaborative Study of 53 Multi-Center Trials in Korea Pulmonary surfactant (PS) therapy was proven to be highly successful for the treatment of  respiratory distress syndrome in premature infants.",Non-OADS,/arxiv_data1/oa_pdf/4d/f5/jkms-29-1126.PMC4129206.pdf
"Received: 19 January 2014 Accepted: 20 May 2014 Address for Correspondence:  Chong-Woo Bae, MD Department of Pediatrics, Kyung Hee University Hospital at  Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 134-727,  Korea Tel: +82.2-440-6130, Fax: +82.2-440-7175 E-mail: baecw@khnmc.or.krhttp://dx.doi.org/10.3346/jkms.2014.29.8.1126  • J Korean Med Sci 2014; 29: 1126-1131 INTRODUCTION Respiratory distress syndrome (RDS) is defined as respiratory  failure due to lack of pulmonary surfactant (PS).",Non-OADS,/arxiv_data1/oa_pdf/4d/f5/jkms-29-1126.PMC4129206.pdf
"• Early versus Late Surfactant Therapy for Neonatal Respiratory Distress Syndrome  http://jkms.org   1127 http://dx.doi.org/10.3346/jkms.2014.29.8.1126Welfare (KMHW), which has limited its usage strictly to cases of  oxygen need or mechanical ventilation and positive signs on  chest radiograph since 1991.",Non-OADS,/arxiv_data1/oa_pdf/4d/f5/jkms-29-1126.PMC4129206.pdf
• Early versus Late Surfactant Therapy for Neonatal Respiratory Distress Syndrome  1128  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1126morbidity of enrolled cases.,Non-OADS,/arxiv_data1/oa_pdf/4d/f5/jkms-29-1126.PMC4129206.pdf
• Early versus Late Surfactant Therapy for Neonatal Respiratory Distress Syndrome  http://jkms.org   1129 http://dx.doi.org/10.3346/jkms.2014.29.8.1126and the US.,Non-OADS,/arxiv_data1/oa_pdf/4d/f5/jkms-29-1126.PMC4129206.pdf
"• Early versus Late Surfactant Therapy for Neonatal Respiratory Distress Syndrome  1130  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1126Sacred Heart Hospital (Shim EJ), Hanyang University Medical  Center (Park HK), Inha University Hospital (Jun YH), Inje Uni - versity Ilsan Paik Hospital (Hwang JH), Inje University Sanggye  Paik Hospital (Chey MJ), Inje University Pusan Paik Hospital  (Shin JB), Inje University Seoul Paik Hospital (Park YW), Keimy - ung University Dongsan Medical Center (Lee SL, Kim CS),  Konyang University Hospital (KoKO, Im JW), Korea University  Anam Hospital (Lee EH), Korea University Ansan Hospital  (Choi BM), Konkuk University Medical Center (Kim MH),  Kyunghee University Hospital at Gangdong (Bae CW), Kyung - hee University Medical Center (Choi YS), Kyungpook National  University Hospital (Kim HM, Park SH), Kwangju Christian Hos - pital (Kim KS), Pusan National University Hospital (Byun SY),  Samsung Medical Center (Park WS, Chang YS, Ahn SY), Seoul  National University Bundang Hospital (Kim BI, Choi CW), Seoul  National University Children’s Hospital (Choi JH, Kim HS),  Seoul National University Boramae Medical Center (Lee JA),  Soonchunhyang University Bucheon Hospital (Kim SS), Hospi - tal of Sungae (Kim ER), Soonchunhyang University Seoul Hos - pital (Lee WY), The Catholic University of Korea Seoul St. Mary’s  Hospital (Sung IK), The Catholic University of Korea St. Mary’s  Hospital (Kim SY), The Catholic University of Korea St. Vincent’s  Hospital (Lee JH), Ulsan University Hospital (Oh KW), Universi - ty of Ulsan Asan Medical Center (Kim KS, Kim ER), Wonkwang  University Hospital (Oh YK), Yonsei University Severance Chil - dren’s Hospital (Namgung R, Eun HS), Yonsei University Gang - nam Severance Hospital (Lee SM), Yonsei University Wonju  Severance Christian Hospital (Lim BK).",Non-OADS,/arxiv_data1/oa_pdf/4d/f5/jkms-29-1126.PMC4129206.pdf
ORCID Sung Mi Kim http://orcid.org/0000-0002-1426-7828 Young Jin Park http://orcid.org/0000-0002-3044-3289 Sung-Hoon Chung http://orcid.org/0000-0002-0352-9722 Yong-Sung Choi http://orcid.org/0000-0001-9181-7849 Chang Hoon Kim http://orcid.org/0000-0001-5971-863X Chong-Woo Bae http://orcid.org/0000-0001-5971-863X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/f5/jkms-29-1126.PMC4129206.pdf
• Early versus Late Surfactant Therapy for Neonatal Respiratory Distress Syndrome  http://jkms.org   1131 http://dx.doi.org/10.3346/jkms.2014.29.8.1126art G. Prophylactic administration of porcine-derived lung surfactant is  a significant factor in reducing the odds for peri-intraventricular haem - orrhage in premature infants.,Non-OADS,/arxiv_data1/oa_pdf/4d/f5/jkms-29-1126.PMC4129206.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Effect of Renal Insufficiency on Stone Recurrence in Patients with Urolithiasis The study was designed to assess the relationship between glomerular filtration rate (GFR)  and urinary stone-forming constituents, and to assess the effect of renal insufficiency on  stone recurrence risk in first stone formers (SF).",Non-OADS,/arxiv_data1/oa_pdf/85/00/jkms-29-1132.PMC4129207.pdf
"PJ009621), Rural  Development Administration, Republic of Korea.http://dx.doi.org/10.3346/jkms.2014.29.8.1132  • J Korean Med Sci 2014; 29: 1132-1137 INTRODUCTION Urolithiasis is one of the most common diseases, with increas - ing incidence and prevalence worldwide (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/85/00/jkms-29-1132.PMC4129207.pdf
• Renal Insufficiency and Stone Recurrence  http://jkms.org   1133 http://dx.doi.org/10.3346/jkms.2014.29.8.1132sion criteria (there is some overlap in categories).,Non-OADS,/arxiv_data1/oa_pdf/85/00/jkms-29-1132.PMC4129207.pdf
• Renal Insufficiency and Stone Recurrence  1134  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1132Table 2.,Non-OADS,/arxiv_data1/oa_pdf/85/00/jkms-29-1132.PMC4129207.pdf
• Renal Insufficiency and Stone Recurrence  http://jkms.org   1135 http://dx.doi.org/10.3346/jkms.2014.29.8.1132Table 3.,Non-OADS,/arxiv_data1/oa_pdf/85/00/jkms-29-1132.PMC4129207.pdf
"• Renal Insufficiency and Stone Recurrence  1136  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1132In addition, tubular dysfunction secondary to chronic renal da- mage leads to a reduction in electrolyte reabsorption and con - sequent urinary loss (12, 24).",Non-OADS,/arxiv_data1/oa_pdf/85/00/jkms-29-1132.PMC4129207.pdf
DISCLOSURE The authors have no conflicts of interest to disclose.ORCID Ho Won Kang http://orcid.org/0000-0002-8164-4427  Sung Phil Seo http://orcid.org/0000-0001-6179-7031  Won Tae Kim http://orcid.org/0000-0002-7482-4550  Yong-June Kim http://orcid.org/0000-0001-7638-7174  Seok-Joong Yun http://orcid.org/0000-0001-7737-4746  Sang-Cheol Lee http://orcid.org/0000-0002-4163-2210  Wun-Jae Kim http://orcid.org/0000-0002-8060-8926  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/85/00/jkms-29-1132.PMC4129207.pdf
• Renal Insufficiency and Stone Recurrence  http://jkms.org   1137 http://dx.doi.org/10.3346/jkms.2014.29.8.113216.,Non-OADS,/arxiv_data1/oa_pdf/85/00/jkms-29-1132.PMC4129207.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Neuropathic Pain Model of Peripheral Neuropathies Mediated  by Mutations of Glycyl-tRNA Synthetase  Charcot-Marie-Tooth disease (CMT) is the most common inherited motor and sensory  neuropathy.",Non-OADS,/arxiv_data1/oa_pdf/8c/1c/jkms-29-1138.PMC4129208.pdf
"Received: 2 January 2014 Accepted: 24 April 2014 Address for Correspondence: Youngbuhm Huh, MD Department of Anatomy and Neurobiology, School of Medicine,  Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu,  Seoul 130-701, Korea  Tel: +82.2-961-0285, Fax: +82.2-969-6958 E-mail: ybhuh@khu.ac.kr Funding:  This work was supported by a grant from the Kyung  Hee University in 2011 (KHU-20110905).http://dx.doi.org/10.3346/jkms.2014.29.8.1138  • J Korean Med Sci 2014; 29: 1138-1144 INTRODUCTION Neuropathic pain is a common consequence of damage to the  nervous system via the mechanisms of infection, nerve injury,  diabetes, and so forth (1).",Non-OADS,/arxiv_data1/oa_pdf/8c/1c/jkms-29-1138.PMC4129208.pdf
"• New Neuropathic Pain Model by Mutations of GARS  http://jkms.org   1139 http://dx.doi.org/10.3346/jkms.2014.29.8.1138mice, which were obtained from Semtako (Osan, Korea).",OADS,/arxiv_data1/oa_pdf/8c/1c/jkms-29-1138.PMC4129208.pdf
"• New Neuropathic Pain Model by Mutations of GARS  1140  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1138actin (1:5,000; Sigma; St. Louis, MO, USA), rabbit anti-FLAG  (1:1,000; Cell Signaling Technology), and p-ERK1/2 (1:1,000;  Cat #: 9101, Cell Signaling Technology).",Non-OADS,/arxiv_data1/oa_pdf/8c/1c/jkms-29-1138.PMC4129208.pdf
• New Neuropathic Pain Model by Mutations of GARS  http://jkms.org   1141 http://dx.doi.org/10.3346/jkms.2014.29.8.1138ing portion (Fig.,Non-OADS,/arxiv_data1/oa_pdf/8c/1c/jkms-29-1138.PMC4129208.pdf
• New Neuropathic Pain Model by Mutations of GARS  1142  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1138dorsal horn compared with WT GARS-expressing samples (Fig.,Non-OADS,/arxiv_data1/oa_pdf/8c/1c/jkms-29-1138.PMC4129208.pdf
"• New Neuropathic Pain Model by Mutations of GARS  http://jkms.org   1143 http://dx.doi.org/10.3346/jkms.2014.29.8.1138ages showed that the expression of GFP fluorescence in the dor - sal horn was only accomplished in the GARS WT-expressing  central processes of DRG neurons whose peripheral axons were  infected by adenovirus vectors, but did not in the GARS mutant- expressing dorsal horn.",OADS,/arxiv_data1/oa_pdf/8c/1c/jkms-29-1138.PMC4129208.pdf
ORCID  Seo Jin Lee http://orcid.org/0000-0001-6531-0526  Ah Jung Seo http://orcid.org/0000-0002-5211-3213 Byung Sun Park http://orcid.org/0000-0001-6131-6808 Hyun Woo Jo http://orcid.org/0000-0002-8984-8694 Youngbuhm Huh http://orcid.org/0000-0002-7687-0374REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8c/1c/jkms-29-1138.PMC4129208.pdf
• New Neuropathic Pain Model by Mutations of GARS  1144  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1138pendent manner in the dorsal horn.,Non-OADS,/arxiv_data1/oa_pdf/8c/1c/jkms-29-1138.PMC4129208.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Influence of Depression, Anxiety and Somatization on the  Clinical Symptoms and Treatment Response in Patients with  Symptoms of Lower Urinary Tract Symptoms Suggestive of  Benign Prostatic Hyperplasia  This is the first study to investigate the influence of depression, anxiety and somatization  on the treatment response for lower urinary tract symptoms/benign prostatic hyperplasia  (LUTS/BPH).",Non-OADS,/arxiv_data1/oa_pdf/5d/42/jkms-29-1145.PMC4129209.pdf
"Keywords:  Lower Urinary Tract Symptoms; Benign Prostatic Hyperplasia; Depression;  Anxiety; Somatization; ResponseYong June Yang,1 Jun Sung Koh,2   Hyo Jung Ko,3 Kang Joon Cho,2   Joon Chul Kim,2 Soo-Jung Lee,1   and Chi-Un Pae1,4 1Department of Psychiatry, The Catholic University  of Korea College of Medicine, Seoul; 2Department of  Urology, The Catholic University of Korea College of  Medicine, Seoul; 3Department of Psychiatry, Seoul  Metropolitan Eunpyeong Hospital, Seoul, Korea;  4Department of Psychiatry and Behavioral Sciences,  Duke University Medical Center, Durham, NC, USA  Received: 17 February 2014 Accepted: 8 May 2014 Address for Correspondence: Chi-Un Pae, MD Department of Psychiatry, Bucheon St. Mary’s Hospital,   The Catholic University of Korea College of Medicine,   327 Sosa-ro, Bucheon 420-717, Korea Tel: +82.32-340-7067, Fax: +82.32-340-2255 E-mail: pae@catholic.ac.kr Funding:  This work was supported by a grant of the Korean  Health Technology R&D Project, Ministry of Health & Welfare,  Republic of Korea (HI12C0003) and supported partly by Astellas.http://dx.doi.org/10.3346/jkms.2014.29.8.1145  • J Korean Med Sci 2014; 29: 1145-1151 INTRODUCTION Lower urinary tract symptoms (LUTS) manifest multiple do - main of clinical symptoms such as storage, voiding and post- micturition and are common among older men (1).",Non-OADS,/arxiv_data1/oa_pdf/5d/42/jkms-29-1145.PMC4129209.pdf
"• Depression, Anxiety and Somatization with Treatment Response for LUTS/BPH 1146  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1145(14) have also demonstrated the important relationship between  LUTS/BPH and depression, in which depression was signifi - cantly associated with the severity of the diseases as well as it  also involves in all stages of LUTS.",Non-OADS,/arxiv_data1/oa_pdf/5d/42/jkms-29-1145.PMC4129209.pdf
"• Depression, Anxiety and Somatization with Treatment Response for LUTS/BPH http://jkms.org   1147 http://dx.doi.org/10.3346/jkms.2014.29.8.1145analysis as well.",Non-OADS,/arxiv_data1/oa_pdf/5d/42/jkms-29-1145.PMC4129209.pdf
"• Depression, Anxiety and Somatization with Treatment Response for LUTS/BPH 1148  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1145were not different between the two groups (Tables 2, 3).",Non-OADS,/arxiv_data1/oa_pdf/5d/42/jkms-29-1145.PMC4129209.pdf
"• Depression, Anxiety and Somatization with Treatment Response for LUTS/BPH http://jkms.org   1149 http://dx.doi.org/10.3346/jkms.2014.29.8.1145various mental health and physical diseases.",Non-OADS,/arxiv_data1/oa_pdf/5d/42/jkms-29-1145.PMC4129209.pdf
ORCID Yong June Yang http://orcid.org/0000-0003-0135-0080 Jun Sung Koh http://orcid.org/0000-0001-7432-4209 Hyo Jung Ko http://orcid.org/0000-0002-9034-1524 Kang Joon Cho http://orcid.org/0000-0002-5305-901X Joon Chul Kim http://orcid.org/0000-0002-4019-620X Soo-Jung Lee http://orcid.org/0000-0002-1299-5266 Chi-Un Pae http://orcid.org/0000-0002-6774-9417 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5d/42/jkms-29-1145.PMC4129209.pdf
"• Depression, Anxiety and Somatization with Treatment Response for LUTS/BPH 1150  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.11454.",Non-OADS,/arxiv_data1/oa_pdf/5d/42/jkms-29-1145.PMC4129209.pdf
"• Depression, Anxiety and Somatization with Treatment Response for LUTS/BPH http://jkms.org   1151 http://dx.doi.org/10.3346/jkms.2014.29.8.1145RS 2011.",Non-OADS,/arxiv_data1/oa_pdf/5d/42/jkms-29-1145.PMC4129209.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Association between Bone Mineral Density and Clinical  Consequences: Cross-Sectional Study of Korean Postmenopausal  Women in an Orthopaedic Outpatient Clinic This study is to identify the characteristics of BMD and the related clinical consequences  through a nationwide, consecutive, cross-sectional study.",Non-OADS,/arxiv_data1/oa_pdf/fa/c5/jkms-29-1152.PMC4129210.pdf
"http://dx.doi.org/10.3346/jkms.2014.29.8.1152  • J Korean Med Sci 2014; 29: 1152-1160 INTRODUCTION  As the proportion of postmenopausal women is increasing with  the recent increase of aging population in Korea, it is anticipated  that aging is proceeding more rapidly in the future.",Non-OADS,/arxiv_data1/oa_pdf/fa/c5/jkms-29-1152.PMC4129210.pdf
• Association between BMD and Clinical Consequences http://jkms.org   1153 http://dx.doi.org/10.3346/jkms.2014.29.8.1152and determine for its treatment and the most important factor  to predict osteoporotic fracture (10).,Non-OADS,/arxiv_data1/oa_pdf/fa/c5/jkms-29-1152.PMC4129210.pdf
"• Association between BMD and Clinical Consequences 1154  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1152confirmed by an orthopedic specialist, and the presence of the  symptom was confirmed.",Non-OADS,/arxiv_data1/oa_pdf/fa/c5/jkms-29-1152.PMC4129210.pdf
• Association between BMD and Clinical Consequences http://jkms.org   1155 http://dx.doi.org/10.3346/jkms.2014.29.8.1152Fig.,Non-OADS,/arxiv_data1/oa_pdf/fa/c5/jkms-29-1152.PMC4129210.pdf
• Association between BMD and Clinical Consequences 1156  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1152Fig.,Non-OADS,/arxiv_data1/oa_pdf/fa/c5/jkms-29-1152.PMC4129210.pdf
• Association between BMD and Clinical Consequences http://jkms.org   1157 http://dx.doi.org/10.3346/jkms.2014.29.8.1152Table 3.,Non-OADS,/arxiv_data1/oa_pdf/fa/c5/jkms-29-1152.PMC4129210.pdf
"• Association between BMD and Clinical Consequences 1158  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1152tent (14, 15), but there are reports that obesity, especially fat  mass, interrupts bone health (16, 17).",Non-OADS,/arxiv_data1/oa_pdf/fa/c5/jkms-29-1152.PMC4129210.pdf
• Association between BMD and Clinical Consequences http://jkms.org   1159 http://dx.doi.org/10.3346/jkms.2014.29.8.1152this manuscript.,Non-OADS,/arxiv_data1/oa_pdf/fa/c5/jkms-29-1152.PMC4129210.pdf
ORCID Jae Hyup Lee http://orcid.org/0000-0002-2141-0266  Ye-Hyun Lee http://orcid.org/0000-0003- 4890-5792  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fa/c5/jkms-29-1152.PMC4129210.pdf
• Association between BMD and Clinical Consequences 1160  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.115230.,Non-OADS,/arxiv_data1/oa_pdf/fa/c5/jkms-29-1152.PMC4129210.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Aminophylline Partially Prevents the Decrease of Body  Temperature during Laparoscopic Abdominal Surgery Aminophylline can elicit thermogenesis in rats or increase metabolic rate during cold stress  in lambs.",Non-OADS,/arxiv_data1/oa_pdf/0d/46/jkms-29-1161.PMC4129211.pdf
"http://dx.doi.org/10.3346/jkms.2014.29.8.1161  • J Korean Med Sci 2014; 29: 1161-1165 INTRODUCTION Intraoperative hypothermia is common because anesthetics  impair thermoregulatory control (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/0d/46/jkms-29-1161.PMC4129211.pdf
"• Reduced Hypothermia with Aminophylline 1162  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1161 To prepare the study drug, aminophylline (10 mg/kg) was  mixed with saline in a syringe to a volume of 100 mL by an in - dependent researcher.",Non-OADS,/arxiv_data1/oa_pdf/0d/46/jkms-29-1161.PMC4129211.pdf
"• Reduced Hypothermia with Aminophylline http://jkms.org   1163 http://dx.doi.org/10.3346/jkms.2014.29.8.1161ing room temperature, fluid intake, urine output, and blood  loss, did not differ significantly between the groups.",Non-OADS,/arxiv_data1/oa_pdf/0d/46/jkms-29-1161.PMC4129211.pdf
• Reduced Hypothermia with Aminophylline 1164  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.116164% increase in plasma norepinephrine during a high-dose in - fusion of theophylline (plasma theophylline level of 20 μg/mL)  resulted in dose-dependent cardiovascular and metabolic ef - fects.,Non-OADS,/arxiv_data1/oa_pdf/0d/46/jkms-29-1161.PMC4129211.pdf
ORCID Dae Woo Kim http://orcid.org/0000-0002-0270-0727 Jung Ah Lee http://orcid.org/0000-0001-6107-1484 Hong Soo Jung http://orcid.org/0000-0001-7690-7969 Jin Deok Joo http://orcid.org/0000-0001-9035-3288 Jang Hyeok In http://orcid.org/0000-0001-6206-0103 Yeon Soo Jeon http://orcid.org/0000-0002-7677-2002 Ga Young Chun http://orcid.org/0000-0001-8587-7183 Jin Woo Choi http://orcid.org/0000-0003-0444-4015 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0d/46/jkms-29-1161.PMC4129211.pdf
"• Reduced Hypothermia with Aminophylline http://jkms.org   1165 http://dx.doi.org/10.3346/jkms.2014.29.8.1161GM, Gottlieb SO.",Non-OADS,/arxiv_data1/oa_pdf/0d/46/jkms-29-1161.PMC4129211.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Transplantation of a Horseshoe Kidney Found During Harvest  Operation of a Cadaveric Donor: A Case Report A 34-yr-old female was diagnosed as being brain dead.",Non-OADS,/arxiv_data1/oa_pdf/71/92/jkms-29-1166.PMC4129212.pdf
"Keywords:  Horseshoe Kidney; Kidney TransplantationSangchul Yun,1 Hee-Doo Woo,1   Seung-Whan Doo,2 Soon Hyo Kwon,3  Hyunjin Noh,3 and Dan Song1 Departments of 1Surgery, 2Urology, 3Internal  Medicine, Soonchunhyang University College of  Medicine, Seoul, Korea Received: 19 October 2013 Accepted: 12 March 2014 Address for Correspondence: Dan Song, MD Department of Surgery, Soonchunhyang University Seoul  Hospital, Soonchunhyang University School of Medicine,   59 Daesagwan-ro, Yongsan-gu, Seoul 140-743, Korea Tel: +82.2-709-9490, Fax: +82.2-749-0449 E-mail: backsa7@schmc.ac.kr Funding:  This work was supported by the Soonchunhyang  University Research Fund.http://dx.doi.org/10.3346/jkms.2014.29.8.1166  • J Korean Med Sci 2014; 29: 1166-1169 INTRODUCTION The horseshoe kidney is one of the most common anatomical  variations of the kidney with an incidence of one in every 600- 800 individuals (1, 2), and is twice as commonly in males (3).",Non-OADS,/arxiv_data1/oa_pdf/71/92/jkms-29-1166.PMC4129212.pdf
• Transplantation of a Split Horseshoe Kidney http://jkms.org   1167 http://dx.doi.org/10.3346/jkms.2014.29.8.1166end-to-side fashion.,Non-OADS,/arxiv_data1/oa_pdf/71/92/jkms-29-1166.PMC4129212.pdf
• Transplantation of a Split Horseshoe Kidney 1168  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1166other problem is that the incidence of Wilm’s tumor in people  who have the horseshoe kidneys is twice as high as in the gen - eral population.,Non-OADS,/arxiv_data1/oa_pdf/71/92/jkms-29-1166.PMC4129212.pdf
"• Transplantation of a Split Horseshoe Kidney http://jkms.org   1169 http://dx.doi.org/10.3346/jkms.2014.29.8.1166the transplantation of kidneys with a normal anatomy (8, 9).",Non-OADS,/arxiv_data1/oa_pdf/71/92/jkms-29-1166.PMC4129212.pdf
ORCID Sangchul Yun http://orcid.org/0000-0002-6321-4319  Hee-Doo Woo http://orcid.org/0000-0002-5065-9677  Seung-Whan Doo http://orcid.org/0000-0002-5924-6908  Soon Hyo Kwon http://orcid.org/0000-0002-4144-4196  Hyunjin Noh http://orcid.org/0000-0002-1904-1684  Dan Song http://orcid.org/0000-0002-2417-9899  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/71/92/jkms-29-1166.PMC4129212.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Acute Pancreatitis Induced by Methimazole Treatment in a  51-Year-Old Korean Man: A Case Report Methimazole (MMI)-induced acute pancreatitis is very rare but severe adverse reaction.",Non-OADS,/arxiv_data1/oa_pdf/6b/88/jkms-29-1170.PMC4129213.pdf
"Keywords:  Methimazole; Graves Disease; Pancreatitis; Drug-Related Side Effects and  Adverse ReactionsJung Hwa Jung,1,2 Jong Ryeal Hahm,1,2  Jaehoon Jung,1,2 Soo Kyoung Kim,1,2  Sungsu Kim,1 Kyong Young Kim,1  Bo Ra Kim,1 Hong Jun Kim,1,2  Yi Yeong Jeong,1,2 and Sun Joo Kim2,3 Department of 1Internal Medicine, 2Institute of  Health Science, 3Department of Laboratory  Medicine, Gyeongsang National University School  of Medicine, Jinju, Korea Received: 15 January 2014 Accepted: 31 March 2014 Address for Correspondence:  Jong Ryeal Hahm, MD  Department of Internal Medicine, Gyeongsang National  University School of Medicine, 15 Jinju-daero 816-Beongil, Jinju 660-290, Korea Tel: +82.55-750-8736, Fax: +82.55-758-9122 E-mail: jrhahm@hanmail.nethttp://dx.doi.org/10.3346/jkms.2014.29.8.1170  • J Korean Med Sci 2014; 29: 1170-1173 INTRODUCTION Methimazole (1-methyl-2-mercaptoimidazole, MMI) is an ef - fective and generally safe antithyroid drug for the treatment of  Graves’ disease.",Non-OADS,/arxiv_data1/oa_pdf/6b/88/jkms-29-1170.PMC4129213.pdf
• Methimazole-Induced Acute Pancreatitis http://jkms.org   1171 http://dx.doi.org/10.3346/jkms.2014.29.8.1170TSH-receptor antibody of 8.8 IU/L (normal range: 0.00-1.75).,Non-OADS,/arxiv_data1/oa_pdf/6b/88/jkms-29-1170.PMC4129213.pdf
"• Methimazole-Induced Acute Pancreatitis 1172  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1170IgG subclass-4 were in the normal range (901.5 mg/dL, normal  range: 700-1,600; and 349 mg/L, normal range: 30-2,010, respec - tively).",Non-OADS,/arxiv_data1/oa_pdf/6b/88/jkms-29-1170.PMC4129213.pdf
ORCID Jung Hwa Jung http://orcid.org/0000-0001-6285-8262 Jong Ryeal Hahm http://orcid.org/0000-0003-4785-7119 Jaehoon Jung http://orcid.org/0000-0001-6550-139X Soo Kyoung Kim http://orcid.org/0000-0003-1810-7642 Sungsu Kim http://orcid.org/0000-0002-8858-1932 Kyong Young Kim http://orcid.org/0000-0002-7709-1284 Bo Ra Kim http://orcid.org/0000-0002-2820-7463 Hong Jun Kim http://orcid.org/0000-0002-0411-668X,Non-OADS,/arxiv_data1/oa_pdf/6b/88/jkms-29-1170.PMC4129213.pdf
• Methimazole-Induced Acute Pancreatitis http://jkms.org   1173 http://dx.doi.org/10.3346/jkms.2014.29.8.1170Yi Yeong Jeong http://orcid.org/0000-0003-1015-1411   Sun Joo Kim http://orcid.org/0000-0001-8099-8891   REFERENCES 1. Cooper DS.,Non-OADS,/arxiv_data1/oa_pdf/6b/88/jkms-29-1170.PMC4129213.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Trends and Risk Factors of the Epidemic of Charcoal Burning  Suicide in a Recent Decade among Korean People  The aims of this study were to analyze annual trends of charcoal burning (CB) suicide, 2000  to 2011, and to examine the risk factors of CB suicide in Korea.",Non-OADS,/arxiv_data1/oa_pdf/3b/08/jkms-29-1174.PMC4129214.pdf
"Keywords:  Charcoal Burning; Mass Media; SuicideNam-Ju Ji,1 Yeon-Pyo Hong,1   Steven John Stack,2   and Weon-Young Lee1  1Department of Preventive Medicine, College of  Medicine, Chung-Ang University, Seoul, Korea;  2Center for the Study of Suicide, Department of  Psychiatry and Department of Criminology, Wayne  State University, Detroit, MI, USA  Received: 21 January 2014 Accepted: 24 April 2014 Address for Correspondence: Weon-Young Lee, MD Department of Preventive Medicine, College of Medicine,  Chung-Ang University, 84 Heukseok-ro, Dongjak-gu,   Seoul 156-756, Korea Tel: +82.2-820-5695, Fax: +82.2-815-9509 E-mail: wylee@cau.ac.krhttp://dx.doi.org/10.3346/jkms.2014.29.8.1174  • J Korean Med Sci 2014; 29: 1174-1177 Korea’s suicide rate has been the highest in the Organization of  Economic Co-operation and Development (OECD) countries  for eight consecutive years since 2004 and is still on the rise (1).",Non-OADS,/arxiv_data1/oa_pdf/3b/08/jkms-29-1174.PMC4129214.pdf
• Epidemic of Charcoal Burning Suicide in Korea  http://jkms.org   1175 http://dx.doi.org/10.3346/jkms.2014.29.8.11742000 is insignificant due to few cases and changes in the trend.,Non-OADS,/arxiv_data1/oa_pdf/3b/08/jkms-29-1174.PMC4129214.pdf
"• Epidemic of Charcoal Burning Suicide in Korea  1176  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1174(1,251 cases) in 2011 (Fig.",Non-OADS,/arxiv_data1/oa_pdf/3b/08/jkms-29-1174.PMC4129214.pdf
ORCID Nam-Ju Ji http://orcid.org/0000-0001-9333-738X Yeon-Pyo Hong http://orcid.org/0000-0001-6375-1213,Non-OADS,/arxiv_data1/oa_pdf/3b/08/jkms-29-1174.PMC4129214.pdf
• Epidemic of Charcoal Burning Suicide in Korea  http://jkms.org   1177 http://dx.doi.org/10.3346/jkms.2014.29.8.1174Weon-Young Lee http://orcid.org/0000-0003-3062-3973  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3b/08/jkms-29-1174.PMC4129214.pdf
Available at http://www.oecd.org/statistics [accessed on 1 Jan - uary 2014].,OADS,/arxiv_data1/oa_pdf/3b/08/jkms-29-1174.PMC4129214.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Susceptibility of Escherichia coli from Community-Acquired  Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and  Temocillin in Korea With increase of multi-drug resistant Escherichia coli  in community-acquired urinary tract  infections (CA-UTI), other treatment option with a therapeutic efficacy and a low antibiotic  selective pressure is necessary.",Non-OADS,/arxiv_data1/oa_pdf/a9/9d/jkms-29-1178.PMC4129215.pdf
"Received: 6 March 2014 Accepted: 14 May 2014 Address for Correspondence: Hyunjoo Pai, MD Department of Internal Medicine, Hanyang University College of  Medicine, 232 Wangsimni-ro, Seongdong-gu, Seoul 133-792,  Korea Tel: +82.2-2290-8356, Fax: +82.2-2298-9183 E-mail: paihyunjoo@gmail.com Funding:  This work was supported by a grant of the Korea  Healthcare technology R&D Project, Ministry of Health and  Welfare, Republic of Korea (A084063).http://dx.doi.org/10.3346/jkms.2014.29.8.1178  • J Korean Med Sci 2014; 29: 1178-1181 Urinary tract infections (UTIs) are common with an annual global incidence of at least  250 million cases; and Escherichia coli  is the most common pathogen (1).",Non-OADS,/arxiv_data1/oa_pdf/a9/9d/jkms-29-1178.PMC4129215.pdf
"• Susceptibility of Escherichia coli  from Urinary Tract Infection http://jkms.org   1179 http://dx.doi.org/10.3346/jkms.2014.29.8.1178 As part of a nationwide multicenter surveillance study, a total  of 346 community-acquired E. coli  from patients with UTI were  collected from April 2010 to March 2011.",OADS,/arxiv_data1/oa_pdf/a9/9d/jkms-29-1178.PMC4129215.pdf
• Susceptibility of Escherichia coli from Urinary Tract Infection 1180  http://jkms.org http://dx.doi.org/10.3346/jkms.2014.29.8.1178 We compared the antimicrobial resistance of 76 (22%) CIP- resistant (CIP-R) and 270 (78%) CIP-susceptible (CIP-S) isolates  (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/a9/9d/jkms-29-1178.PMC4129215.pdf
• Susceptibility of Escherichia coli  from Urinary Tract Infection http://jkms.org   1181 http://dx.doi.org/10.3346/jkms.2014.29.8.1178are an excellent therapeutic option for lower UTI in Korea.,Non-OADS,/arxiv_data1/oa_pdf/a9/9d/jkms-29-1178.PMC4129215.pdf
ORCID Mi-Ran Seo http://orcid.org/0000-0002-7438-7071  Seong-Jong Kim http://orcid.org/0000-0003-2807-1866 Yeonjae Kim http://orcid.org/0000-0003-4144-9077  Jieun Kim http://orcid.org/0000-0002-6214-3889  Tae Yeal Choi http://orcid.org/0000-0002-0607-3513  Jung Oak Kang http://orcid.org/0000-0002-9181-6819  Seong-Heon Wie http://orcid.org/0000-0002-7603-5520  Moran Ki http://orcid.org/0000-0002-8892-7104  Young Kyun Cho http://orcid.org/0000-0003-3781-3665  Seung-Kwan Lim http://orcid.org/0000-0003-1941-6359  Jin Seo Lee http://orcid.org/0000-0003-3913-6370  Ki Tae Kwon http://orcid.org/0000-0003-4666-0672  Hyuck Lee http://orcid.org/0000-0002-4115-0748  Hee Jin Cheong http://orcid.org/0000-0002-2532-1463  Dae Won Park http://orcid.org/0000-0002-7653-686X  Seong Yeol Ryu http://orcid.org/0000-0002-6023-8550  Moon-Hyun Chung http://orcid.org/0000-0003-2905-3459  Hyunjoo Pai http://orcid.org/0000-0003-4143-035X  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a9/9d/jkms-29-1178.PMC4129215.pdf
Available at http://clsi.crg [ac - cessed on 1 January 2005].,Non-OADS,/arxiv_data1/oa_pdf/a9/9d/jkms-29-1178.PMC4129215.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Erratum: Addition of Author’s Affiliated Institute and Correction of the Author’s  Name Corrected: Safety and Immunogenicity Assessment of an Oral Cholera  Vaccine through Phase I Clinical Trial in Korea Yeong Ok Baik,1,4 Seuk Keun Choi,1,4 Jae Woo Kim,2 Jae Seung Yang,3 Ick Young Kim,4 Chan Wha Kim,4 and Jang Hee Hong2  1EuBiologics Co., Ltd., Chuncheon; 2Department of Pharmacology and Clinical Trials Center, Chungnam National University, College of Medicine and Hospital, Daejeon;  3Clinical Immunology Section, International Vaccine Institute (IVI), Seoul; 4Department of Biotechnology, Korea University, Seoul, Korea To the Editor: We found errors in our published article: J Korean Med Sci 2014; 29: 494-501.",Non-OADS,/arxiv_data1/oa_pdf/87/1b/jkms-29-1182.PMC4129216.pdf
"In addition,   Young Ok Baik is corrected as Yeong Ok Baik.http://dx.doi.org/10.3346/jkms.2014.29.8.1182  • J Korean Med Sci 2014; 29: 1182CORRESPONDENCE",Non-OADS,/arxiv_data1/oa_pdf/87/1b/jkms-29-1182.PMC4129216.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Erratum: Correction of the Author’s Name Risk Factors between Patients with Lone and Non-Lone Atrial  Fibrillation by Lee SH, et al.",Non-OADS,/arxiv_data1/oa_pdf/48/92/jkms-29-1183.PMC4129217.pdf
"APPENDIX Yongkeun Cho , Division of Cardiology, Kyungpook National University School of Medicine,  Daegu.http://dx.doi.org/10.3346/jkms.2014.29.8.1183  • J Korean Med Sci 2014; 29: 1183CORRESPONDENCE",Non-OADS,/arxiv_data1/oa_pdf/48/92/jkms-29-1183.PMC4129217.pdf
 http://dx.doi.org/10.4082/kjfm.2014.35.4.171 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/4c/d0/kjfm-35-171.PMC4129243.pdf
  http://dx.doi.org/10.4082/kjfm.2014.35.4.173 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/ac/70/kjfm-35-173.PMC4129244.pdf
"Keywords:  Binge Drinking; Metabolic Syndrome; Asian Continental Ancestry Group; Men Received: August 28, 2013,  Accepted: July 1, 2014 *Corresponding Author: Sang-Min Park T el: +82-2-2072-3331, Fax: +82-2-766-3276E-mail: smpark.snuh@gmail.com Korean Journal of Family Medicine Copyright © 2014 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.hypertension.1,2) The prevalence of metabolic syndrome has been  increasing worldwide over the past few years.3) According to the  Korea National Health and Nutrition Examination Survey, the prevalence of metabolic syndrome in Korea was 24.1% in 2005.",Non-OADS,/arxiv_data1/oa_pdf/ac/70/kjfm-35-173.PMC4129244.pdf
Available from: http://knhanes.cdc.go.kr/knhanes/index.do.,OADS,/arxiv_data1/oa_pdf/ac/70/kjfm-35-173.PMC4129244.pdf
 http://dx.doi.org/10.4082/kjfm.2014.35.4.182 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/2f/6c/kjfm-35-182.PMC4129245.pdf
"The protective effect of appendicular fat against metabolic risk factors in non-MS was less characteristic in MS. Keywords:  Metabolic Syndrome; Body Fat Distribution; Android Fat; Appendicular Fat; Dual-Energy X-ray Absorptiometry  Received: August 31, 2012,  Accepted: June 16, 2014 *Corresponding Author: Jee Hye Han T el: +82-2-970-8515, Fax: +82-2-970-8370E-mail: hnjh66@daum.net Korean Journal of Family Medicine Copyright © 2014 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Obesity is increasing world-wide and the World Health  Organization has already declared obesity a global epidemic that constitutes a major health problem.",Non-OADS,/arxiv_data1/oa_pdf/2f/6c/kjfm-35-182.PMC4129245.pdf
 http://dx.doi.org/10.4082/kjfm.2014.35.4.190 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/4a/e3/kjfm-35-190.PMC4129246.pdf
"Keywords:  Food Labeling; Food Habits; Recommended Dietary Allowances Received: August 31, 2013,  Accepted: May 8, 2014 *Corresponding Author: Seung-Won Oh T el: +82-2-2112-5643, Fax: +82-2-2112-5794E-mail: sw.oh@snu.ac.kr Korean Journal of Family Medicine Copyright © 2014 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Nutrition labels provide the information on the main  nutrients and their quantities in food s. In general, nutrition  labels show the nutrient content of one serving of food and give a comparison with the daily recommended intake in a specific format.",Non-OADS,/arxiv_data1/oa_pdf/4a/e3/kjfm-35-190.PMC4129246.pdf
Available from: http://www.mfds.go.kr/nutrition.,Non-OADS,/arxiv_data1/oa_pdf/4a/e3/kjfm-35-190.PMC4129246.pdf
  http://dx.doi.org/10.4082/kjfm.2014.35.4.199 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/01/b1/kjfm-35-199.PMC4129247.pdf
"Keywords:  Drug Prescription; Perception; Medication Errors Received: August 24, 2012,  Accepted: April 14, 2014 *Corresponding Author: Mee Y oung Kim T el: +82-31-8086-2390, Fax: +82-31-8086-2709E-mail: doctorkmy@hallym.or.kr Korean Journal of Family Medicine Copyright © 2014 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.administration of psychiatric medications in response to changes  in patient symptoms and pain management in postoperative patients has shown to benefit from PRN prescriptions.",Non-OADS,/arxiv_data1/oa_pdf/01/b1/kjfm-35-199.PMC4129247.pdf
  http://dx.doi.org/10.4082/kjfm.2014.35.4.207 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/29/99/kjfm-35-207.PMC4129248.pdf
"Keywords:  Childhood Socioeconomic Status; Metabolic Syndrome Received: August 30, 2012,  Accepted: June 16, 2014 *Corresponding Author: Jee-Y on Lee T el: +82-2-2228-2330, Fax: +82-2-362-2473E-mail: jeeyon14@yuhs.ac Korean Journal of Family Medicine Copyright © 2014 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Metabolic syndrome (MetS) is clinically defined as a  clustering of metabolic indicators, including abdominal obesity, elevated blood pressure, glucose intolerance, and dyslipidemia.",Non-OADS,/arxiv_data1/oa_pdf/29/99/kjfm-35-207.PMC4129248.pdf
"    Journal of Epidemiology and  Global Health    ISSN (Online): 2210 -6014  ISSN (Print): 2210 -6006   Journal Home Page:  https://www.atlantis -press.com/journals/jegh      Mammography use among women with and without diabetes:  Results from the Southern Community Cohort Study   Maureen Sanderson, Loren Lipworth, Xijing Han, Alicia Beeghly -Fadiel, David  Shen -Miller, Kushal Patel, William J. Blot, Margaret K. Hargreaves   To cite this article : Maureen Sanderson, Loren Lipworth, Xijing Han, Alicia Beeghly - Fadiel, David Shen -Miller, Kushal Patel, William J. Blot, Margaret K. Hargreaves  (2014 )  Mammography use among women with and without diabetes: Results from the  Southern Community Cohort Study , Journal of Epidemiology and Global Health  4:3, 223– 230, DOI: https://doi.org/10.1016/j.jegh.2014.03.001  To link to this article : https://doi.org/10.1016/j.jegh.2014.03.001    Published online: 23  April 2019",Non-OADS,/arxiv_data1/oa_pdf/db/f0/JEGH-4-3-223.PMC4129367.pdf
Although there was some 2210-6006/$ - see front matter ª2014http://dx.doi.org/10.1016/j.jegh.2014.03.001*Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/db/f0/JEGH-4-3-223.PMC4129367.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/f0/JEGH-4-3-223.PMC4129367.pdf
This is an open accessarticleundertheCCBY-NC-NDlicense( http://creativecommons.org/licenses/ by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/f0/JEGH-4-3-223.PMC4129367.pdf
"    Journal of Epidemiology and  Global Health    ISSN (Online): 2210 -6014  ISSN (Print): 2210 -6006   Journal Home Page:  https://www.atlantis -press.com/journals/jegh      Objective cardiac markers and cerebrovascular lesions in Indian  seniors   Stephanie H. Charles, Amanda C. Tow, Joe Verghes e  To cite this article : Stephanie H. Charles, Amanda C. Tow, Joe Verghes e (2014 ) Objective  cardiac markers and cerebrovascular lesions in Indian seniors , Journal of Epidemiology  and Global Health 4:3, 245– 247, DOI: https://doi.org/ 10.1016/j.jegh.2014.02.003  To link to this article : https://doi.org/ 10.1016/j.jegh.2014.02.003    Published online: 23  April 2019",Non-OADS,/arxiv_data1/oa_pdf/6e/dc/JEGH-4-3-245.PMC4129368.pdf
2210-6006/$ - see front matter ª2014http://dx.doi.org/10.1016/j.jegh.2014.02.003Abbreviations : MRI; magnetic resonance imaging; EKG; electrocardiogram; LVH; left ventricular hypertrophy *Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/6e/dc/JEGH-4-3-245.PMC4129368.pdf
This is an open accessarticleundertheCCBY-NC-NDlicense( http://creativecommons.org/licenses/ by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6e/dc/JEGH-4-3-245.PMC4129368.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/6e/dc/JEGH-4-3-245.PMC4129368.pdf
"2.2  Software The experiment was coded, presented, and analyzed in Python 2.7 (with an exception of compari - son of patient DF to control participants, which was analyzed using custom software developed by  Crawford et al., 2010, accessible at http://homepages.abdn.ac.uk/j.crawford/pages/dept/SingleCase   Methodology.htm) using psychopy_ext  extension (Kubilius, 2013a) for PsychoPy  (Peirce, 2009,  2009), pandas, and matplotlib .",OADS,/arxiv_data1/oa_pdf/70/7a/i-perception-4-493.PMC4129382.pdf
"Retrieved from https://github.com/qbilius /psychopy_ext   Kubilius, J.",Non-OADS,/arxiv_data1/oa_pdf/70/7a/i-perception-4-493.PMC4129382.pdf
"Retrieved September 23, 2013, from  http://dx.doi.org/10.6084/m9.figshare.106794   Kubilius, J., Wagemans, J., & Op de Beeck, H. P. (2011).",OADS,/arxiv_data1/oa_pdf/70/7a/i-perception-4-493.PMC4129382.pdf
"7Pseudoneglect:  “A mild asymmetry in spatial attention, displayed by neurologically normal individuals, in which  the left side of space tends to be favored, making leftward errors in line bisections as well as in the judgment of  brightness, numerosity, and size quite common.” (http://en.wiktionary.org/wiki/pseudoneglect)Figure 12.",Non-OADS,/arxiv_data1/oa_pdf/15/59/i-perception-4-532.PMC4129387.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6035 | DOI: 10.1038/srep06035 6",Non-OADS,/arxiv_data1/oa_pdf/50/3a/srep06035.PMC4129410.pdf
contributed to the interpretation of the results and reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b5/44/srep06034.PMC4129411.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cd/b1/srep06023.PMC4129412.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6023 | DOI: 10.1038/srep06023 7",Non-OADS,/arxiv_data1/oa_pdf/cd/b1/srep06023.PMC4129412.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/23/5c/srep06037.PMC4129415.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6037 | DOI: 10.1038/srep06037 6",Non-OADS,/arxiv_data1/oa_pdf/23/5c/srep06037.PMC4129415.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/05/ec/srep06024.PMC4129417.pdf
"http://csrc.nist.gov/groups/ST/toolkit/rng/documents/SP800-22rev1a.pdf, (2010) (Date of access:2/7/2014).",OADS,/arxiv_data1/oa_pdf/55/f4/srep06039.PMC4129418.pdf
"http://csrc.nist.gov/publications/fips/fips140-2/fips1402.pdf, (2001) (Date of access:2/7/2014).",OADS,/arxiv_data1/oa_pdf/55/f4/srep06039.PMC4129418.pdf
"http://stat.fsu.edu/pub/diehard/, (1995) (Date of access:2/7/2014).",OADS,/arxiv_data1/oa_pdf/55/f4/srep06039.PMC4129418.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/55/f4/srep06039.PMC4129418.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/68/9d/srep06026.PMC4129423.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/dc/da/srep06030.PMC4129424.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/29/41/srep06028.PMC4129425.pdf
"1995;121(5):577-82, http://dx.doi.org/10.1001/archotol.1995.",Non-OADS,/arxiv_data1/oa_pdf/a4/1a/cln-69-08-505.PMC4129551.pdf
"2002;128(10):1137-44, http://dx.doi.org/10.1001/archotol.128.10.",Non-OADS,/arxiv_data1/oa_pdf/a4/1a/cln-69-08-505.PMC4129551.pdf
"2007;236(10):2952-61, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a4/1a/cln-69-08-505.PMC4129551.pdf
"2008;3:367-97, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a4/1a/cln-69-08-505.PMC4129551.pdf
"2010;80(2):195–201, http://dx.doi.org/10.1016/j.mvr.2010.04.002.",OADS,/arxiv_data1/oa_pdf/a4/1a/cln-69-08-505.PMC4129551.pdf
"1999;34(7) 1164-8, http://dx.doi.org/10.1016/S0022-3468(99)90590-0.",Non-OADS,/arxiv_data1/oa_pdf/a4/1a/cln-69-08-505.PMC4129551.pdf
"2005;69 (1):75–80, http://dx.doi.org/10.1016/j.ijporl.2004.08.008.",OADS,/arxiv_data1/oa_pdf/a4/1a/cln-69-08-505.PMC4129551.pdf
"1995;30(9):1282–7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a4/1a/cln-69-08-505.PMC4129551.pdf
"2005;39(1):67-81, http://dx.doi.org/10.1177/153857440503900107.",Non-OADS,/arxiv_data1/oa_pdf/a4/1a/cln-69-08-505.PMC4129551.pdf
"1990;98(2):507, http://dx.doi.org/ 10.1378/chest.98.2.507.",Non-OADS,/arxiv_data1/oa_pdf/a4/1a/cln-69-08-505.PMC4129551.pdf
"2005;19(2):131-5, http://dx.doi.org/10.1007/BF03027392.",Non-OADS,/arxiv_data1/oa_pdf/a4/1a/cln-69-08-505.PMC4129551.pdf
"1999;25(8):631–8, http://dx.doi.org/10.1046/j.1524-4725.1999.98257.x.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2007;31(5):468–92, http://dx.doi.org/10.1007/s00266-006-0253-y.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"J Plast Reconstr Aesthet Surg 2009;62:77-84, http://dx.doi.org/10.1016/j.bjps.2007.10.052.",OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2007;5(3):175–80, http://dx.doi.org/10.1016/ S1479-666X(07)80045-X.",OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2006;32(8):1023-9; discussion 1029-30, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"J Cosmet Laser Ther 2010;12:227-34, http://dx.doi.org/10.3109/14764172.2010.514923.",OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2006;117:286–300, http://dx.doi.org/10.1097/01.prs.0000195073.73580.46.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2005;115(5):1312–4, http://dx.doi.org/ 10.1542/peds.2004-1085.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2001;15(5):427–9, http://dx.doi.org/10.1046/j.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2007;26(6):649–51, http://dx.doi.org/10.1016/j.healun.2007.",OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2006;33(1):47–50, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2005;71(5):345–7, http://dx.doi.org/10.4103/0378-6323.16787.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2001;27(1):89–90, http://dx.doi.org/10.1016/S0305-4179 (00)00074-7.",OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2001;202(1):78–9, http://dx.doi.org/10.1159/000051597.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2009;62(6):660-4, http://dx.doi.org/10.1097/SAP.0b013e31817e9d67.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2007;4(9):e234, http://dx.doi.org/10.1371/journal.pmed.0040234.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2003;29(4):299–302, http://dx.doi.org/10.1016/ S0305-4179(03)00067-6.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2005;19(6):363–81, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2011;19(2):274–85, http://dx.doi.org/10.1111/j.1524-475X.2011.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2011;19(3):368–78, http://dx.doi.org/10.1111/j.1524-475X.2011.00677.x.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2001;130(5):798–808, http://dx.doi.org/ 10.1067/msy.2001.116453.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2004;198(3):350–8, http://dx.doi.org/10.1002/jcp.10415.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2010;36(6):883-90, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2007;21(12):3250-61, http://dx.doi.org/10.1096/fj.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2011;226(5):1265-73, http://dx.doi.org/10.1002/ jcp.22454.50.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2002;110(2):560-7, http://dx.doi.org/10.1097/ 00006534-200208000-00031.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2007;31(2):183–7, http://dx.doi.org/10.1007/s00266-005-0122-0.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2009;35(8):1097–103, http://dx.doi.org/10.1016/j.burns.2009.06.",OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2003;11(3):235–6, http://dx.doi.org/10.1046/j.1524-475X.2003.11313.x.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2002;23(3):208-14, http://dx.doi.org/10.1097/00004630-200205000- 00010.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"1998;102(6):1962-72, http://dx.doi.org/10.1097/00006534-199811000-00023.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2001;27(3):205-14, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2003;24(6):411-7, http://dx.doi.org/10.1097/01.BCR.0000095516.98523.04.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2009;35(4):463–75, http://dx.doi.org/10.1016/ j.burns.2008.07.016.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"1993;19(1):17–21, http://dx.doi.org/10.1016/0305-4179(93)90095-P. 63.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2006;85(4): 383-413, http://dx.doi.org/10.1097/01.phm.0000202095.51037.a3.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2006;32(1):10-5, http://dx.doi.org/10.1016/j.burns.2004.06.018.",OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2005;13(3): 255-61, http://dx.doi.org/10.1111/j.1067-1927.2005.130307.x.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2010;36(7)975–83, http://dx.doi.org/ 10.1016/j.burns.2010.04.014.",OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2005;31(6):696-702, http://dx.doi.org/10.1016/ j.burns.2005.04.014.",OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2006;32(7):891–6, http://dx.doi.org/10.1111/j.1524-4725.2006.32192.x.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2008;34(11):1507-14, http://dx.doi.org/10.1111/j.1524-4725.2008.34314.x.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2005;13(4):242-7, http://dx.doi.org/10.1097/01.moo.0000170525.74264.f8.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"1999;104(5):1435-58, http://dx.doi.org/10.1097/00006534-199910000-00031.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2002;138(9):1149-55, http://dx.doi.org/ 10.1001/archderm.138.9.1149.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2008;7(3):137-45, http://dx.doi.org/10.1177/ 1534734608320786.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"1979;90(6):945-8, http://dx.doi.org/10.7326/0003-4819-90-6-945.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2001;27(1):23–7, http://dx.doi.org/10.1111/j.1524-4725.2001.99315.x.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"1994;130(5):577–83, http://dx.doi.org/ 10.1001/archderm.1994.01690050045006.85.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2010;64(3): 355-61, http://dx.doi.org/10.1097/SAP.0b013e3181afaab0.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2013;66(3):e92-3, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2006;32(6):663–8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2012;27(3):369-73, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/00/f4/cln-69-08-565.PMC4129552.pdf
"2007;147(7):478-91, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"1994;19(7):801-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"2007;106(3):591-614, http://dx.doi.org/10.1097/00000542-200703000-00024.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"2009;169(3):251-8, http://dx.doi.org/10.1001/archinternmed.2008.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"1979;4(5):441- 6, http://dx.doi.org/10.1097/00007632-197909000-00009.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"1981;6(6):598-605, http://dx.doi.org/10.1097/ 00007632-198111000-00011.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"1988;13(9):966-71, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"1995B20(8):907-12, http://dx.doi.org/10.1097/00007632- 199504150-00005.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"1996;77(3):290-300, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"1996;65(1):77-85, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"1998;23(17):1847-52, http://dx.doi.org/10.1097/00007632-199809010-00008.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"2003;3(3 Suppl):50S-59S, http://dx.doi.org/10.1016/ S1529-9430(02)00450-3.",OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"1983;8(3):286-93, http://dx.doi.org/10.1097/00007632-198304000-00009.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"1994B58(2):195-200, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"Curr Rev Pain 2000;4(5):337-44, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"1997;86(1):216-41, http://dx.doi.org/10.1097/ 00000542-199701000-00026.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"1988;13(1):61-4, http://dx.doi.org/10.1097/00007632-198801000-00015.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"1999;24(18):1937-42, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"2008;33(12):1291-7; discussion 1298, http://dx.doi.org/ 10.1097/BRS.0b013e31817329f0.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"2000;288(5472):1765-9, http://dx.doi.org/10.1126/science.288.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"1997;22(8):895-902, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"2001;26(13):1411-6; discussion 1417, http://dx.doi.org/10.1097/ 00007632-200107010-00003.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
"2005;51(1):18-33, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/86/29/cln-69-08-529.PMC4129553.pdf
Disponı ´vel em: https://www.nscisc.uab.edu/PublicDocuments/reports/pdf/2010% 20NSCISC%20Annual%20Statistical%2 0Report%20-%20Complete%20Public% 20 Version.pdf.,Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
Disponı ´vel em: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/ qiuf.def.,Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"2005;14(9):910-4, http://dx.doi.org/10.1007/s00586-005-0924-4.",Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"2008;33(19):2059-65, http://dx.doi.org/10.1097/BRS.0b013e31818018f6.",Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"2000;25(18):2294-302, http://dx.doi.org/10.1097/00007632- 200009150-00006.",Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"2013;21(2):87-91, http://dx.doi.org/10.1590/S1413- 78522013000200004.",Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"1995;12(1):1-21, http://dx.doi.org/10.1089/neu.1995.12.1.",Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"2007;11(1):6-15, http://dx.doi.org/10.1177/1089253206297409.",Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"1987;7(6):729-38, http://dx.doi.org/10.1038/jcbfm.",Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"2002;40(2):220-30, http://dx.doi.org/10.1067/ mem.2002.123697.14.",Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"2003;31(7):2041-51, http://dx.doi.org/10.1097/ 01.CCM.0000069731.18472.61.",Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"2012;37(25):E1551-9, http://dx.doi.org/10.1097/BRS.0b013e31826ff7f1.",Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"2005;2(3):308-18, http://dx.doi.org/10.3171/spi.2005.2.3.0308.",Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"2012;40(2):573-9, http://dx.doi.org/10.1097/CCM.0b013e318232d97e.",Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"1985;88(1):123-34, http://dx.doi.org/10.1016/0014-4886(85)90118-9.",Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"2000;17(4):321-32, http://dx.do i.org/10.1089/neu.2000.17.321.Hypothermia in spinal cord lesion Barbosa MO et al.CLINICS 2014;69(8):559-564 564",Non-OADS,/arxiv_data1/oa_pdf/10/36/cln-69-08-559.PMC4129554.pdf
"1994;190(4):362-71, http://dx.doi.org/10.1016/ S0344-0338(11)80408-5.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"1992;20(2):99-106, http://dx.doi.org/ 10.1111/j.1365-2559.1992.tb00938.x.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"1973;111(3):209-11, http://dx.doi.org/10.1002/path.1711110309.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2012; 19(2):183-6, http://dx.doi.org/10.1007/s12282-009-0147-3.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2010;6(1):86-8, http://dx.doi.org/10.4103/0973-1482.63559.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2010;5(5):331-4, http://dx.doi.org/10.1159/000321341.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2007;13(1):85-7, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
":B37-9, http://dx.doi.org/ 10.1111/j.1440-1673.2007.01818.x.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2006;7(4):345-6, http://dx.doi.org/10.3816/CBC.2006.n.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2006;15(1):135-6, http://dx.doi.org/10.1016/j.breast.2005.03.004.",OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2006;79(3):186- 8, http://dx.doi.org/10.1016/S0009-739X(06)70848-X.",OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2005;11(6):508-9, http://dx.doi.org/10.1111/j.1075-122X.2005.00144.x.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2005;89(2):145-7, http://dx.doi.org/10.1007/ s10549-004-1656-6.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2003;58(1):80-3, http://dx.doi.org/10.1053/ crad.2003.1133.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2003;9(3):246-8, http://dx.doi.org/10.1046/j.1524-4741.2003.09313.x.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2002;55(7):541-2, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2002;55(1):76-7, http://dx.doi.org/10.1136/jcp.55.1.76.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2002;41(1):30-4, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2002;55(12):951-4, http://dx.doi.org/10.1136/jcp.55.12.951.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2001;7(4):266-8, http://dx.doi.org/10.1046/j.1524- 4741.2001.20079.x.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2001;107(5):1216-20, http://dx.doi.org/10.1097/00006534- 200104150-00019.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2001;7(2):101- 5, http://dx.doi.org/10.1046/j.1524-4741.2001.007002101.x.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2001;8(3):243-5, http://dx.doi.org/10.1007/BF02967516.39.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2000;175(1):64-6, http://dx.doi.org/10.2214/ajr.175.1.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"1999;195(4):231-6, http://dx.doi.org/10.1016/S0344- 0338(99)80039-9.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"1997;31(4):365-9, http://dx.doi.org/10.3109/02844319709008985.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"1996;192(12):1187-94, http://dx.doi.org/10.1016/S0344-0338(96) 80149-X.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"2006;11(5):435-49, http://dx.doi.org/10.1634/ theoncologist.11-5-435.",Non-OADS,/arxiv_data1/oa_pdf/14/0f/cln-69-08-515.PMC4129555.pdf
"1986;20(2): 161-6, http://dx.doi.org/10.3109/14017438609106495.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"ASAIO J 1998;44(3):212-8, http://dx.doi.org/10.1097/ 00002480-199805000-00017.",OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"2003;22(3):215-9, http://dx.doi.org/10.1016/S0750-7658(03)00009-1.",OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"2003;97:1590-4, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"Anesthesiology 2010;113(2):470-81, http://dx.doi.org/10.1097/ALN.0b013e3181dcd88f.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"1995;74(9):707-13, http://dx.doi.org/ 10.3109/00016349509021179.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"2009;108(1):128-33, http://dx.doi.org/10.1213/ane.0b013e31818c95e1.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"2000;44 (10):1220-25, http://dx.doi.org/10.1034/j.1399-6576.2000.441006.x.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"2001;45 (6):720-8, http://dx.doi.org/10.1034/j.1399-6576.2001.045006720.x.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"2005;49(7):949-55, http://dx.doi.org/10.1111/j.1399-6576.2005.00743.x.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"1997;11(3):367-75, http://dx.doi.org/10.1016/S1053-0770(97)90107-5.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"2004;19(5):277-81, http://dx.doi.org/10.1191/0267659104pf753oa.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"2005;103(3):460-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"2007;107(1):24-32, http://dx.doi.org/10.1097/01.anes.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"2008;23(6):311-22, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"J Am Coll Cardiol 2002;39(12):1901-8, http://dx.doi.org/10.1016/S0735-1097 (02)01903-4.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"2001;13(3):167-74, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/99/91/cln-69-08-535.PMC4129556.pdf
"2005;19(suppl 4):S14-21, http://dx.doi.org/ 10.1097/01.aids.0000191485.92285.c7.",Non-OADS,/arxiv_data1/oa_pdf/98/8a/cln-69-08-574.PMC4129557.pdf
"2008;52(4):658-67, http://dx.doi.org/10.1590/ S0004-27302008000400012.",Non-OADS,/arxiv_data1/oa_pdf/98/8a/cln-69-08-574.PMC4129557.pdf
"2012;12(4):117-24, http://dx.doi.org/10.2147/HIV.S32321.",Non-OADS,/arxiv_data1/oa_pdf/98/8a/cln-69-08-574.PMC4129557.pdf
"2012;58(1):70-5, http://dx.doi.org/ 10.1016/S0104-4230(12)70157-4.",Non-OADS,/arxiv_data1/oa_pdf/98/8a/cln-69-08-574.PMC4129557.pdf
"2011;86(5):843-64, http://dx.doi.org/10.1590/S0365-05962011000500001.",Non-OADS,/arxiv_data1/oa_pdf/98/8a/cln-69-08-574.PMC4129557.pdf
"2011;25(9):800-13, http://dx.doi.org/10.1177/0269215511399476.",Non-OADS,/arxiv_data1/oa_pdf/98/8a/cln-69-08-574.PMC4129557.pdf
"2006;39(5): 366-80, http://dx.doi.org/10.1016/j.jcomdis.2006.06.011.21.",OADS,/arxiv_data1/oa_pdf/98/8a/cln-69-08-574.PMC4129557.pdf
"2006;39(5):381-90, http://dx.doi.org/10.1016/j.jcomdis.2006.06.014.",OADS,/arxiv_data1/oa_pdf/98/8a/cln-69-08-574.PMC4129557.pdf
"2009;17:187-93, http://dx.doi.org/10.1097/MOO.0b013e32832b312a.",Non-OADS,/arxiv_data1/oa_pdf/98/8a/cln-69-08-574.PMC4129557.pdf
"2009;87(11):2399-2405, http://dx.doi.org/10.1002/jnr.",Non-OADS,/arxiv_data1/oa_pdf/98/8a/cln-69-08-574.PMC4129557.pdf
"2007;22(3):251-65, http://dx.doi.org/10.1007/ s00455-006-9074-z.",Non-OADS,/arxiv_data1/oa_pdf/98/8a/cln-69-08-574.PMC4129557.pdf
"&ETHICS The study was approved by the Hospital de Clı ´nicas de Porto Alegre Research Ethics Committee (Institutional Review Board-equivalent) and registered at clinicaltrials.gov (Efficacy Study of Two Formulations of Erythropoietin/ NCT01184495, http://clinicaltrials.gov/ct2/show/NCT01184495?",Non-OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"2012;34(3):272-7, http://dx.doi.org/10.5935/0101-2800.",Non-OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"2007;297(15):1667-74, http://dx.doi.org/10.1001/jama.",Non-OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"2009;169(12):1104-12, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm126488.,Non-OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"2008(110):S12-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"2010;56(2):209-13, http://dx.doi.org/10.1590/ S0104-42302010000200021.",Non-OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"2003;64(4):1514-21, http://dx.doi.org/10.1046/j.1523-1755.",Non-OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"2003;41(1):111-24, http://dx.doi.org/10.1053/ajkd.2003.50030.",Non-OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"2005; 68(3):1337-43, http://dx.doi.org/10.1111/j.1523-1755.2005.00532.x.",Non-OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"2007;22(8):2129-32, http://dx.doi.org/10.1093/ndt/gfm384.",Non-OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"1998;32(5 Suppl 3):S112-9, http://dx.doi.org/10.1053/ajkd.1998.v32.pm9820470.",Non-OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"2012;55(3):849-55, http://dx.doi.org/10.1016/j.jvs.2011.07.095.",OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"2011;54(4):1095-9, http://dx.doi.org/10.1016/j.jvs.2011.04.023.",OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"1997;26(6):1009-19, http://dx.doi.org/10.1016/ S0741-5214(97)70014-4.33.",Non-OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"2000;58(3):1325-35, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/35/6f/cln-69-08-547.PMC4129558.pdf
"2000;57(5):754-55, http://dx.doi.org/10.1001/archneur.57.5.",Non-OADS,/arxiv_data1/oa_pdf/5c/c3/cln-69-08-524.PMC4129559.pdf
"2007;87(8):986-94, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5c/c3/cln-69-08-524.PMC4129559.pdf
"2008;36(9):1742-9, http://dx.doi.org/10.1177/0363546508318193.8.",Non-OADS,/arxiv_data1/oa_pdf/5c/c3/cln-69-08-524.PMC4129559.pdf
"2008;46(12):1263-70, http://dx.doi.org/ 10.1007/s11517-008-0409-9.",Non-OADS,/arxiv_data1/oa_pdf/5c/c3/cln-69-08-524.PMC4129559.pdf
"2007;21(4):299-314, http://dx.doi.org/10.1177/ 0269215507077294.",Non-OADS,/arxiv_data1/oa_pdf/5c/c3/cln-69-08-524.PMC4129559.pdf
"1998;79(12):1540-4, http://dx.doi.org/10.1016/S0003-9993(98)90416-6.",Non-OADS,/arxiv_data1/oa_pdf/5c/c3/cln-69-08-524.PMC4129559.pdf
"1994;19(3):410-5, http://dx.doi.org/10.1016/0363- 5023(94)90054-X.",Non-OADS,/arxiv_data1/oa_pdf/5c/c3/cln-69-08-524.PMC4129559.pdf
"1994;75(11):1241-4, http://dx.doi.org/10.1016/0003-9993(94)90012-4.",Non-OADS,/arxiv_data1/oa_pdf/5c/c3/cln-69-08-524.PMC4129559.pdf
"2002;113(9):1429- 34, http://dx.doi.org/10.1016/S1388-2457(02)00201-8.",Non-OADS,/arxiv_data1/oa_pdf/5c/c3/cln-69-08-524.PMC4129559.pdf
"2001;24(8):1020-5, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/5c/c3/cln-69-08-524.PMC4129559.pdf
"2002;14(5):603-67, http://dx.doi.org/10.1097/00002281- 200209000-00022.",Non-OADS,/arxiv_data1/oa_pdf/5c/c3/cln-69-08-524.PMC4129559.pdf
"2009;27(1):119-25, http://dx.doi.org/10.1089/pho.2008.2211.",Non-OADS,/arxiv_data1/oa_pdf/5c/c3/cln-69-08-524.PMC4129559.pdf
"2007;50(25):2357-68, http://dx.doi.org/10.1016/j.jacc.2007.09.021.",OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2003;35(8):915-22, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2004;138(1):1-4, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2005;119(2):215-308, http://dx.doi.org/10.1016/j.ejogrb.2004.09.005.",OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2008;149(3):1399-406, http://dx.doi.org/10.1210/en.2007- 0572.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2003;57(1):186-94, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2007;293(1):R267-75, http://dx.doi.org/10.1152/ajpregu.00071.2007.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2001;98(20):11765-70, http://dx.doi.org/10.1073/ pnas.201394198.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2001;141(5):751-8, http://dx.doi.org/10.1067/mhj.2001.114371.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2012:96(3):411-21, http://dx.doi.org/10.1093/cvr/cvs281.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"1997;30(3 Pt 2):549-56, http://dx.doi.org/10.1161/01.HYP.30.3.549.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2007;189(5):457-64, http://dx.doi.org/10.1016/ j.aanat.2006.11.006.",OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2008;18(3):346-53, http://dx.doi.org/10.1111/j.1600-0838.2007.00684.x.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"1986;43:3-45, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2008;130(2):299-313, http://dx.doi.org/10.1007/s00418-008- 0451-6.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2005; 46(4):998-1003, http://dx.doi.org/10.1161/01.HYP.0000176238.90688.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"Maturitas, 2010;65(3):267-271, http://dx.doi.org/10.1016/j.maturitas.2009.11.007.",OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"1997;30(3):767-771, http://dx.doi.org/ 10.1161/01.HYP.30.3.767.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2001;104(12):1419-23, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2005;184(1):209-17, http://dx.doi.org/10.1677/ joe.1.05702.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"1998;102(1):176-83, http://dx.doi.org/10.1172/JCI2034.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"1993;53(9):689-96, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/34/d7/cln-69-08-554.PMC4129560.pdf
"2010;106(7):963-8, http://dx.doi.org/10.1016/j.amjcard.",OADS,/arxiv_data1/oa_pdf/a8/dc/cln-69-08-542.PMC4129561.pdf
"2008; 24(6):459-64, http://dx.doi.org/10.1002/dmrr.873.",Non-OADS,/arxiv_data1/oa_pdf/a8/dc/cln-69-08-542.PMC4129561.pdf
"2004;8(3):521-33, viii, http://dx.doi.org/10.1016/j.cld.2004.04.004.",OADS,/arxiv_data1/oa_pdf/a8/dc/cln-69-08-542.PMC4129561.pdf
"2013;58(8):2376-82, http://dx.doi.org/10.1007/s10620-013- 2658-1.",Non-OADS,/arxiv_data1/oa_pdf/a8/dc/cln-69-08-542.PMC4129561.pdf
"2013;23(8):792-8, http://dx.doi.org/10.1016/j.numecd.",OADS,/arxiv_data1/oa_pdf/a8/dc/cln-69-08-542.PMC4129561.pdf
"2013; 60(6):743-52, http://dx.doi.org/10.1507/endocrj.EJ12-0387.",Non-OADS,/arxiv_data1/oa_pdf/a8/dc/cln-69-08-542.PMC4129561.pdf
"2007;17(7):517-24, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/a8/dc/cln-69-08-542.PMC4129561.pdf
"2011;9:85, http://dx.doi.org/10.1186/ 1741-7015-9-85.13.",Non-OADS,/arxiv_data1/oa_pdf/a8/dc/cln-69-08-542.PMC4129561.pdf
"2008;53(12):3218-24, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a8/dc/cln-69-08-542.PMC4129561.pdf
"2011;25(9):3262-70, http://dx.doi.org/10.1096/fj.11-180935.",Non-OADS,/arxiv_data1/oa_pdf/a8/dc/cln-69-08-542.PMC4129561.pdf
"2006;80(1):97-108, http://dx.doi.org/10.1016/j.yexmp.2005.03.008.",OADS,/arxiv_data1/oa_pdf/a8/dc/cln-69-08-542.PMC4129561.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/3e/20/AJNS-9-58.PMC4129578.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/27/98/AJNS-9-62.PMC4129579.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/27/98/AJNS-9-62.PMC4129579.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/30/60/AJNS-9-68.PMC4129580.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/1c/03/AJNS-9-96.PMC4129585.pdf
Available from URL: http://clinicaltrials.gov/ ct2/show/study/NCT01245036.,Non-OADS,/arxiv_data1/oa_pdf/31/ce/LI-31-205.PMC4129588.pdf
Available from: http://apps.who.int/ iris/bitstream/10665/75938/1/9789241564502_eng.pdf.,OADS,/arxiv_data1/oa_pdf/21/57/LI-31-244.PMC4129596.pdf
"MBBS (with proven track record in the field of Allergy & Asthma and at least 5 years  experience in the field) Course Commencement  : Jan 2015  Last date for receipt of completed application  : 14th August 2014  Download application from :http://www.cmch -vellore.edu/DAA/main.html Email (for clarifications) : daacmc@gmail.comDepartment of Pulmonary Medicine,   CHRISTIAN MEDICAL COLLEGE (CMC), VELLORE, TN   (in collaboration with)   INTERNATIONAL ASTHMA SERVICES (IAS), COLORADO, USA   Announcement",Non-OADS,/arxiv_data1/oa_pdf/78/15/LI-31-289.PMC4129608.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/7d/f3/LI-31-314.PMC4129621.pdf
Available from: http://www.en.wikipedia.org/wiki/Tracheobronchial_ injury.,Non-OADS,/arxiv_data1/oa_pdf/7d/f3/LI-31-314.PMC4129621.pdf
Available from: http://en.wikipedia.org/wiki/Tracheobronchial_ injury.,Non-OADS,/arxiv_data1/oa_pdf/7d/f3/LI-31-314.PMC4129621.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/99/c8/LI-31-315.PMC4129622.pdf
Available from: http://www.en.wikipedia.org/wiki/Tracheobronchial_ injury.,Non-OADS,/arxiv_data1/oa_pdf/99/c8/LI-31-315.PMC4129622.pdf
Available from: http://en.wikipedia.org/wiki/Tracheobronchial_ injury.,Non-OADS,/arxiv_data1/oa_pdf/99/c8/LI-31-315.PMC4129622.pdf
"), Simon Fraser   University; 1991 http://www.sfu.ca/archaeology/graduate/theseslist/thesisduffyj.html.",Non-OADS,/arxiv_data1/oa_pdf/b3/77/JFDS-6-107.PMC4130012.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/8e/3b/JFDS-6-73.PMC4130020.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/8e/3b/JFDS-6-73.PMC4130020.pdf
Available from: http://www.cstl.nist.gov/biotech/strbase.,OADS,/arxiv_data1/oa_pdf/64/16/JFDS-6-81.PMC4130022.pdf
http://www.cstl.nist.gov/strbase [Last accessed on 2013 Dec 09].,OADS,/arxiv_data1/oa_pdf/64/16/JFDS-6-81.PMC4130022.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/60/bb/JFDS-6-86.PMC4130023.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Reversal phase for coupling J-M Delaisse 8 AUGUST 2014 |www.nature.com/bonekey",Non-OADS,/arxiv_data1/oa_pdf/8d/fc/bonekey201456.PMC4130129.pdf
Thalhamer@sbg.ac.at Submitted: 10/15/2013Revised: 10/31/2013Accepted: 11/13/2013http://dx.doi.org/10.4161/hv.27183,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Ann Med 2011;  43:356 -65; PMID:21651440 ; http://dx.doi.org/10.3 109/07853890.2011.565065 2.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Curr Opin Immunol 2002; 14:172 -7; PMID:11869888 ;  http://dx.doi.org/10.1016/S0952 -7915(02)00317 -5 3.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Lancet Neurol 2004; 3:484 - 92; PMID :15261609 ; http://dx.doi.org/10.1016/ S1474 -4422(04)00825 -7 4.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
PLoS One 2013; 8:e57606; PMID:23555563 ;  http://dx.doi.org/10.1371/journal.pone.0057606 5.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Nat Rev Genet 2008; 9:776 -88;  PMID :18781156 ; http://dx.doi.org/10.1038/ nrg2432 7.,OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Semin Immunol  2013 ; 25:152 -9; PMID:23735226 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Expert Rev Vaccines 2009; 8:1251 - 76; PMID:19722897 ; http://dx.doi.org/10.1586/ erv.09.77 9.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Clin Infect Dis  2011; 53:296 -302; PMID:21765081 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Lancet Infect Dis 2011; 11:916 -24; PMID:21975270 ;  http://dx.doi.org/10.1016/S1473 -3099(11)70240 -7 11.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
J Infect Dis 2013; 208:418 -22; PMID:23633407 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Curr  Opin Immunol 2009; 21:346 -51; PMID:19500964 ;  http://dx.doi.org/10.1016/j.coi.2009.05.016 13.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Curr Opin Allergy Clin Immunol 2010; 10:567 -74; PMID:20856111 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Vaccine 2012; 31:96 -108;  PMID:23142307 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
BMC Pulm  Med 2009; 9:24; PMID:19454036 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
"J Allergy Clin Immunol 2013;  131:1288 -96, e3; PMID:23498595 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
J Allergy Clin Immunol 2006; 118:481 -8;  PMID:16890775 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
J Intern Med 2012; 272:144 -57; PMID:22640224 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Clin Vaccine Immunol 2010; 17:1055 - 65; PMID:20463105 ; http://dx.doi.org/10.1128/ CVI.00131 -10 22.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Drug Discov Today 2008; 13:596 - 600;  PMID:18598915 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
J Allergy Clin Immunol 2006; 118:734 -41; PMID:16950295 ;  http://dx.doi.org/10.1016/j.jaci.2006.04.048 24.,OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Immunol Lett 2013; 151:23 - 30; PMID:23396105 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
"J Allergy Clin Immunol 2009; 124:1070 -7,  e1-11; PMID:19665781 ; http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Cell Mol Life Sci 2012; 69:1635 - 40; PMID:22481438 ; http://dx.doi.org/10.1007/ s00018 -012-0972 -y 27.,OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
BMC Immunol 2013; 14:14;  PMID:23521868 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
J Exp Med 2004; 199:1567 - 75; PMID:15173208 ; http://dx.doi.org/10.1084/ jem.20032058 29.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Clin Exp Allergy 2005;  35:1535 -41; PMID:16393318 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Immunology  2004; 112:352 -63; PMID :15196202 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Curr Opin Allergy  Clin Immunol 2013; 13:70 -7; PMID:23103806 ;  http://dx.doi.org/10.1097/ACI.0b013e32835ad0d2 33.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Hum Vaccin Immunother 2013; 9: 1019 - 31; PMID:23324570 ; http://dx.doi.org/10.4161/ hv.23518 34.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Vaccine 2013; Forthcoming; PMID:23954383 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
J Allergy Clin Immunol  2006; 118:269 -76; PMID:16815165 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
2012: http://clinicaltrials.gov/show/NCT01707069 .,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
Allergy  2006; 61:828 -35; PMID:16792580 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
J Exp Med 2007; 204:273 -83; PMID:17283209 ;  http://dx.doi.org/10.1084/jem.20062175 41.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
J Exp Med 2009;  206:1755 -67; PMID:19635862 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
J Allergy Clin Immunol 2007; 120:707 - 13; PMID:17681368 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
J Allergy Clin Immunol  2009; 123:911 -6; PMID:19348926 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
J Allergy Clin Immunol 1999; 103:1173 - 9; PMID:10359902 ; http://dx.doi.org/10.1016/ S0091 -6749(99)70195 -8 45.,Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
"J Allergy Clin Immunol 2012; 130:894 -901, e5;  PMID:22841010 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/59/59/hvi-10-703.PMC4130253.pdf
"Post-vaccination shedding of Rotarix® and  *Correspondence to: Michael D Bowen; Email: mkb6@cdc.gov Submitted: 09/27/2013; Revised: 11/22/2013; Accepted: 12/02/2013http://dx.doi.org/10.4161/hv.27388Real-time RT-PCR assays to differentiate   wild-type group A rotavirus strains from Rotarix®  and RotaTeq® vaccine strains in stool samples Rashi Gautam1, Mathew D e sona1, slavica Mijatovic-Rustempasic1, Ka Ian Tam1, Jon R Gentsch1, and Michael D Bowen1,* 1Gastroenteritis and Respiratory Viruses Laboratory Branch; Division of Viral Diseases; National c enter for Immunization and Respiratory Diseases; c enters for Disease control  and Prevention; a tlanta, G a Usa Keywords:  rotavirus vaccine, acute gastroenteritis, Rotarix®, RotaTeq®, qRT-PCR Abbreviations:  RVA-, group A rotaviruses; WHO, World Health Organization; AGE, acute gastroenteritis; qRT-PCR, quantitative  real-time RT-PCR Group a rotaviruses (RV a) are the leading cause of severe diarrhea in young children worldwide.",Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
"The primer and probe sequences were checked for specificity using NCBI-Nucleotide blast [nblast] (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and were checked for self-annealing sites, hairpin loop formation and 3 ′ complementarity using the IDT oligonucle - otide calculator (http://www.idtdna.com/analyzer/Applications/OligoAnalyzer/).",OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Pediatr Infect Dis J 2011; 30(Suppl):S48-53; PMID:21183840 ; http://dx.doi.org/10.1097/ INF.0b013e3181fefd903.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Indian J Med Microbiol  2006; 24:252-7;  PMID:17185842 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
J Infect Dis 2005; 192(Suppl 1):S146-59;  PMID:16088798 ; http://dx.doi.org/10.1086/431499 5.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Lancet 2007; 370:1757-63; PMID:18037080 ; http://dx.doi.org/10.1016/ S0140-6736(07)61744-96.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
N Engl J Med 2006; 354:23- 33; PMID:16394299 ; http://dx.doi.org/10.1056/ NEJMoa052664 7.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Pediatr Infect Dis J 2011; 30(Suppl):S1-5; PMID:21183833 ; http://dx.doi.org/10.1097/ INF.0b013e3181fefa1f 8.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
J Pediatr (Rio J)  2007; 83:193-5;  PMID:17551651 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Clin  Microbiol Rev 2008; 21:198-208;  PMID:18202442 ;  http://dx.doi.org/10.1128/CMR.00029-07 10.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Vaccine  2009; 27(Suppl 6):G72-81;  PMID:20006144 ;  http://dx.doi.org/10.1016/j.vaccine.2009.09.107 11.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Virology 2010; 403:111-27;  PMID:20451234 ;  http://dx.doi.org/10.1016/j.virol.2010.04.004 12.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Vaccine 2011; 29:4151-5; PMID:21477676 ;  http://dx.doi.org/10.1016/j.vaccine.2011.03.074 13.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Lancet Infect Dis 2008; 8:642- 9; PMID:18922486 ; http://dx.doi.org/10.1016/ S1473-3099(08)70231-7 14.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
N Engl J Med 2010; 362:314-9; PMID:20107217 ;  http://dx.doi.org/10.1056/NEJMoa0904485 15.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Pediatrics 2010; 125:e438-41; PMID:20100758 ; http://dx.doi.org/10.1542/ peds.2009-1901 16.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
J Infect Dis 2012; 206:1275-9;  PMID:22872730 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Pediatr Infect Dis J  2012; 31:992-4;  PMID:22581224 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Clin Infect Dis 2011; 53:245-53;  PMID:21705316 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
J Infect Dis 2012; 206:377-83;  PMID :22615314 ; http://dx.doi.org/10.1093/infdis/ jis36121.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
J Allergy Clin Immunol  2010; 125:270-1;  PMID:20109754 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Vaccine  2010; 28:6609-12;  PMID:20674876 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
J Allergy Clin Immunol 2009; 124:600; PMID:19660805 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Infect Genet Evol 2012; 12:1282-94;  PMID:22487061 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
J Virol Methods  2013; 194:197-205;  PMID:24012969 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Clin Immunol 2012; 142:399-401;  PMID:22244360 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
J Virol Methods  2006; 131:193-201;  PMID:16214228 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
J  Clin Microbiol 2009; 47:2704-12; PMID:19553575 ;  http://dx.doi.org/10.1128/JCM.00378-09 29.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Mem Inst Oswaldo Cruz 2010; 105:1068-72; PMID:21225209 ; http://dx.doi.org/10.1590/ S0074-02762010000800021 30.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Vaccine 2011; 29:8141- 6; PMID:21856359 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
J Med Virol 2008; 80:1489- 96; PMID:18551614 ; http://dx.doi.org/10.1002/ jmv.2122833.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
J Clin Microbiol 2001; 39:3796-8;  PMID :11574622 ; http://dx.doi.org/10.1128/ JCM.39.10.3796-3798.2001 36.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
J Virol 2006; 80:3801-10;  PMID:16571797 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Emerg Infect Dis  2009; 15:83-6 ;  PMID:19116059 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Infect Genet Evol  2011; 11:522-7;  PMID:21130184 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Sequencing 2012; 2012; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
Nucleic Acids Res 1988; 16:10881-90; PMID:2849754 ; http://dx.doi.org/10.1093/ nar/16.22.10881 42.,OADS,/arxiv_data1/oa_pdf/1e/ed/hvi-10-767.PMC4130254.pdf
"3-6 Haemophilus influenzae  type  b conjugated with tetanus toxoid (Hib) became licensed in December 2008, and 7-valent pneumococcal conjugated with recombinant diphtheria toxoid (PCV7) vaccines  in February  *Corresponding author: Tetsuo Nakayama; Email: tetsuo-n@lisci.kitasato-u.ac.jp Submitted: 07/22/2013; Revised: 11/08/2013; Accepted: 11/19/2013http://dx.doi.org/10.4161/hv.27264Production of inflammatory cytokines in  response to diphtheria-pertussis-tetanus (DPT),  haemophilus influenzae  type b (Hib), and 7-valent  pneumococcal (PCV7) vaccines Yasuyo Kashiwagi1,2, akiko Miyata3, Takuji Kumagai4, Kouji Maehara5, eitarou s uzuki6, Takao Nagai7, Takao Ozaki8,  Naoko Nishimura8, Kenji Okada9, hisashi Kawashima2, and Tetsuo Nakayama1 1Laboratory of Viral Infection I; Kitasato Institute for Life s ciences; Tokyo, Japan; 2Department of Pediatrics; Tokyo Medical University; Tokyo, Japan; 3Miyata Pediatric c linic;  Tachikawa; Tokyo, Japan; 4Kumagai Pediatric c linic; s apporo, Japan; 5Maehara Pediatric c linic; Tama, Tokyo, Japan; 6suzuki Pediatric c linic; Ube, Yamaguchi Prefecture, Japan;  7Nagai Pediatric c linic; Takamatsu, Kagawa Prefecture, Japan; 8Department of Pediatrics; Konan Kosei h ospital; Konan; a ichi Prefecture, Japan; 9Department of Pediatrics;  National Fukuoka h ospital; Fukuoka, Japan Keywords: innate immunity, cytokine, peripheral blood mononuclear cells, PBMCs, Haemophilus influenzae  type b T-conjugated  vaccine, Hib, 7-valent pneumococcal conjugated vaccine, PCV7, Diphtheria and tetanus toxoids combined with acellular pertussis  vaccine, DPT Abbreviations:  ASC, apoptosis-associated speck-like protein; BCG, Bacille de Calmette et Guérin; CTL, cytotoxic T lymphocytes;  DPT, diphtheria and tetanus toxoids combined with acellular pertussis vaccine; G-CSF, granulocyte-colony stimulating factor; Hib,  Haemophilus influenzae  type b vaccine; IFN, interferon; IL, interleukin; IPV, inactivated polio vaccine; JEV, Japanese encephalitis  vaccine; LPS, lipo-polysaccharides; MIP-1, macrophage inflammatory protein-1; MMR, measles mumps and rubella combined  vaccine; MR, measles and rubella combined vaccine; NF-kB, nuclear factor kappa B; NLRP-3, NOD-like-receptor-family member  (NLRP)-3; PBMCs, peripheral blood mononuclear cells; PCV7, 7-valent pneumococcal vaccine; PGE2, prostaglandin E2; PMNs,  polymorph nuclear neutrophils; RIG-I, retinoic acid inducible gene-based-like receptors; ROX, reactive oxygen species; TLRs, Toll- like receptors; TNF- α, tissue necrotic factor- α Haemophilus influenzae  type b ( hib) and 7-valent pneumococcal (P cV7) vaccines both became recommended in  Japan in 2010.",Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Lancet  1995; 346:701-2;  PMID:7658837 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
BMC Int Health Hum Rights 2009 ;  9(Suppl 1 ):S2; PMID:19828060 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Clin  Microbiol Rev 2001 ; 14:872-908; PMID :11585789 ;  http://dx.doi.org/10.1128/CMR.14.4.872-908.2001 6.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Clin Vaccine  Immunol  2009 ; 16:1709 -19; PMID:19793898 ;  http://dx.doi.org/10.1128/CVI.00290-09 7.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Eur J Pediatr  2002 ; 161(Suppl 2 ):S127 -31; PMID:12494258 ;  http://dx.doi.org/10.1007/s00431-002-1064-z 8.,OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Vaccine  2008 ; 26:3142 - 52; PMID:18502545 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
"J Pediatr  2007 ; 151:43-9,  e1-2; PMID:17586189 ; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Pediatr Res  2009 ;  65:98R-105R ; PMID :19918215 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Immunity  2010 ; 33:464-78;   PMID:21029958 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Nature  2011 ; 470:543- 7; PMID:21350488 ; http://dx.doi.org/10.1038/ nature09737 14.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Cell 2006 ;  124:783-801; PMID:16497588 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Expert Rev Vaccines  2010 ; 9:1315 -24; PMID:21087109 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Expert Rev Vaccines  2008 ; 7:1435 -45; PMID:18980544 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Cell  2010 ; 140:821-32; PMID:20303873 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Biomed J  2012 ;  35:437-49; PMID:23442356 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
J Exp Med 2008 ;  205:869-82; PMID:18362170 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Eur  J Immunol  2010 ; 40:638-42; PMID:20201020 ;  http://dx.doi.org/10.1002/eji.200940039 21.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Toxicol Lett  2011 ; 203:97-105;  PMID:21392560 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Vaccine  2012 ;  30:3885 -90; PMID:22507655 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Curr Opin Virol  2011 ; 1:226-32; PMID:22440781 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
J Reprod Immunol 2000 ; 47:87-103;  PMID:10924744 ; http://dx.doi.org/10.1016/ S0165-0378(00)00060-7 26.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Neonatology   2010 ; 97:266-73; PMID:19955831 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
PLoS One  2011 ; 6:e18185 ;  PMID:21533209 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
J Leukoc Biol  2006 ; 80:267-77; PMID:16731773 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Immunity  2010 ;  33:492-503; PMID:21029960 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Viral Immunol  2011 ; 24:179-87; PMID:21668359 ;  http://dx.doi.org/10.1089/vim.2010.012532.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Vaccine  1993 ;  11:293-306; PMID :8447157 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Expert Opin Drug Metab Toxicol  2007 ; 3:209-34; PMID:17428152 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Med Microbiol Immunol  2008 ; 197:369-79;  PMID:18283493 ; http://dx.doi.org/10.1007/ s00430-008-0081-6 35.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
ScientificWorldJournal   2010 ; 10:490-503; PMID:20305990 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Immunology   2008 ; 125:281-8; PMID:19128361 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Vaccine  2011 ; 29:1812 -23; PMID:21215831 ;  http://dx.doi.org/10.1016/j.vaccine.2010.12.090 39.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Blood  2010 ; 116:5191- 9; PMID:20876456 ; http://dx.doi.org/10.1182/ blood-2010-03-27552940.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
J Neuroinflammation  2012 ; 9:102;  http://dx.doi.org/10.1186/1742-2094-9-102 ;  PMID:22642771 41.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Immunity   2011 ; 34:514-26; PMID:21497116 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
PLoS Pathog   2011 ; 7:e1002344 ; PMID:22241978 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
Immunol Rev  2011 ;  239:197-208; PMID:21198673 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0f/47/hvi-10-677.PMC4130255.pdf
"11 Oral transmission of LA-1 to a marmoset *Correspondence to: Zhi-Yi Xu; Email: xuzhiyi@shmu.edu.cn Submitted: 06/27/2013; Revised: 10/30/2013; Accepted: 11/08/2013http://dx.doi.org/10.4161/hv.27124Live attenuated hepatitis A vaccines developed   in China Zhi-Yi Xu1,2 and Xuan-Yi w ang1,3 1institutes of Biomedical Sciences; Shanghai Medical College; Fudan University; Shanghai, PR China; 2Department of e pidemiology; School of Public Health, Shanghai Medical  College; Fudan University; Shanghai, PR China; 3Key Laboratory of Medical Molecular v irology Mo e/MoH; Shanghai Medical College; Fudan University; Shanghai, PR China  Keywords:  hepatitis A, live attenuated, vaccine, immunization, China Two live, attenuated hepatitis A vaccines, H2 and LA-1 virus  strains, were developed through serial passages of the viruses  in cell cultures at 32 °C and 35 °C respectively.",Non-OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
Int J Epidemiol  2005 ; 34:600-9; PMID :15831565 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
Lancet  2006 ; 367:546-8;  PMID:16488780 ; http://dx.doi.org/10.1016/ S0140-6736(06)68196-8,Non-OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
Vaccine  1992 ; 10(Suppl 1 ):S99-101; PMID:1335671 ;  http://dx.doi.org/10.1016/0264-410X(92)90557-Z 7.,Non-OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
J Hepatol 1993 ;  18(Suppl 2 ):S20-6; PMID:8182268 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
Infection   1996 ; 24:447-58; PMID:9007593 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
"Glück R, Mischler  R, Brantschen  S, Just M, Althaus   B, Cryz  SJ Jr. Immunopotentiating reconstituted  influenza virus virosome vaccine delivery system for immunization against hepatitis A.  J Clin Invest  1992 ; 90:2491 -5; PMID:1334977 ; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
J Infect Dis  1989 ; 159:621-4; PMID:2538518 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
J Infect Dis  1988 ; 157:338-45; PMID:2826614 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
J Med Virol 1991 ; 34:227- 31; PMID:1658214 ; http://dx.doi.org/10.1002/ jmv.189034040621.,Non-OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
Vaccine  1997 ; 15:944-7; PMID:9261939 ;  http://dx.doi.org/10.1016/S0264-410X(96)00304-0 25.,Non-OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
J Med Virol 1993 ; 41:61- 4; PMID:8228940 ; http://dx.doi.org/10.1002/ jmv.1890410113 29.,Non-OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
Vaccine  2007 ; 25:446- 9; PMID:16949710 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
Vaccine  2008 ; 26:2297 -301; PMID:18395305 ;  http://dx.doi.org/10.1016/j.vaccine.2007.11.008 32.,Non-OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
J  Hepatol  1993 ; 18(Suppl 2 ):S51-5; PMID:8182275 ;  http://dx.doi.org/10.1016/S0168-8278(05)80379-4 34.,Non-OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
JAMA   1994 ; 271:1328 -34; PMID:8158817 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
N Engl J Med  1992 ; 327:453-7; PMID:1320740 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
J Viral Hepat 2008 ;  15(Suppl 2 ):33-7; PMID:18837831 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
J Viral Hepat 2010 ;  17:293-7; PMID:19691457 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/ae/hvi-10-659.PMC4130259.pdf
"Nigeria is one of the 10 countries with the greatest number of pneumococcal deaths in HIV-negative children aged less than 5 years, with a pneumococcal mortality rate in this age group of 300 to 500 per 100  000 children.1 In young children, 10 to 15 pneumococcal serotypes account  for at least 80% of invasive pneumococcal disease (IPD), with variations in the distribution of specific serotypes among global  *Correspondence to: Olumuyiwa O Odusanya; Email: oolumuyiwa@yahoo.com Submitted: 10/02/2013; Revised: 11/08/2013; Accepted: 11/20/2013http://dx.doi.org/10.4161/hv.27276Safety and immunogenicity of 10-valent  pneumococcal nontypeable Haemophilus  influenzae  protein D conjugate vaccine (PHiD-CV)  in Nigerian children Booster dose and 2-dose catch-up regimens in the second  year of life Olumuyiwa O Odusanya1,*, Yetunde a Kuyinu1, Omolara a Kehinde2, Fakrudeen  shafi3, Nancy François4, Juan Pablo Yarzabal4,  Kurt Dobbelaere4, Jens U Rüggeberg4, Dorota Borys4, and Lode s chuerman4 1Department of c ommunity h ealth and Primary h ealth c are; Lagos s tate University c ollege of Medicine; Ikeja, Lagos, Nigeria; 2Department of Paediatrics and c hild h ealth;  Lagos s tate University c ollege of Medicine Ikeja; Ikeja, Lagos, Nigeria; 3Glaxos mithKline Pharmaceuticals; Bangalore, India; 4Glaxos mithKline Vaccines; Wavre, Belgium Keywords:  PHiD-CV, pneumococcal conjugate vaccine, safety, reactogenicity, immunogenicity, Nigeria, booster, catch-up Abbreviations:  AE, adverse event; ATP, according-to-protocol; CI, confidence interval; DTPa, diphtheria-tetanus-acellular  pertussis; DTPw-HBV/Hib, diphtheria-tetanus-whole-cell pertussis-hepatitis B/ Haemophilus influenzae  type b; 22F-ELISA,  22F-inhibition enzyme-linked immunosorbent assay; EPI, Expanded Program on Immunization; GAVI, Global Alliance for  Vaccines and Immunization; GCP, Good clinical practices; GMC, geometric mean antibody concentration; GMT, geometric  mean titer; IPD, invasive pneumococcal disease; NAFDAC, National Agency for Food and Drug Administration and Control;  NTHi, nontypeable Haemophilus influenzae ; OPA, opsonophagocytic activity; PCV, pneumococcal conjugate vaccine; PHiD-CV,  10-valent pneumococcal nontypeable Haemophilus influenzae  protein D conjugate vaccine; SAE, serious adverse event; SAS,  Statistical Analysis System; WHO, World Health Organization  In a previous study, 3-dose primary vaccination of Nigerian infants with the 10-valent pneumococcal nontypeable  Haemophilus influenzae  protein D conjugate vaccine (P hiD-cV) was immunogenic for vaccine pneumococcal serotypes,  with comparable tolerability between P hiD-cV and control groups.",Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Immune responses in our study in terms of antibody GMCs  and OPA GMTs in the PHiD-CV booster group were in line with or higher than those observed in a Latin American study population (manuscript submitted and results publicly available via ClinicalTrial.gov: http://clinicaltrials.gov/ct2/show/results/Table 2.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Lancet 2009; 374:893-902;  PMID:19748398 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
PLoS Med  2010 ; 7:7; PMID:20957191 ;  http://dx.doi.org/10.1371/journal.pmed.1000348 3.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Available  from: http://www.gavialliance.org/funding/ pneumococcal-amc/about/ .,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Available  from: http://www.gavialliance.org/results/ countries-approved-for-support/ .,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Clin Infect Dis 2009 ;  48(Suppl 2 ):S190 -6; PMID:19191615 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
PLoS One  2012 ; 7:e30548 ;  PMID:22291984 ; http://dx.doi.org/10.1371/ journal.pone.0030548 8.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Pediatr Infect Dis J 2011 ; 30:227-33;  PMID:20861756 ; http://dx.doi.org/10.1097/ INF.0b013e3181f87802 9.,OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
BMC Public Health  2011 ; 11:882; PMID:22112189 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Clin Infect Dis 2008 ; 46:726-31;  PMID:18230042 ; http://dx.doi.org/10.1086/52739612.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Expert Rev Vaccines 2009 ;  8:1479 -500; PMID:19863240 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Hum Vaccin  2011 ; 7:511-22; PMID:21441782 ;  http://dx.doi.org/10.4161/hv.7.5.14634 14.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Pediatr Infect Dis J 2011 ; 30:e130 - 41; PMID:21540760 ; http://dx.doi.org/10.1097/ INF.0b013e31821d1790 16.,OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Vaccine  2013 ; 31:2080 - 8; PMID:23391599 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Lancet   2009 ; 374:1339 -50; PMID:19837254 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Pediatr  Infect Dis J 2011 ; 30:69-72; PMID:20980933 ;  http://dx.doi.org/10.1097/INF.0b013e3181f2da06 22.,OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Expert Rev Vaccines 2011 ; 10:951- 80; PMID:21806394 ; http://dx.doi.org/10.1586/ erv.11.76 23.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Hum Vaccin Immunother 2012 ;  8:612-22; PMID:22634448 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Clin Vaccine  Immunol  2006 ; 13:356-60; PMID:16522777 ;  http://dx.doi.org/10.1128/CVI.13.3.356-360.2006 26.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Clin Vaccine Immunol  2010 ; 17:134-42; PMID:19889940 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
Vaccine   2007 ; 25:2518 -27; PMID:17034907 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/eb/hvi-10-757.PMC4130271.pdf
"11,12 As a result, investigators have turned to  RSV subunit vaccines adjuvanted with new immunostimulants  *Correspondence to: Paul E Makidon; Email: pmakidon@umich.edu Submitted: 09/20/2013; Revised: 11/22/2013; Accepted: 12/01/2013http://dx.doi.org/10.4161/hv.27383Intranasal immunization with W805EC adjuvanted  recombinant RSV rF-ptn enhances clearance of  respiratory syncytial virus in a mouse model cr ystal Passmore1,†, Paul  e Makidon1,2,†,*, Jessica J O’Konek1, Joseph  a Zahn3, Jessie Pannu4, Tarek  h amouda4, Vira Bitko4,  a ndrzej Myc1,5, Nicolas W Lukacs6, al i Fattom4, and James R Baker Jr1 1Michigan Nanotechnology Institute for Medicine and Biological sc iences; University of Michigan Medical sc hool; an n ar bor, MI U s a; 2The Unit for Laboratory an imal  Medicine; Medical  sc hool; University of Michigan;  an n  ar bor, MI U s a; 3University of Michigan Medical sc hool; an n ar bor, MI U s a; 4 NanoBio co rporation; an n ar bor, MI U s a;  5Department of Immunology of Infectious Diseases; Ludwik hi rszfeld Institute of Immunology and ex perimental Therapy; Polish ac ademy of sc iences; Wroclaw, Poland;  6Department of Pathology; University of Michigan; an n ar bor, MI U s a †Both authors contributed equally to the study.",Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
N Engl J Med 2009; 360:588-98; PMID:19196675 ;  http://dx.doi.org/10.1056/NEJMoa0804877 2.,OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Lancet 2010; 375:1545-55; PMID:20399493 ;  http://dx.doi.org/10.1016/S0140-6736(10)60206-1 3.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Pediatr Infect Dis J 2008; 27(Suppl):S63-70; PMID:18820581 ;  http://dx.doi.org/10.1097/INF.0b013e3181684d67 4.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Am J Respir Crit Care Med 2008; 178:1123-9;  PMID :18776151 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Semin Respir Crit Care Med 2007; 28:171-81;  PMID:17458771 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
J Clin Virol 2009; 46:129-33;  PMID:19665425 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
JAMA 2003; 289:179-86; PMID:12517228 ; http://dx.doi.org/10.1001/ jama.289.2.179 8.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
J Infect Dis 1997; 176:1428-36; PMID:9395351 ; http://dx.doi.org/10.1086/51413812.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Immun Ageing 2012; 9:21; PMID:23031690 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Viral Immunol 2007; 20:261-75;  PMID:17603843 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Pediatr Res 2011; 70:186-91; PMID:21522037 ; http://dx.doi.org/10.1203/ PDR.0b013e318220a553 17.,OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Vaccine 1997; 15:525-32; PMID:9160520 ; http://dx.doi.org/10.1016/ S0264-410X(97)00218-1 19.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Vaccine 2013; 31:524-32;  PMID :23153449 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Vaccine 2009; 27:5913-9; PMID:19651171 ;  http://dx.doi.org/10.1016/j.vaccine.2009.07.03822.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
PLoS One 2011; 6:e21823; PMID:21789184 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Clin Infect Dis 2012; 54:905-12; PMID:22238168 ; http://dx.doi.org/10.1093/ cid/cir955 26.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Expert Rev Vaccines 2011; 10:1415-33; PMID:21988307 ; http://dx.doi.org/10.1586/ erv.11.120 27.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Vaccine 1994; 12:731-5;  PMID:8091852 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
PLoS One 2008; 3:e2954; PMID:18698426 ;  http://dx.doi.org/10.1371/journal.pone.0002954 29.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Eur J Immunol 2012; 42:2073-86; PMID:22653620 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Vaccine 2003; 21:3801-14; PMID:12922114 ; http://dx.doi.org/10.1016/ S0264-410X(03)00381-5 31.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Science 2011; 332:47- 8; PMID:21454778 ; http://dx.doi.org/10.1126/ science.1205311 34.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Nat Immunol 2007; 8:369-77; PMID:17351619 ; http://dx.doi.org/10.1038/ni1449 35.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Am J Pathol 2011; 179:248-58; PMID:21703407 ;  http://dx.doi.org/10.1016/j.ajpath.2011.03.003 36.,OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Crit Rev Immunol 2010; 30:189-99;  PMID:20370629 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Vaccine 2012; 30:6871-7; PMID:22989689 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Vaccine 2012; 30:307-16;  PMID:22079079 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Clin Vaccine Immunol 2011; 18:1167-75;  PMID :21543588 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Hum Vaccin 2010; 6:585-94; PMID:20421727 ; http://dx.doi.org/10.4161/ hv.6.7.11818 44.,Non-OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
Am J Pathol 2001; 159:631-8; PMID:11485921 ; http://dx.doi.org/10.1016/ S0002-9440(10)61734-8,OADS,/arxiv_data1/oa_pdf/f1/e4/hvi-10-615.PMC4130273.pdf
"I was in charge of the quality control and evaluation of hepatitis vaccines and enterovirus vaccines such as hepatitis A vaccines, hepatitis B vaccines (HB vaccine), hepatitis E vaccines and a  Quality control and evaluation of vaccines in China Zhenglun Liang National Institutes for Food and Drug Control; Beijing, PR China Keywords:  hepatitis vaccine, enterovirus  71 vaccine, quality control and evaluation of vaccine Correspondence to: Zhenglun Liang;  Email: lzhenglun@126.com Submitted: 03/03/2014Accepted: 03/03/2014http://dx.doi.org/10.4161/hv.28456",Non-OADS,/arxiv_data1/oa_pdf/f9/b7/hvi-10-533.PMC4130278.pdf
"*Correspondence to: Ronald Ellis; Email: rellis@landesbioscience.com Submitted: 12/12/2013; Accepted: 12/12/2013http://dx.doi.org/10.4161/hv.28050Letter from the Editor ronald Ellis1,* and Eva M r iedmann2 1senior Vice President r &d and Chief t echnology o fficer; n asVax, Ltd.; n ess Ziona, i srael; 2Acquisitions Editor; Landes Bioscience; Vienna, AustriaEditor's CornEr",Non-OADS,/arxiv_data1/oa_pdf/3e/61/hvi-10-527.PMC4130281.pdf
"These variations in dosing appear to be driven by cost-reduction goals and supported by a retrospective literature review comprising preterm infants over a range of  *Correspondence to: Doris Makari; Email: MakariD@MedImmune.com Submitted: 08/26/2013; Revised: 11/26/2013; Accepted: 12/04/2013http://dx.doi.org/10.4161/hv.27426Rationale for full-season dosing for passive  antibody prophylaxis of respiratory syncytial virus Doris Makari1,*, Paul a c hecchia2, and John DeVincenzo3,4 1MedImmune; Gaithersburg, MD U sa; 2Texas children’s hospital; Baylor c ollege of Medicine; h ouston, TX U sa; 3Departments of Pediatrics; Microbiology, Immunology and  Molecular Biology; University of Tennessee s chool of Medicine; Memphis, TN U sa; 4children’s Foundation Research Institute; Le Bonheur c hildren’s h ospital; Memphis, TN U sa Keywords:  palivizumab, preterm infants, monthly dosing, guidelines, respiratory syncytial virus Abbreviations: AAP, American Academy of Pediatrics; BPD, bronchopulmonary dysplasia; CHD, congenital heart disease; CLD,  chronic lung disease; RSV, respiratory syncytial virus; RSVH, respiratory syncytial virus hospitalization; wGA, weeks gestational age Palivizumab monthly injections throughout the R sV season prevent severe respiratory syncytial virus (R sV) disease in  preterm infants ≤ 35 wG a. however, some R sV guidelines currently recommend stopping palivizumab after 3 months of  age in the midst of the R sV season.",Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Available from:  http://www.childhealthbc.ca/guidelines/ category/17-rsv-immuno-prophylaxis-guidelines 3.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
J Gen Virol 2003; 84:2153- 62; PMID:12867647 ; http://dx.doi.org/10.1099/ vir.0.19079-0 4.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatrics  2003 ; 112:1442 - 6; PMID:14654627 ; http://dx.doi.org/10.1542/ peds.112.6.1442 5.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatrics  2009 ; 124:1694 -701; PMID:19736258 ;  http://dx.doi.org/10.1542/peds.2009-23456.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatrics   2003 ; 112:193-8; PMID:12837889 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
J Infect Dis 1997 ; 176:1215 -24;  PMID:9359721 ; http://dx.doi.org/10.1086/514115 12.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Am J Physiol Lung Cell Mol Physiol 2011 ; 301:L148 - 56; PMID :21571908 ; http://dx.doi.org/10.1152/ ajplung.00065.201113.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
J Infect Dis  2007 ; 195:1084 -6; PMID:17357042 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
J Infect Dis 2007 ; 195 :1126 -36;  PMID:17357048 ; http://dx.doi.org/10.1086/512615 15.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatr Infect  Dis J 1998 ; 17:110-5; PMID:9493805 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatr Infect Dis J 1998 ;  17:787-91; PMID:9779762 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatrics  1998 ; 102:531-7; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
J Pediatr  2003 ; 143:532-40; PMID:14571236 ;  http://dx.doi.org/10.1067/S0022-3476(03)00454-2 19.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pulm Pharmacol Ther 2013 ; 26:666-71;  PMID:23523663 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Antimicrob Agents Chemother  2012 ; 56:4927 - 36; PMID:22802243 ; http://dx.doi.org/10.1128/ AAC.06446-11 22.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
J Perinatol   2008 ; 28:511-7; PMID:18368063 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
PMID:23870086; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Adv Ther  2011 ; 28:195-201; PMID:21327753 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatrics  2013 ; 132:e341 - 8; PMID:23878043 ; http://dx.doi.org/10.1542/ peds.2013-030328.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatrics  2004 ;  114:e437 -44; PMID:15466069 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pharmacoeconomics  2004 ;  22:275-84; PMID :15061677 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Eur  J Pediatr  2007 ; 166:1267 -72; PMID:17308898 ;  http://dx.doi.org/10.1007/s00431-007-0418-y 32.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatr Infect Dis  J 2012 ; 31:5-9; PMID:21817948 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
J Perinat Med  2012 ; 40:685-91; PMID:23093079 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatr Infect Dis J  2001 ; 20:874-9; PMID:11734767 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatr Infect Dis J 2004 ; 23:815-20;  PMID :15361718 ; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatr Infect Dis  J 2008 ; 27:788-93; PMID:18664927 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatr Infect Dis J 2004 ; 23:806- 14; PMID:15361717 ; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatr Infect Dis J 2004 ; 23(Suppl ):S193 -201;  PMID:15577573 ; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Lancet  1968 ; 1:1167- 70; PMID:4172289 ; http://dx.doi.org/10.1016/ S0140-6736(68)91865-5 42.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatr  Res 2012 ; 71:590-7; PMID:22398700 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Am J Respir Crit Care Med  2007 ; 176:1269 -73; PMID:17885265 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
Pediatrics  2010 ;  126:115-28; PMID:20530073 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/d2/hvi-10-607.PMC4130285.pdf
"This is an Open Access article distributed under the termsof the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/61/ciu383.PMC4130310.pdf
"Although the main mu-nicipal supply water pumps showed no evidence of fecal con- tamination, the water taps all had thermotolerant coliform counts above those recommended by the World Health Organi-zation (0 per 100 mL; available at: http://www.who.int/water_ sanitation_health/dwq/2edvol3a.pdf , Accesssed 8 June 2014), suggesting that drinking water becomes contaminated through poorly maintained water distribution systems.",Non-OADS,/arxiv_data1/oa_pdf/00/61/ciu383.PMC4130310.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/bc/tcrm-10-621.PMC4130327.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2014:10 621–629Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  621Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6506 6Clinical utility of the neutrophil elastase   inhibitor sivelestat for the treatment   of acute respiratory distress syndrome Naoki Aikawa1 Yasushi Kawasaki2 1School of Medicine, Keio   University, T okyo,  2Ono  Pharmaceutical Co, Ltd, Osaka,    Japan Correspondence: Yasushi Kawasaki   Ono Pharmaceutical Co, Ltd,   1-8-2, Kyutaromachi, Chuo-ku,   Osaka  541-8564, Japan   Tel +81 6 6263 3902  Fax +81 6 6263 2970  email y.kawasaki@ono.co.j pAbstract:  Acute respiratory distress syndrome is a serious condition that can arise following  direct or indirect lung injury.",Non-OADS,/arxiv_data1/oa_pdf/b3/bc/tcrm-10-621.PMC4130327.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/b3/bc/tcrm-10-621.PMC4130327.pdf
Visit  http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/bc/tcrm-10-621.PMC4130327.pdf
Available from http://www.info.pmda.,Non-OADS,/arxiv_data1/oa_pdf/b3/bc/tcrm-10-621.PMC4130327.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/58/tcrm-10-631.PMC4130328.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 631–639Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  631ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6182 1Impact of pharmacist interventions   on drug-related problems and laboratory   markers in outpatients with human   immunodeficiency virus infection Caroline de Godoi Rezende  Costa Molino Renata Cavalcanti  Carnevale Aline T eotonio Rodrigues Marília Berlofa Visacri Patricia Moriel Priscila Gava Mazzola Department of Clinical Pathology,   Faculty of Medical Sciences (FCM),   University of Campinas (UNICAMP),   São Paulo, Brazil Correspondence: Priscila Gava Mazzola   Department of Clinical Pathology,   Faculty of Medical Sciences,   University of Campinas   (FCM – Unicamp), Rua Tessália   Vieira de Camargo, 126, Campinas,   São Paulo 13083-970, Brazil   Tel +55 19 3521 8884   Fax +55 19 3521 9434   Email pmazzola@fcm.unicamp.b rBackground:  Substantial complexity has been introduced into treatment regimens for patients  with human immunodeficiency virus (HIV) infection.",Non-OADS,/arxiv_data1/oa_pdf/c9/58/tcrm-10-631.PMC4130328.pdf
"Available from: http://www.aids.gov.br/sites/default/files/anexos/ publicacao/2012/52140/consenso_adulto2012_principais_mudan - cas_pdf_11946.pd f. Accessed July 24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c9/58/tcrm-10-631.PMC4130328.pdf
Avaliable  from: http://aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL .pdf.,Non-OADS,/arxiv_data1/oa_pdf/c9/58/tcrm-10-631.PMC4130328.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/c9/58/tcrm-10-631.PMC4130328.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/58/tcrm-10-631.PMC4130328.pdf
The work cannot be changed in any way or used commercially.http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/9d/96/nen-72-1106.PMC4130339.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-CommercialLicense(http://creativecommons.org/licenses/by-nc/),whichpermitsunrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/ac/dat005.PMC4130373.pdf
http://www.cdc.gov/tobacco/global/gats/countries/ wpr/fact_sheets/vietnam/2010/pdfs/vietnam_2010.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d7/ac/dat005.PMC4130373.pdf
http://www.cdc.gov/tobacco/global/gyts/factsheets/ wpr/2007/vietnamhaiphong_factsheet.htlm .,Non-OADS,/arxiv_data1/oa_pdf/d7/ac/dat005.PMC4130373.pdf
http://www.health-policy-sy stems.com/content/4/1/6 .,Non-OADS,/arxiv_data1/oa_pdf/d7/ac/dat005.PMC4130373.pdf
